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Abstract 
 
The tammar wallaby (Macropus eugenii) is born altricial after a short gestation of around 27 
days, and climbs unaided into the mother’s pouch where it resides permanently for the first 
200 days of life. This extreme lactation strategy provides unique opportunities for the study 
of neonatal development, maternal protective strategies and the identification and function 
of immune compounds. While secretions from the mammary gland sustain the infant 
nutritionally, the pouch provides physical protection, temperature homeostasis and a humid 
environment to maintain skin moisture. This warm and damp cavity, however, also provides 
a favourable environment for the growth of bacteria; a seemingly dangerous reality for an 
infant born without functional lymphoid tissue and incapable of mounting an adaptive 
immune response. While a variety of immunoglobulins, innate defense molecules and cells 
are delivered via the milk, mounting evidence suggests a primary role for the secretion of 
antimicrobial compounds into the pouch for the protection of the neonate.  Research to 
date has confirmed antibacterial activity in samples collected from the pouches of the 
wallaby and koala, although the detection of proteins such as α-lactalbumin, β-lactoglobulin 
and β-casein demonstrates the presence of mammary gland secretions and possibly faecal 
matter in the samples. This thesis presents molecular evidence for antimicrobial secretions 
of the pouch epithelium for the first time, circumventing the implications of the former 
published proteomics approach. A novel marsupial protein named S100A19 is the focus of 
this study, and is demonstrated to have selective activity against pathogenic bacteria, 
expressed during the initial stages of lactation (days 1 to 40 post-partum) when the neonate 
is most at risk of disease.  
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The S100A19 protein belongs to a group of small EF-hand calcium binding proteins 
called the S100 family, which are involved in many intra- and extra-cellular processes. A 
phylogenetic and bioinformatics approach is used to investigate evolution of the S100A19 
gene and its relationship to the broader S100 family, and provides clues regarding the 
functional role of the subsequent protein in the wallaby. 
The tammar wallaby demonstrates the incredible capacity to carry out asynchronous 
concurrent lactation, in which the nursing female simultaneously feeds two young of 
different ages by producing phase specific milk of contrasting composition from two 
adjacent mammary glands. Awareness of this unusual capability has created interest in the 
wallaby as an animal model for the study of regulatory factors in mammary gland. 
Hormones, extracellular matrix and milk compounds have all been a focus in recent research 
regarding the wallaby. This study investigates the regulatory role of S100A19 in wallaby 
mammary gland development, and demonstrates the proliferative effect of the protein on 
wallaby mammary epithelial cells extracted from a pregnant animal. The S100A19 gene was 
also found to be temporally regulated throughout the lactation cycle, with expression 
peaking during pregnancy and involution. It is proposed that S100A19 protein aids 
mammary epithelial cell proliferation during the extension of ducts throughout the stroma 
and the formation of alveoli during gestation, while also increasing resistance of the 
mammary gland to infection during this period of change. In contrast, extensive apoptosis of 
mammary epithelial cells occurs during involution. This widespread cell death is regulated 
by the extracellular matrix, and the dominant influence of the microenvironment is 
suspected to override the proliferative effects of S100A19 protein during involution. Hence, 
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upregulation of the S100A19 gene at involution is most likely for the purpose of 
antibacterial protection. 
Regulation of the S100A19 gene is then explored at a pre- and post-transcriptional 
level. The effects of the lactogenic hormones and extracellular matrix are examined, and the 
transcription factor C/EBPβ identified as a possible participant controlling S100A19 gene 
expression at a nuclear level. MircoRNA sequencing was performed on mammary gland 
samples from each phase of lactation, providing insight into phase-specific regulation of 
genes by miRNA at a post-transcriptional level.   
Collectively this study has shown the S100A19 gene is differentially regulated in both 
the pouch and mammary gland of the tammar wallaby, and that the subsequent protein 
exhibits antibacterial and mitogenic abilities. It is hypothesised that the S100A19 protein is 
secreted into the wallaby pouch during early lactation as a principal defense molecule for 
protection of the pouch young. Additionally, the protein is likely to increase resistance of 
the mammary gland to bacterial invasion during periods of vulnerability, and function as a 
stimulant of cell proliferation during gestation as the mammary gland prepares for lactation.  
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Preface 
At the time of printing, a portion of data presented in Chapter 2 has been published in the 
journal Molecular Phylogenetics and Evolution.  
For clarity, the genomic sequence of S100A19 (devoid of the 5’ non-coding exon) was 
previously identified by Joly Kwek in 2009 and printed in her PhD thesis. Chapter 2 of this 
thesis describes the first identification of the complete genomic organisation and sequence 
which includes an additional 5’ exon. Kwek (2009) also reported temporal expression of the 
S100A19 gene in the wallaby mammary gland using a limited number of animals, and the 
research presented in this thesis examined the expression pattern in detail using a larger 
sample size to validate results. The S100 family exon analysis (figure 2.3 of this thesis), 
S100A19 and related gene structure analysis (figure 2.4 of this thesis) and S100A19 gene 
expression analysis in the wallaby mammary gland (figure 3.5 of this thesis) were combined 
with the earlier work with Kwek to compile the Molecular Phylogenetics and Evolution 
manuscript.  
I performed all data analyses, laboratory and molecular work described in this thesis unless 
otherwise indicated. 
All experimentation carried out for this research project was approved by Deakin University 
Animal Ethics Committee and conformed to the National Health and Medical Research 
Council code of practice (NHMRC Australia, Australian code for the care and use of animals 
for scientific purposes 8th Edition 2013). 
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Chapter 1 
General Introduction 
 
1.1 Introduction  
Functional development of the mammary gland occurs relatively late in comparison to other 
tissues, and cyclical periods of growth, differentiation and regression continue throughout 
the reproductive life of the female. This provides an exceptional opportunity for the study of 
physiological and anatomical change, cell differentiation and growth and the signalling 
mechanisms involved in these processes. Furthermore, marsupials provide a unique model 
for the study of lactation due to their distinctive reproductive strategy involving birth of an 
altricial neonate, nutritionally sustained by highly specialised milk for much of its 
development. For this reason, the marsupial, specifically the tammar wallaby (Macropus 
eugenii), is the animal model used for the research carried out in this thesis.  
1.2 Lactation diversity 
Mammals evolved from therapsids, a line of ‘mammal-like reptiles’ during the Triassic 
period over 225 million years ago, at approximately the same time the first dinosaurs 
appeared (Hickman et al., 1997, Lillegraven et al., 1979). Selective pressures and the process 
of evolution have since given rise to over 4200 mammalian species. The class mammalia 
consists of three sub-classes; Protetheria, Methatheria and Eutheria (Hickman et al., 1997). 
Milk composition and lactation strategies vary between orders and species, and are specific 
to the energy and growth requirements of the infant, as well as the maternal metabolic rate 
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which varies according to factors such as activity levels, feeding frequency and 
environmental conditions such as temperature (Peaker, 2002). 
1.2.1 Sub-class Protetheria 
The sub-class Protetheria consists of a single order, Monotremata, which are unique in that 
the highly altricial suckled young are born from eggs. The living monotremes are ordered 
into three genera confined to Australia and New Guinea; Ornithorynchus (platypus), and the 
two echidna genera, Tachyglossys and Zoglossus  (Behringer et al., 2006). Unlike the 
marsupials and eutherians who suckle young via teats, the monotremes secrete milk via 
approximately 200 small glands on their skin beside the ventral midline, and the milk then 
travels down hair fibres to be suckled by the young (Tyndale-Biscoe and Janssens, 1988).  
1.2.2 Sub-class Methatheria 
Like Protetheria, Methatheria also contains only one order, Marsupialia. The marsupial 
reproductive strategy differs greatly to eutheria, with a comparatively short gestation and 
long lactation (Nicholas et al., 1997). The highly altricial young are wholly dependent on 
attachment to the maternal teat for a period of time, in a relationship similar to that of the 
eutherian umbilical cord (Tyndale-Biscoe and Janssens, 1988, Nicholas et al., 1997). The milk 
composition changes both qualitatively and quantitatively to support the growth and 
development of the young from a foetus-like state, through to a well-developed juvenile 
nearing independence (Janssens et al., 1997, Tyndale-Biscoe and Janssens, 1988). One 
species belonging to the order Marsupialia, Macropus eugenii, commonly known as the 
tammar wallaby, will be used as a model here and the focus of this thesis.  
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 1.2.4 Sub-class Eutheria 
The eutherians comprise the remaining 95% of mammals including common experimental 
animals such as the rodents, common livestock including cows, pigs, horses, sea mammals 
such as dolphins and seals, domestic animals such as dogs and cats, as well as the primates. 
The majority of current knowledge of the mammary gland is derived from the eutherians, 
primarily due to economic and medical significance. The eutherians typically secrete milk of 
a constant composition in terms of lipids, protein and carbohydrate, with the exception of 
colostrum or ‘first milk’ suckled in the hours and days following birth. In some species such 
as ruminants, horses and pigs, the intake of colostrum is crucial for a viable young as it 
provides the newborn with the majority of its immunity in the form of immunoglobulins and 
immune cells, as well as major innate immune molecules such as lactoferrin and lysozyme 
(Przybylska et al., 2007).  
1.3. The Reproduction cycle of the tammar wallaby  
Mammals have the extraordinary ability to provide complete nutrition to the young via 
secretions from the mammary gland. These secretions are a precise mixture of protein, 
carbohydrate and fats, supplemented with a diverse range of bioactive molecules with the 
ability to support growth, development and immunity. Marsupials have evolved with a 
contrasting strategy to eutherians, which have a comparatively long gestation and short 
lactation (Tyndale-Biscoe and Renfree, 1987). The tammar wallaby gives birth to a small 
relatively undeveloped young which relies solely on the milk of its mother  for 
approximately the first 200 days of its life (Nicholas et al., 1995b). The wallaby lactation 
cycle is divided into 4 phases characterised by secretion of specific components (Figure 1.1) 
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(Nicholas et al., 1995b, Nicholas et al., 1997, Sharp et al., 2009). Phase 1 refers to the 26 to 
27 days of gestation. Phase 2A is the initial 100 days of lactation, during which time a milk 
rich in complex carbohydrates yet low in protein and lipids is secreted, and the young is 
permanently attached to the teat (Green et al., 1980, Green et al., 1983). Phase 2B spans 
from days 100 to 200; macronutrient composition is similar to phase 2A, but the young 
begins to detach from the mothers teat and suck intermittently (Messer and Green, 1979, 
Green et al., 1980, Green et al., 1983). The young begins to exit the pouch and commence 
herbage consumption at the onset of phase 3, at around 200 days post-parturition. At this 
time, carbohydrate concentration decreases sharply and monosaccharaides are secreted as 
opposed to complex oligosaccharides, in synchrony with a sharp increase in protein and lipid 
concentration as well as a large increase in milk production (Messer and Green, 1979, 
Nicholas, 1988a). Milk protein composition also changes according to phase, with Early 
Lactation Protein (ELP) secreted primarily in phase 2A, Whey Acidic Protein (WAP) primarily 
secreted in phase 2B, while the Late Lactation Proteins LLP-A and LLP-B are exclusively 
secreted in phase 3. A number of other genes coding for secretory protein genes are also 
differentially expressed throughout lactation, supporting the pouch young at each specific 
developmental stage (Sharp et al., 2009).  Weaning occurs when the young is between 300 
and 350 days of age, by which time it becomes independent of the mother (Nicholas et al., 
1997, Trott et al., 2003). The progressive changes in milk production and composition 
throughout marsupial lactation have been well documented and validated as a crucial 
element for successful pouch young development (Trott et al., 2003, Waite et al., 2005, 
Menzies et al., 2007, Kwek et al., 2009). The importance of phase specific milk was made 
apparent through fostering experiments performed by Trott et al. (2003), Waite et al. (2005) 
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Figure 1.1: Progressive changes to milk composition throughout wallaby lactation.  
During the initial 200 days of lactation, tammar wallabies produce a milk low in total solids, 
particularly protein and fats, but high in carbohydrate consisting primarily of 
oligosaccharides. Around mid-lactation, milk composition changes dramatically with a 
marked increase in the concentration of fat and protein, coinciding with a rapid decrease in 
total carbohydrate. The oligosaccharides are replaced by monosaccharides which are 
secreted at a relatively low concentration. Reproduced from Nicholas et al. (1997).  
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and Kwek et al. (2009) whereby young of various ages were fostered on lactating animals at 
a more advanced stage of lactation. The studies demonstrated that organ development and 
maturation and growth rate of the pouch young are influenced by the phase specific milk 
constituents. 
1.4 Mammary gland development and regulation 
Throughout the life of a mammal, the fate of mammary epithelial cells (MECs) is 
characterised by cycles of growth, differentiation and apoptosis (Groner, 2002), processes 
which are under the control of steroid and peptide hormones (Topper and Freeman, 1980, 
Akers, 1985, Travers et al., 1996), extracellular matrix (Wanyonyi et al., 2013a, Wicha et al., 
1982, Bissell et al., 1982), and compounds in the milk (Li et al., 1997, Sharp et al., 2007, 
Brennan et al., 2007).  
1.4.1 Mammary gland development 
In eutherians, development of the mammary gland begins during embryonic and foetal 
development when the anlage forms (with the exception of marsupials), and periods of 
isometric growth then follow during neonatal and pre-pubertal stages of growth. During the 
pre-pubertal period, ducts elongate and begin to branch, and branching continues through 
to sexual maturity when alveolar buds form (Brisken and Rajaram, 2006), processes which 
are dependent on hormones and transforming growth factors (TGFs) (Groner, 2002). This 
prepares the mammary gland for pregnancy, during which mammary epithelial cells (MECs) 
undergo structural and functional differentiation into alveolar cells, capable of the synthesis 
and secretion of milk (Jahchan et al., 2012). The mammary gland continues to secrete milk 
until the end of the lactation period when the majority of alveolar cells undergo 
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Figure 1.2:  Schematic representation of mammary gland development.  
Mammary gland development begins during foetal development, and grows at the same 
rate as the animal until the onset of puberty. The cyclical generation of oestrogen and 
progesterone during puberty accelerates ductal outgrowth, when the terminal end buds 
(TEB) become visible.  At maturity, the complete fat pad is interspersed with a system of 
ducts, and side branches appear and disappear with each oestrous cycle (Hennighausen and 
Robinson, 2005). During pregnancy, alveolar buds begin to form. The buds increase in size 
and differentiate into milk secreting alveoli in preparation for parturition. The luminal cells 
of the alveoli produce and secrete milk into the lumen. At the onset of involution at 
weaning, the mammary epithelial cells enter apoptosis and the gland is remodeled back to 
a virgin-like state. 
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programmed cell death and the mammary gland remodels to a pre-pregnancy-like state in a 
process called involution (Jahchan et al., 2012).   
A few exceptions occur in marsupial mammary gland development. In all marsupials, 
the teat anlage forms a few days post-partum, and unlike eutherian mammals the teat does 
not differentiate from a mammary cell line, but each teat develops as a separate anlage 
(Bresslau, 1920). The anlage is a result of local proliferation and epidermal thickening, and 
the downward growth of epidermal cells into the subdermal tissue forms mammary hair 
follicles and the mammary gland (Bresslau, 1920). The external surface of each teat anlage 
become sebaceous and the central region develops into the mammary gland primordia 
(Bresslau, 1920). The teat remains an inverted solid structure which hollows and becomes 
tubular, and the formation of ducts and acini follows (Tyndale-Biscoe and Renfree, 1987). 
The formation of mammary hairs during mammary gland development is unique to 
marsupial and monotremes, and the loss of these hairs, along with the eversion of teats, 
indicates sexual maturation has commenced (Bresslau, 1920). In marsupials, the majority of 
mammary  epithelial cell proliferation occurs while embryos are unattached vesicles 
(O'Donoghue, 1911).  Alveolar development occurs around day 10-15 of pregnancy, when 
alveolar lumens become lined by a single layer of cuboidal cells (Griffiths et al., 1972). After 
birth, only glands which are suckled will become enlarged and continue to lactate, whereas 
the other mammary glands promptly regress to the anoestrous state (Stewart, 1984). The 
generalised stages of mammary gland development are shown in Figure 1.2.  
1.4.2 Hormonal control of mammary gland development 
While hormonal regulation of growth, development and function of the mammary gland has 
been well characterised in a number of eutherian species (Peaker et al., 1998, Freeman et 
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al., 2000, Nandi et al., 1995, Akers, 1985, Topper and Freeman, 1980), much less is known 
about regulation of the marsupial mammary gland (Brennan et al., 2007, Bathgate et al., 
1995). Hormonal control of growth and development in the mammary gland is known to 
involve complex interplay between the reproductive hormones and metabolic hormones 
(Kumar et al., 2000). Below is a generalised overview of hormonal control of the mammary 
gland, with particular focus on what is known about regulation in marsupials.  
1.4.2.1. The role of reproductive hormones in mammary gland development 
1.4.2.1.1. Prolactin 
Prolactin is important for the morphological changes and development which occur in the 
mammary in preparation for lactation. Prolactin controls the differentiation of mammary 
epithelial cells into a mature state capable of milk secretion, as well as the formation of 
alveolar buds during pregnancy (Groner, 2002, Mizoguchi et al., 1997, Ormandy et al., 
1997). 
Prolactin also has a crucial role in the regulation of milk protein synthesis during lactation 
(Hinds and Tyndale-Biscoe, 1982b, Freeman et al., 2000).  It is secreted by the anterior 
pituitary and is under hypothalamic control, and it in turn maintains ovarian progesterone 
and oestrogen secretion (Tyndale-Biscoe and Renfree, 1987). These hormones are essential 
for processes such as ductal outgrowth in the mammary gland and development of the 
placenta (Freeman et al., 2000, Brisken, 2002). As in many species, prolactin is essential for 
the initiation of milk secretion in the tammar wallaby (Fletcher et al., 1990, Nicholas and 
Tyndale-Biscoe, 1985). The concentration of prolactin in the peripheral circulation is low in 
the tammar wallaby in comparison with other species (Hinds and Tyndale-Biscoe, 1982b), 
and unlike species such as the rat, it does not increase during pregnancy with the exception 
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of a transitory pulse pre-partum (Nicholas and Hartmann, 1981, Hinds and Tyndale-Biscoe, 
1982b, Andrews et al., 2001). While the requirement of prolactin for milk secretion is clear 
(Nicholas and Tyndale-Biscoe, 1985), the manner in which prolactin induces lactation is yet 
to be resolved. As prolactin levels remain unchanged around the time of parturition, it has 
been suggested that the binding affinity of the prolactin receptors in the mammary gland 
increases at this time (Sernia and Tyndale-Biscoe, 1979, Hinds and Tyndale-Biscoe, 1982b), 
leading to the induction of milk secretion. In contrast, Bird et al. (1994) stated that the 
initiation of milk secretion is brought about by an increase in the number of prolactin 
receptors, although this claim is based on a correlation rather than experimental evidence 
of a cause and effect relationship.  Prolactin in circulation increases at around the 150th day 
of lactation, and remains elevated until the cessation of suckling, although the function of 
this increase also remains unknown (Hinds and Tyndale-Biscoe, 1982b). 
1.4.2.1.2. Placental Lactogen  
Placental lactogen is not involved in galactopoesis directly, but it is involved in the 
differentiation of mammary epithelial cells during pregnancy in many species (Forsyth, 
1986, Akers, 1985, Schams, 1972, Hinds and Tyndale-Biscoe, 1982a). There is not yet 
evidence of marsupial placental lactogen; this absence most likely relates to the contrasting 
lactation strategy involving a yolk-type placenta associated short gestation period (Tyndale-
Biscoe and Renfree, 1987, Ward and Renfree, 1984).    
1.4.2.1.3 Progesterone 
Progesterone has an important role in alveolar proliferation (Brisken, 2002). In marsupials, 
progesterone levels are raised during the later stages of pregnancy (Harderm and Fleming, 
1981, Cake et al., 1980, Walker et al., 1983, Tyndale-Biscoe and Renfree, 1987, Hinds and 
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Tyndale-Biscoe, 1982a) and, as in many species, circulating levels fall sharply at parturition 
(Tyndale-Biscoe and Renfree, 1987, Hinds and Tyndale-Biscoe, 1982a, Cake et al., 1980, 
Ward and Renfree, 1984), which is a common trigger for the onset of lactation (Neville et al., 
2002, Nicholas and Hartmann, 1981). However, in marsupials, another regulatory process is 
thought to be responsible for milk synthesis (Tyndale-Biscoe and Renfree, 1987). Increasing 
levels of progesterone does not inhibit hormone-induced milk protein synthesis in 
mammary explant culture (Nicholas and Tyndale-Biscoe, 1985), supporting the hypothesis of 
an alternative process in the tammar wallaby. Prolactin has been proposed to be the 
initiating factor, and has been proven to be the only hormone required for the synthesis of 
the milk proteins α-lactalbumin and β-lactoglobulin in vitro , although cortisol and insulin 
are also required for expression of the casein genes (Nicholas and Tyndale-Biscoe, 1985).  
1.4.2.1.4 Oestrogen 
Oestrogen is a steroid hormone released by the corpus luteum, responsible for the surge in 
luteinising hormone (LH) which triggers ovulation (Clarke, 2002). Oestrogen stimulates 
mammary epithelial cell proliferation and ductal development, alone or in combination with 
progesterone (Schams et al., 1984, Woodward et al., 1993, Haslam, 1988, Topper and 
Freeman, 1980). In mouse mammary explant culture, the synthesis of casein was enhanced 
by the addition of oestrogen in the presence of insulin, cortisol, physiological levels of 
prolactin and triiodothyronine (Bolander and Topper, 1980), suggesting the hormone also 
has a role in epithelial cell differentiation. Oestrogen is secreted during pregnancy and in 
many species the serum concentration is raised during late pregnancy (Mizoguchi et al., 
1997), however in the tammar wallaby a relatively constant concentration of peripheral 
plasma oestradiol is maintained throughout pregnancy (Tyndale-Biscoe and Renfree, 1987).   
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1.4.2.1.5. Oxytocin  
Exogenous oxytocin is required for milk ejection in all eutherian species, monotremes and 
marsupials, acting on myoepithelial cells which contract to release milk from the alveoli 
(Cross, 1977, Griffiths, 1978, Crowley and Armstrong, 1992). While most mammals secrete 
only oxytocin, marsupials secrete mesotocin, a typically reptilian oxytocic peptide, instead of  
or in addition to oxytocin (Bathgate et al., 1995). In the agile wallaby (Macropus agilis), the 
threshold of oxytocin required for milk ejection increases as lactation progresses (Lincoln 
and Renfree, 1981). Increased sensitivity to oxytocin during early galactopoesis allows the 
maternal marsupial to nourish the altricial pouch young, and in some macropod species 
allows the concomitant discontinuous suckling of an older sibling, a process called 
asynchronous concurrent lactation (Tyndale-Biscoe and Renfree, 1987). In the tammar 
wallaby, the number of mesotocin receptors in the mammary gland is high after birth and 
slowly decreases as the young matures (Sebastian et al., 1998). The older sibling which has 
permanently exited the pouch suckles one gland intermittently; the gland with infrequent 
milk ejections is less sensitive to mesotocin due to a decreased number of receptors 
(Sebastian et al., 1998). In the tammar wallaby, mesotocin is also critical for the delivery of a 
live pouch young (Parry et al., 1997).  
1.4.2.2. Metabolic hormones 
1.4.2.2.1 Growth hormone 
Growth hormone plays an important role in stimulating ductal elongation and proliferation 
during development of the mammary gland in eutherians (Allan et al., 2002, Hovey et al., 
2002, Gallego et al., 2001). Studies have shown that human growth hormone exerts a 
lactogenic effect by binding to receptors in the adrenals of rats, cows and pigs, while growth 
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hormone from other species showed no such effect (Teh et al., 1988, Caron et al., 1994). 
Growth hormone is also proposed to act in cooperation with prolactin to maintain lactation 
and regulate milk yield and composition in rats (Madon et al., 1986, Caron et al., 1994). 
There is no proof of a role for marsupial growth hormone in lactation or mammary gland 
development to date.  
1.4.2.2.2. Glucocorticoids 
Glucocorticoids play an important role in nutrient flux and blood glucose homeostasis 
during starvation (Neville, 2006). Therefore species such as ruminants and rodents, which 
undergo deprivation of nutrient stores during lactation to point of partial starvation, 
experience an increase in glucocorticoids during this time (Feng et al., 1995). Some species 
also show an increase in glucocorticoids at parturition, which is a probably the result of 
stress (Neville et al., 2002). There is evidence for a role in mammary differentiation and milk 
protein synthesis in ruminants (Akers, 1985), rodents (Freeman and Topper, 1978, Nicholas 
and Hartmann, 1981) and also marsupials (Nicholas and Tyndale-Biscoe, 1985, Collet et al., 
1992). Glucocorticoids are also thought to be involved in casein transcription and selective 
stabilisation of casein mRNA (Doppler et al., 1990, Chomczynski et al., 1986). The immediate 
result of withdrawal of glucocorticoids from mouse mammary epithelial cell  culture was a 
reduction in the casein transcript half-life by one hour, and after some time casein 
transcription ceased (Chomczynski et al., 1986).  
1.4.2.2.3. Thyroid hormones 
Thyroid hormones are galactopoietic and assist in establishing the mammary glands 
metabolic priority during lactation (Capuco et al., 2008).  Thyroid hormones are thought to 
be necessary for responsiveness of the rodent mammary gland to growth hormone and 
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prolactin during lactation (Capuco et al., 1999), and are required for efficient milk 
production (Blaxter et al., 1949, Vonderhaar, 1979). Thriiodothyronine (T3) and thyroxine 
(T4) are known to compete for plasma membrane binding sites in macropodids, and free T4 
concentrations in the tammar wallaby are similar to those found in eutherians (McDonald 
and Waring, 1979). In tammar wallaby mammary explant culture, T3 together with 
prolactin, cortisol oestradiol and insulin, induced whey acidic protein (WAP) gene expression 
(Simpson et al., 2000), and enhanced β-1,3 galactosyltransferase activity (Menzies and 
Nicholas, 2007) but did not effect α-lactalbumin levels (Nicholas and Tyndale-Biscoe, 1985). 
Therefore, it appears that wallaby thyroid hormones stimulate the production of some milk 
proteins.  
1.4.2.2.4. Insulin 
Insulin levels are low during lactation in most species, which allows the release of nutrients 
from storage to be recruited for milk synthesis (Butte et al., 1999, Neville and Picciano, 
1997). In culture, high concentrations (5μg/mL) were thought to maintain alveolar structure 
and tissue explants (Elias, 1959), however successful maintenance is now known to be 
possible in the absence of insulin (Brennan et al., 2008). Insulin appears to stimulate DNA 
polymerase activity (Lockwood et al., 1967), and is believed to cooperate with ovarian 
steroids to promote mammary ductal development (Ahren and Jacobson, 1956). It can also 
stimulate growth of the mammary epithelium by increasing progression through the cell 
cycle and also decreasing apoptosis (Rosen et al., 1999). Insulin is essential for milk protein 
gene expression in species such as cattle (Menzies et al., 2009, Griinari et al., 1997) and mice 
(Bolander et al., 1981, Kulski et al., 1983, Chomczynski et al., 1984). Previous studies using 
mammary explants from the tammar wallaby have shown that insulin, in combination with 
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prolactin and hydrocortisone plays a critical role in the synthesis of wallaby milk proteins 
(Nicholas and Tyndale-Biscoe, 1985, Nicholas et al., 1991, Trott et al., 2002). Insulin is a 
critical regulator of wallaby α-casein (Nicholas et al., 1997, Nicholas et al., 1995a), and in 
cooperation with prolactin, regulates the synthesis and secretion of fatty acids in wallaby 
mammary epithelial cells (Kwek et al., 2007). 
1.4.2.3. Mammary hormones 
In addition, the mammary gland also has the ability to secrete hormones. These can act in 
either an autocrine or paracrine manner, and include prolactin, insulin, growth hormone, 
thyroid stimulating hormone, parathyroid hormone-related protein, insulin-like growth 
factor I and fibroblast growth factor  (Wilson et al., 1994, Mol et al., 2000, Finch et al., 1995, 
Lippuner et al., 1996, Brennan, 2008). Local control of the mammary gland effectively co-
exists with systemic endocrine and metabolic control, and is involved in various processes 
such as the release of calcium into the milk (Lippuner et al., 1996), proliferation (Clevenger 
and Plank, 1997) and ductal maturation (Mol et al., 2000). It is also thought to be a 
mechanism involved in enabling asynchronous lactation in marsupials (Knight et al., 1998), 
whereby the mother can provide milk of very different compositions simultaneously from 
separate mammary glands for two pouch young of different ages (Nicholas et al., 1995b). 
Another local regulatory factor enabling asynchronous lactation, and also involved in the 
regulation of milk protein synthesis, is the extracellular matrix (ECM) (Wanyonyi et al., 
2013a, Wanyonyi et al., 2013b). 
1.4.3 Mammary gland regulation by ECM 
The ECM is a non-cellular component of all organs and tissues consisting of water, proteins 
and polysaccharides, which provides structural support as well as chemical and mechanical 
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signals to cells (Frantz et al., 2010). The ECM has been implicated in the regulation of 
epithelial cell growth (Wang et al., 2011b, Woodward et al., 2001), differentiation (Streuli, 
2009), control of milk protein gene expression (Bissell et al., 1982, Wicha et al., 1982, 
Wanyonyi et al., 2013a) and apoptosis and glandular reorgansiation (Schedin et al., 2004, 
Schedin et al., 2007). 
The composition of the ECM is tissue specific and progressively changes within the 
mammary gland during lactation in the tammar wallaby, regulating morphological changes 
as the organ moves through the distinct phases of lactation (Wanyonyi et al., 2013a). The 
importance of ECM in the mammary gland was described by Cunha et al. (1995), who 
showed that undifferentiated epidermal cells exhibit the mammary epithelial cell phenotype 
when cultured on mammary mesenchyme. The group later concluded that the proliferation 
of mammary epithelial cells is also driven by stromal interactions (Cunha et al., 1997). More 
recent studies have shown that the ECM from nulliparous rats promoted epithelial duct 
formation while ECM from mid and late involution induced apoptosis and gland restoration 
respectively (Schedin et al., 2004).  Wanyonyi et al. (2013a) expanded on these studies, 
demonstrating that when wallaby mammary epithelial cells were cultured on ECM from the 
mammary gland at various stages of lactation, the ECM regulates phenotypic changes in the 
cells specific to the phase of lactation from which the ECM was extracted.  
1.4.4 The role of milk in mammary gland regulation 
Milk proteins secreted by the mammary gland have also been shown to have regulatory 
activity affecting the lactation cycle. A folding variant of the milk protein alpha-lactalbumin 
has been identified as an apoptosis-inducing molecule in human (Håkansson et al., 1999, 
Håkansson et al., 1995, Baltzer et al., 2004) and bovine (Svensson et al., 2003, Lisková et al., 
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2010) species, and the lack of this protein in the Cape fur seal is thought be responsible for 
its ability to evade involution in the absence of suckling young when the animal is off-shore 
feeding for extended periods (Sharp et al., 2008). Wallaby whey acidic protein (WAP) has 
been shown to induce proliferation of some cell types including wallaby and mouse 
mammary epithelial cells lines, and is thought to be involved in the regulation of mammary 
gland development (Topcic et al., 2009). Splice variants of the wallaby cathelicidin gene, 
MaeuCath1 and MaeuCath7, also stimulated proliferation of wallaby MECs and are thought 
to have an autocrine role in mammary gland development (Wanyonyi et al., 2011).  
 1.4.5 Downstream effectors are required to sense and process stimuli 
Regulatory molecules such as hormones, ECM constituents and milk proteins rely on 
downstream effectors and signaling networks to carry out their effect at a molecular level.  
In many cases, cell surface receptors allow a signal to be transduced across the membrane, 
which in turn activates an intracellular signaling cascade. The cascade may then result in the 
passage of secondary signaling molecules into the nucleus to bind to DNA, regulating gene 
expression (Berg et al., 2002). Some molecules, such as the steroid hormones, are able to 
pass directly through the cell membrane to bind steroid receptors which act as transcription 
factors, modulating gene transcription directly (Beato and Klug, 2000).  Transcription factors 
play a critical role in modulating the physiological response to stimuli through the activation 
of target genes. The importance of transcription factors with regard to regulation of the 
mammary gland is discussed below.  
1.4.6 Transcription factor regulation in the mammary gland  
Stimuli such as lactogenic hormones and matrix interactions regulate milk protein gene 
expression through the activation of transcription factors. The composite response 
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elements (CoREs) within promoter regions of milk protein genes are known to contain 
multiple binding sites for transcription factors (See Figure 1.3) (Rosen et al., 1998). The 
casein promoters have binding sites for signal transducers and activators of transcription 5 
(Stat5), Yin Yang 1 (YY1), CCAAT/enhancer binding protein (C/EBP) and the glucocorticoid 
receptor (GR) (Doppler et al., 1995, Meier and Groner, 1994, Lechner et al., 1997). Binding 
sites for Stat5 and GR, as well as nuclear factor 1 (NF-1) have also been identified in the 
whey protein gene promoters (Rosen et al., 1998, Rosen et al., 1999, Li and Rosen, 1994, Li 
and Rosen, 1995). Binding of these specific factors results in mammary-gland specific 
lactation-dependent milk protein gene expression (Rosen et al., 1999). The transcription 
factors Stat5a and Stat5b are also activated by prolactin during pregnancy, contributing to 
growth and alveolar differentiation of epithelial cells, and have been identified as a central 
elements for mammary gland function (Watson and Burdon, 1996, Perotti et al., 2008), and  
also contribute to mammary epithelial cell survival (Groner, 2002, Inuzuka et al., 1999, 
Rosen et al., 1998). Stat3, Elf-5 and GATA-3 are all also involved in coordinating 
development of the mammary gland, including the differentiation of ductal and alveolar 
cells and specifying luminal cell fate in the adult mammary gland (Siegel and Muller, 2010, 
Naylor and Ormandy, 2007, Pensa et al., 2009, Oakes et al., 2008).  The C/EBP family 
regulate developmental processes in the mammary gland such as epithelial cell proliferation 
and differentiation (Robinson et al., 1998, Dearth et al., 2001, Seagroves et al., 1998), are 
pertinent to this project and are reviewed in detail in chapter 4. The functional significance 
of some of the described transcription factors in the mammary gland has been studied using 
transgenic and gene knockout mice, (reviewed in Rosen et al. 1999). Briefly, Stat5a-deficient 
mice had impaired mammary alveoli and failed to lactate (Liu et al., 1997), C/EBPβ-deficient 
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Figure 1.3: Diagrammatic representations of well-studied transcription factor motifs in milk 
protein gene promoters. 
Illustration shows composite response elements (CoREs) within eutherian milk gene 
promoters conferring unique temporal an spatial patterns of gene expression. Rat β-casein 
promoter (a), bovine β-casein promoter (b), rat WAP promoter (c), and sheep β-
lactoglobulin promoter (d). Image from Rosen et al. (1999). 
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mice experienced reduced ductal outgrowth and branching (Robinson et al., 1998), and 
mutation of NF-1 binding sites dramatically reduced WAP gene expression (Li and Rosen, 
1995). Thus, transcription factors play a fundamental role in regulating the physiological 
response of the cell to stimuli. 
 Subsequent to transcriptional regulation, many additional factors come into play 
affecting the stability, distribution and the ultimate fate of mRNAs and therefore impact on 
gene expression. Enzymatic processing and degradation, the involvement of RNA-
recognition motifs, short interfering RNA (siRNA) silencing and  micro RNA (miRNA) 
interactions all effect final expression levels (Day and Tuite, 1998, Valencia-Sanchez et al., 
2006, Pillai et al., 2007, Clery et al., 2008). For the purpose of this thesis, this review focuses 
primarily on the post-transcriptional regulatory activity of miRNAs. 
1.4.7 MicroRNA regulation of gene expression 
1.4.7.1 Post-transcriptional regulation of gene expression by microRNAs  
MicroRNAs (miRNA) are short non-coding RNA molecules involved in the post-
transcriptional regulation of gene expression (Cannell et al., 2008). MiRNAs are 
approximately 22 nucleotides in length at maturity and are derived from long stem loop 
precursors (pre-miRNAs) of approximately 70 nucleotides in length (Valencia-Sanchez et al., 
2006). MiRNAs are generally expressed in a tissue specific manner and bind to 
complementary sequences on target mRNA, generally resulting in translational  repression 
in mammals (Berezikov, 2011, Bartel, 2009). MiRNAs have been shown to be differentially 
expressed throughout murine mammary gland development and lactation (Avril-Sassen et 
al., 2009), and play an important role in the regulation of mammary development (Avril-
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Sassen et al., 2009, Tanaka et al., 2009, Wang et al., 2012). Two miRNAs, miR-212 and miR-
132 have been proven indispensable in mouse mammary development through reciprocal 
mammary transplantation experiments (Ucar et al., 2010). Mammary ducts from miR-212 
and miR-132 deficient mice were transplanted into wild type mice, and vice versa.  These 
miRNAs were found to be crucial for the outgrowth of the epithelial ducts and essential in 
the stroma, where they act directly on the matrix metalloproteinase MMP-9, but not the 
epithelia (Ucar et al., 2010). The microRNA miR-101 was shown to control development of 
the mammary gland by regulation of cyclooxygenase-2 expression. Overexpression of miR-
101 supressed expression of β-casein, impeded mammary epithelial cell proliferation, and 
was proposed to influence the differentiation state of the mammary gland (Tanaka et al., 
2009).  
Mounting evidence suggests that miRNAs function as important regulators of the 
development of immune cells, and also act to modulate innate and adaptive immune 
responses (Xiao and Rajewsky, 2009). There is increasing interest in the study of miRNA-
loaded exosomes in the milk, which are thought to be transferred to the gut of the young 
having a role in the development of the infant immune system (Gu et al., 2012, Zhou et al., 
2012, Lässer et al., 2011, Izumi et al., 2012).  
1.4.7.2 How miRNAs regulate gene expression 
The activity of miRNA molecules is tightly regulated at a post-transcriptional level, with 
cleavage of pre-miRNA by Dicer restricted to specific tissues (Obernosterer et al., 2006).  
MiRNAs most commonly bind to the 3’ untranslated region of target mRNA with imprecise 
complementarity, where they work to silence gene expression, but the exact mechanism of 
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action is not yet clear (Cannell et al., 2008). Data has shown that most miRNA-mRNA 
interactions result in mRNA destabilisation and deacetylation (Valencia-Sanchez et al., 2006, 
Wu et al., 2006, Bagga et al., 2005, Cannell et al., 2008), however these events do not 
appear to be responsible for translational repression, which can occur prior to 
destabilisation and deacetylation. This suggests that other mechanisms or events are 
responsible for repression of protein translation. Evidence to date supports two separate 
repression mechanisms, one at translational initiation, dependent on functional m7Gppp 
cap structure (Mathonnet et al., 2007, Bhattacharyya et al., 2006, Humphreys et al., 2005, 
Pillai et al., 2005, Wakiyama et al., 2007, Wang et al., 2006), and one at an unresolved point 
following the initiation of translation, but before completion of protein assembly (Nottrott 
et al., 2006, Olsen and Ambros, 1999, Petersen et al., 2006, Seggerson et al., 2002). Chapter 
4 of this thesis contains further detail regarding regulation by miRNA. 
1.4.8 The tammar wallaby is a valuable model for the study of regulatory 
processes of the reproductive cycle 
The unique lactation strategy of the wallaby provides a rare opportunity for the study of 
regulatory processes involved in both lactation and development of the young. Following 
conception at postpartum oestrus, blastocysts of macropodid marsupials enter a state of 
diapause (Renfree and Tyndale-Biscoe, 1973). Development of the blastocyst recommences 
naturally after the summer solstice, but resumption can also be initiated experimentally by 
removal of the pouch young (Renfree, 1981, Renfree and Tyndale-Biscoe, 1973). This allows 
the reliable prediction of the developmental stage of both the maternal mammary gland 
and the young. Manipulation of the wallaby lactation cycle through removal of pouch young 
and extraction of phase-specific milk, mammary tissue and ECM allows examination of gene 
24 
 
regulation, the function of milk and mammary proteins and their subsequent role in 
mammary gland and pouch young development (Tyndale-Biscoe, 2005, Tyndale-Biscoe and 
Renfree, 1987, Old and Deane, 2000, Janssens et al., 1997). In this thesis I have examined 
the pre- and post-transcriptional regulation of a novel gene expressed in the wallaby 
mammary gland and pouch skin, as well as the capacity of the protein to signal proliferation 
of mammary epithelial cells through a putative autocrine mechanism.   
Since birth occurs at an early stage of development in comparison to eutherian 
mammals, the wallaby also provides an excellent model for the study of foetal growth and 
the maternal immune mechanisms which protect the vulnerable infant, which is born 
without lymphoid tissue and unable to mount an adaptive immune response (Baudinette et 
al., 1988, Old and Deane, 2000). 
1.5 The pouch  
While the mammary gland provides the young with nutrition, developmental signals and 
protection from infection, the young wallaby is also dependent on the pouch for shelter, 
moisture and temperature homeostasis (Tyndale-Biscoe, 2005).  
1.5.1 Structural morphology 
The pouch or marsupium is located on the exterior of the female abdomen of some 
marsupial species. It is the site where the majority of pouch young development takes place 
(Tyndale-Biscoe, 2005). The structure of the pouch varies between species, ranging from 
mere folds of skin surrounding the teats in the sminththopsinae subfamily, to a moist, deep 
protective cavity in macropods such as the tammar wallaby (Ambatipudi et al., 2007). 
Regardless of the pouch morphology, this feature serves an important purpose in the 
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protection and care of the young. As the pouch young is born hairless and without proper 
thyroid function, it is completely ectothermic and relies on the constant temperature of the 
pouch (34 to 36°C) for thermoregulation (Tyndale-Biscoe, 2005, Russell, 1982). The humid 
environment of the pouch is also thought to play a role in cutaneous respiration following 
birth and to prevent the neonate’s skin from drying out and becoming dehydrated (Tyndale-
Biscoe, 2005, Vogelnest and Woods, 2008). 
The epithelial tissue of all mammals, in particular the skin, provides a physical and 
chemical barrier to protect against the external environment and a defense against 
pathogenic insult (Huang et al., 2005).  The infant marsupial lacks functional lymphoid tissue 
and thus relies on a number of maternal strategies for protection during much of its 
development (Old and Deane, 2000, Ambatipudi et al., 2007). Marsupial lactation therefore 
offers a unique biological system for the study of specialised strategies, which are likely to 
include secretion of antimicrobial compounds by the maternal pouch skin (Ambatipudi et 
al., 2007, Bobek and Deane, 2002). Known protective strategies to date include the 
secretion of immunoglobulins, innate defense molecules and cells from the mother’s 
mammary gland throughout lactation (Deane and Cooper, 1984, Young et al., 1997, Young 
and Deane, 2001). The wallaby WFDC2 protein has been identified as a secretory molecule 
in milk with the potential to selectively kill pathogenic bacteria in the gut of the infant (Watt 
et al., 2012). Temporally regulated peptides derived from cathelicidin 1 and 7 present in 
wallaby milk have also exhibited antimicrobial activity; cathelicidin 1 is proposed to act 
synergistically with the humoral and cellular immune systems to protect the infant gut from 
pathogens (Wanyonyi et al., 2011). Both WFDC2 and cathelicidin are secreted during phase 
2A when the pouch young is immunocompromised. 
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Figure 1.4: The reproductive strategy of the tammar wallaby 
(a) Altricial young weighing approximately 400 mg and less than 24 hours post-partum in 
the pouch of the tammar wallaby. Image from Edwards et al. (2012). 
(b) The pouch of a post-reproductive female tammar wallaby showing an oily brown 
secretion. 
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 In the immature female, the pouch is shallow, clean and dry. As the animal reaches 
reproductive maturity, the pouch deepens and becomes clean and moist entering the 
breeding season, and remains this way while occupied by pouch young. When the young has 
permanently exited the pouch, the skin becomes dry and is covered with an oily brown 
accumulation (Figure 1.4b) (Tyndale-Biscoe, 2005). These macroscopic changes do not 
appear to be due to underlying histological changes in the epithelium. Histology of the 
possum pouch epithelium has shown similar histology to other parts of the body during 
stimulation of oestrus, showing no significant changes occurring  (Old et al., 2005). However 
the visible changes of the pouch epithelium may be attributed to secretions from the 
eccrine and sebaceous glands, and the mammary gland-associated glands of Montgomery 
(Old et al., 2005).  
1.5.2 Pouch microflora 
The maternal pouch of a marsupial hosts a range of microorganisms. Old and Deane (1998) 
documented a change in the aerobic bacterial flora in the pouch of the tammar wallaby 
throughout the lactation cycle. Twenty-five microbial species were found in tammars with 
empty pouches, compared to 9 species in pouches hosting pouch young. The most common 
Gram positive isolates from tammars of all stages of the reproductive cycle were 
Corynebacterium spp., Micrococcus spp. and Staphylococcus spp. Gram negative species 
Klebsiella pneumoniae, Pseudomonas aeruginosa, Enterobacter aerogenes, and Escherichia 
coli were present in both occupied and empty pouches, except for those either nearing 
oestrus, at parturition or within 6 days of birth. Pouches contained the lowest diversity of 
bacterial species around the time of birth and within 6 days post-partum (Old and Deane, 
1998, Chhour et al., 2010). A full list of the bacterial isolates can be found in Table 1.1. 
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The death of koala pouch young has been attributed in part to the presence of 
pathogenic microorganisms in the pouch (Osawa et al., 1992). A range of bacteria have been 
also detected in the pouch of the quokka, Setonix brachyurus, throughout the reproductive 
cycle, with population changes associated with the presence of pouch young  (Yadav et al., 
1972, Charlick et al., 1981). However, there is no evidence that the presence of 
microorganisms compromises the health of quokka pouch young. In agreement with data on 
the quokka, the presence of bacteria in the tammar wallaby pouch does not appear to 
increase mortality of pouch young (Old and Deane, 1998). However the specific balance of 
species has undisputable significance; an overgrowth of pathogenic bacteria in the pouch 
would prove hazardous for pouch young.  
Collective data suggests that the microflora of the pouch is controlled by maternal 
strategies which reduce or eliminate pathogenic strains that are harmful to the pouch young 
(Ambatipudi et al., 2008, Baudinette et al., 2005, Charlick et al., 1981, Chhour et al., 2010, 
Old and Deane, 2000, Old and Deane, 1998, Osawa et al., 1992, Yadav et al., 1972).  
Grooming undoubtedly plays an important role, through the mechanical cleaning of the 
pouch with the tongue and the transfer of antimicrobial compounds from saliva (Chhour et 
al., 2010, Tyndale-Biscoe, 2005). However, it is highly likely that the pouch epithelium, 
consistent with most epithelial surfaces, secretes bioactives with antimicrobial activity to 
control bacterial populations.  
1.5.3 Pouch secretions  
The idea of secretory antimicrobial compounds in the marsupial pouch was first conceived 
by Yadav et al. 40 years ago (Yadav et al., 1972). The secretion of inducible antimicrobial 
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Table 1.1: Bacterial species isolated from the tammar wallaby pouch. Reproduced from Old 
& Deane, (1998). 
Major bacterial isolates from the pouch of 12 females with and without pouch young 
Organisms isolated Pouches with no PY Pouches with PY 
  <3 wks of age  >3 wks of age 
Gram positive rods 
Corynebacterium sp. ++ ++ ++ 
Corynebacterium CDC group D-2 ++ + - 
Corynebacterium group A-5 + - - 
C. pseudodiptheriticum + - - 
C. vitarumen + - - 
C. bovis  + - - 
Brevibacterium spp.  + - - 
Athrobacter spp.  + - - 
Gram positive cocci 
Staphylococcus epidermidis  ++ - - 
S. sciuri  + + + 
S. xylosus  + + - 
S. lentus  + + - 
S. equorum  + + - 
S. haemolyticus + - - 
S. mucilagenosus  + - - 
Streptococcus lactis + - - 
Streptococcus spp.  - - + 
Micrococcus spp. - - + 
Micrococcus lylae + - - 
Enterococcus hirae  - - + 
Gram negative rods 
Klebsiella pneumonia  ++ + - 
Flavobacterium spp. ++ + - 
Enterobacter aerogenes  + - + 
Pseudomonas aeruginosa  + - - 
Aeromonas hydrophilia - - + 
Escherichia coli + + + 
Escherichia hermani + - - 
Acinetobacter calcoaceticus var. 
lisoffi  + - - 
Pasteurella spp.  - - + 
Ochrobacterium anthropi  + - - 
++ organism detected >50% of animals; + organism detected <50% of animals; - not 
detected. 
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peptides by the epithelium is an important aspect of first-line host defense in various 
species (Schonwetter et al., 1995) and two particular families, the defensins and 
cathalicidins are thought to have a central role in mammals. Alpha defensins are involved in 
protection of the gut, and are secreted by neutrophils and Paneth cells of the intestine. Beta 
defensins are secreted by various epithelia and are inducible by the presence of bacteria or 
its products, as well as the cytokine TNF-α (Gudmundsson and Agerberth, 1999, Bobek and 
Deane, 2002). The cathelicidins are also secreted by neutrophils, as well as keratinocytes 
(Frohm et al., 1997), and have been found in squamous cells of the mouth, tongue, 
oesophagus, cervix and vagina (Frohm et al., 1999). Cathelicidins are a family of mammalian 
proteins possessing cationic C-terminal domains with antimicrobial activity, which become 
activated after being cleaved from the N-terminal cathelin region. The mature C-terminal 
peptides commonly show wide spectrum antimicrobial activity (Zanetti, 2004). 
In 2007, Ambatipudi et al. demonstrated that the composition of pouch secretions changes 
throughout the reproductive cycle of the tammar wallaby. Proteins secretions were 
collected from pouch washes of 18 female tammar wallabies and identified by two-
dimensional gel electrophoresis and mass spectrometry. The group reported the presence 
of a number of proteins in the pouch, and also tentatively named others which were at a 
concentration too low to allow confirmation (Table 1.2).  Enolase and actin were also 
identified in secretions from the tammar underarm. The group also screened the wombat 
pouch secretions, and identified β-globin, hornerin, dermcidin and possibly prelamin, 
profilin, neuron navigator protein, phospholipase A2, protease inhibitor, poly Ig receptor, 
and GEF factor (Ambatipudi et al., 2007). It could be argued that due to the presence of milk 
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Table 1.2: Proteins isolated from the pouch of the tammar wallaby. Summarised from 
Ambatipudi et al. (2007).  
  Confident Identifications Tentative Identifications 
Reproductively active females 
α-globins Cystatin 
β-globins   
α-lactalbumin,   
β-lactoglobulin   
β-casein   
Fatty acid binding 
protein   
Α-S1-casein   
Transthyretin   
Cysteine proteinase 
inhibitor   
Myomegalin   
Thymopoeitin   
Clusterin   
Post-reproductive females 
α-globins Nesprin 
β-globins   
Lysozyme   
α-intergrin   
Dermcidin   
Gamma non-muscle 
actin   
Actin   
Immature reproductively 
inactive females 
  Histone 
  Hexokinase 
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proteins such as α-lactalbumin, β-lactoglobulin and β-casein, the identified proteins may not 
originate from the epithelium, but from the milk itself.  
Later in 2008, Ambatipudi et al. documented antibacterial activity from pouch 
washes collected from the wallaby, as did Bobek and Deane (2002) from pouches washes 
from koalas. The effects were most significant against E. coli in washes from the time of 
birth. The activity of the pouch washes appeared selective and did not affect S. aureus 
growth. Baundinette et al. (2005) performed similar analysis on wallaby pouch secretions, 
but were unable to demonstrate antimicrobial activity, possibly due to a shortage of 
material from the method of swabbing to obtain samples. They did, however, isolate a 
peptide they named ‘eugenin’, an immunomodulator suspected to interact with the 
cholecystokinin receptor to aid neutrophil proliferation and thus offer a form of immune 
protection (Baudinette et al., 2005).  
In this thesis, a transcriptome approach is used to examine pouch secretions. The 
extraction and examination of RNA from the pouch epidermis provides comprehensive 
information about gene expression patterns and insight into likely quantities of secretory 
protein. Furthermore, through assaying the effects of recombinant protein from wallaby 
genes encoding antimicrobials, the possibility of assaying milk derivatives or other material 
for antimicrobial activity is eliminated.  
1.6 The S100 superfamily 
This thesis characterises a novel marsupial protein belonging to the S100 family. The S100 
family is a non-ubiquitously expressed group of proteins, most of which are located on 
human chromosome 1 within the epidermal differentiation complex, with the exception of 
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S100B, S100G, S100P and S100Z (Donato, 2001, Sedaghat and Notopoulos, 2008, Schäfer et 
al., 1995). The S100 proteins, exclusively found in vertebrates, are small acidic proteins 10-
12 kDa in size (Donato, 2003). In 1965, the first S100 proteins (S100B and S100A1) were 
discovered in a subcellular fraction from the bovine brain. They were named “S100” 
proteins due the solubility of their constituents in 100% saturated ammonium sulphate at 
neutral pH (Moore, 1965), although later it was discovered that not all S100 proteins 
dissolve in this solution (Brodersen et al., 1998). Many of the S100 genes have multiple 
names, resulting in considerable confusion. According to established nomenclature (Schӓfer 
et al., 1995), genes on human chromosome 1q21 with the S100 cluster should be designated 
consecutive Arabic numbers placed after the “S100A” stem. Other S100 genes located on 
another chromosome or in other regions must carry the S100 stem followed by a single 
letter. Non-functional pseudo-genes belonging to the family should be named after the 
functional homologue but carry the suffix “P”, and genes that are highly similar to a named 
gene but with unknown functional relevance should carry the suffix “L” meaning 
“like”(Marenholz et al., 2004). Although these guidelines were defined in 1995, they have 
not been followed in recent years, resulting in further confusion. The genes symbols 
approved by HUGO Gene Nomenclature Committee (HGNC) are listed in Table 1.3.  
1.6.1. S100 protein structure  
S100 proteins are constituents of the calcium binding EF-hand motif superfamily (Zimmer et 
al., 2003, Salama et al., 2008). They typically retain approximately 50% sequence homology 
between genes (Schӓfer and Heizmann, 1996), including important features such as a 
number of hydrophobic residues and calcium binding motifs (Brodersen et al., 1998). 
Typically, S100 genes consist of 3 exons, with the first containing a 5’ untranslated 
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Table 1.3 S100 protein nomenclatures 
Gene symbol (gene name) Previous names and obsolete names 
S100A1 S100A 
S100A2 S100L, CaN19 
S100A3 S100E 
S100A4  Metastasin, calvasculin, MTS1, CAPL, p9KA, pEL98, 
18A2,  42A 
S100A5 S100D 
S100A6  Calcyclin, CACY, 2A9, CABP, 5B10, PRA 
S100A7  Psoriasin, PSOR1 
S100A7L2 (S100A7-like 2) S100A7b 
S100A7P1 (S100A7 pseudogene 1) S100A7L3, S100A7-like 3, S100A7d 
S100A7P2 (S100A7 pseudogene 2) S100A7L4, S100A7-like 4, S100A7e 
S100A7a S100A7L1, S100A7f, S100A15 
S100A8  Calgranulin A , CAGA, MRP8, P8, CGLA, MIF, NIF, L1Ag, 
MAC387, 60B8AG, CFAG 
S100A9  Calgranulin B, CAGB, MRP14, P14, CGLB, MIF, NIF, 
L1Ag,  MAC387, 60BAG,  CFAG 
S100A10  Annexin II ligand (ANX2LG), calpactin I, light 
polypeptide, CALIL,CLPII, ANX2L,  p11, p10, 42C, GP11 
S100A11  Calgazzarin, S100C,  LN70 
S100A11P (S100A11 pseudogene) S100A14 
S100A12  Calgranulin C, CAAF1, CGRP, MRP6, p6, ENRAGE 
S100A13  
S100A14 BCMP84, S100A15 
S100A16  S100F,  DTIPIA7, MGC17528 
S100B S100β, S100 
S100P  
S100G CALB3 (calbindin 3) Calbindin D, CaBP9k, CABP1 
S100Z Gm625, S100-zeta 
TCHHL1 (Anti -Trichohyalin-like 
Protein 1) 
S100A17, Anti -Trichohyalin-like Protein 1, THHL1, 
Basalin 
HRNR (hornerin) FLG3, S100A16, S100A18 
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sequence, the second has a 5’ UTR followed by the start codon and encodes a N-terminal EF 
hand, and the third encoding a C-terminal EF hand (Heizmann et al., 2002, Pietas et al., 
2002).  The EF-hand motif is a calcium binding motif comprised of two helixes, E and F, 
which are connected by a loop, which itself binds the calcium ion. There are two distinct EF-
hands within S100 proteins; one canonical EF hand located to the C- terminus which is 
common to all EF- hand proteins, and variant EF hand on the N-terminus which is specific to 
the S100 family (Zimmer et al., 2003, Salama et al., 2008, Brodersen et al., 1998). The term 
canonical EF hand refers to the high affinity binding of calcium defined by Tufty and 
Kretsinger (1975) whereby the calcium ion is bound by side chain oxygen atoms of primarily 
acidic residues. Variant binding, on the other hand, involves binding of the ion mostly by 
main chain oxygen atoms (Brodersen et al., 1998). Hence, the N-terminal domain of S100 
proteins generally has a much lower affinity for calcium than the C-terminal binding domain 
(Marenholz et al., 2004, Champaiboon et al., 2009). Both EF hands are flanked by a region of 
highly conserved hydrophobic residues (Brodersen et al., 1998). The C-terminal EF-hand is 
followed by a length of amino acids known as the C-terminal extension, and a hinge region is 
located between the two EF-hands. It is this C-terminal extension and hinge which contain 
the most variability between the S100 proteins, and thus are responsible for their specificity 
of biological function (Zimmer et al., 2003, Salama et al., 2008). Many of the S100 proteins 
have an insertion of two amino acid residues within the N-terminal binding motif, which 
results in significant lowering of binding affinity (Hoffmann et al., 1994). S100A7, for 
example, is a highly non-globular protein that has lost a functional metal binding ligand at 
the N-terminal. MAD phasing technology demonstrated formation of a homodimer with 
empty N-terminal helix-loop-helix motif (Brodersen et al., 1998). 
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Many of the S100 proteins exist in vivo as a homodimer, hetrodimers, and oligomers, 
including S100A4, S100A6, S100A7, S100A8, S100A10, S100A11, S100A12 and S100B (Potts 
et al., 1995, Donato, 2001, Ishikawa et al., 2000, Moroz et al., 2000, Réty et al., 1999, Smith 
and Shaw, 1998, Sastry et al., 1998, Drohat et al., 1998, Brodersen et al., 1998, Matsumura 
et al., 1998, Kilby et al., 1996). It is the terminal hydrophobic regions which allow 
dimerization (Brodersen et al., 1998). Covalent disulphide bridges are also thought to be 
significant in the formation of S100 protein dimers, and covalently bound S100A6 dimers 
have been reported in mice, rabbits and humans (Potts et al., 1995). A disulphide bridge is 
present between the only two cysteine residues in S100A7,  at position 46 and 95, and non-
covalently bound dimers are also highly likely to form (Brodersen et al., 1998).  While S100B 
has been reported to form non-covalent dimers (Kilby et al., 1996), it is unlikely that 
cysteine residues  at positions 68 and 84 can form a disulphide bridge, as they are distant 
from one another, and even the conformational change upon binding of calcium is not likely 
to bring cysteine residues within close enough vicinity to form a bond (Brodersen et al., 
1998).  
Tight helical packing seems to be key for the dimerisation and native structure of 
S100 proteins,  since dissociation of dimers results in monomers becoming highly non-
globular with a protruding first helix (Brodersen et al., 1998). Antiparallel arrangement of 
the helices results in highly symmetric packing, stabilised by the hydrophobic side chain 
residues (Brodersen et al., 1998).  Two highly conserved phenylalanine residues play a major 
role in the stacking of helices, and along with other highly conserved hydrophobic residues, 
are important in the formation of the S100 dimers (Brodersen et al., 1998).  
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Not all S100 proteins bind calcium. S100A10 has calcium free loops, unable to bind 
calcium due to being set in the closed ‘calcium bound’ conformation (Santamaria-Kisiel et 
al., 2006). S100A3 also has a distorted C-terminal EF hand, resulting in a very low affinity for 
calcium (Mittl et al., 2002, Moroz et al., 2003). Many S100 proteins also bind other metal 
ions; zinc binding is a process which increases affinity for calcium at binding sites (Baudier et 
al., 1986). Misregulation of zinc homeostastis has been associated with cancer, and thus 
might explain the altered expression levels of S100 proteins in cancer (Murakami and 
Hirano, 2008) 
1.6.2. Functions of the S100 proteins 
1.6.2.1 Intracellular functions 
The functions of S100 proteins are broad and vary considerably between protein family 
members. Calcium binding S100 proteins are involved in many intracellular processes 
including proliferation, differentiation and control of cell shape (Watson et al., 1998), 
regulation of protein phosphorylation and enzyme activity, calcium homeostasis and 
regulation of transcriptional factors (Salama et al., 2008). Some S100 proteins interact with 
p53, including S100A2 (Mueller et al., 2005), S100A4 (Grigorian et al., 2001) and S100B 
(Donato, 2003, Lin et al., 2010, Lin et al., 2001). S100A2 has been reported to enhance p53 
transcriptional activity, and S100A4 has also been noted to increase p53-dependant 
apoptosis (Mueller et al., 2005, Grigorian et al., 2001). Other reports suggest that S100A4, 
like S100B, inhibits p53 phosphorylation and hence inhibits transcriptional activity. 
Therefore it is likely that the specific microenvironment and proportion of different proteins 
present will determine the physiological response (Salama et al., 2008).  S100A1 has been 
38 
 
 
 
 
 
Figure 1.5: S100 protein signalling.  
S100 proteins regulate biological activity by transmitting signals via Ca2+ dependent binding 
to their targets, and acting as Ca2+ sensor proteins. Calcium signalling can also trigger 
secretion of S100 proteins, which once outside the cell, can form polymers in the presence 
of high concentrations of Ca2+ and Zn2+, allowing binding of the RAGE receptor. Image from 
Marenholz et al. (2004).  
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Figure 1.6: Summary of S100 protein activities and functions.  
S100 proteins have been shown to be involved in a diverse range of intracellular and 
extracellular activities. 
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reported to regulate cell proliferation in the phaeochromocytoma cells from rat adrenal 
medulla (Zimmer et al., 1998), as has S100A11 in human keratinocytes and osteosarcoma 
cells (Donato, 2001, Gorsler et al., 2010).  
A number of S100 proteins are known to modulate cytoskeletal dynamics, by direct 
interaction with tubulins, intermediate filaments, myosin, tropomyosin and actin; processes 
which have been linked to mediation of metastasis (Santamaria-Kisiel et al., 2006, Salama et 
al., 2008, Kriajevska et al., 1998, Davies et al., 1996). 
  1.6.2.2. Extracellular functions 
S100 proteins can also act outside the cell, with roles in inflammation and 
cardiomyopathies, via extracellular functions including chemoattraction of leukocytes and 
macrophages, macrophage activation and modulation of cell proliferation (Hiratsuka et al., 
2006, Yen et al., 1997, Cornish et al., 1996, Devery et al., 1994, Lau et al., 1995). It has 
become apparent that some members of the S100 family promote tumourgenesis, while 
others are tumour suppressors, with proteins exhibiting a high level of tissue specificity 
(Salama et al., 2008).  
Several S100 proteins have been associated with breast tumour progression (Ilg et 
al., 1996, Pedrocchi et al., 1994). Due to their significant upregulation in a number of 
cancers, it has been suggested that the S100 family of proteins may have potential as 
markers for the early detection and identification of  tumour type, as well as the prediction 
of tumour behaviour, and possibly as therapeutic targets (Salama et al., 2008).  
While the specific mechanisms by which S100 proteins contribute to carcinogenesis 
is unknown, evidence suggest that they impact on metastasis by interacting with proteins 
including Jab-1, p53, Cox-2, BRCA1, cytoskeletal proteins and matrix metalloproteinases 
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(Mueller et al., 2005, Emberley et al., 2004a, Emberley et al., 2003a, Kennedy et al., 2005, 
Tsai et al., 2006, Grigorian et al., 2001, Lin et al., 2001). Many S100 proteins including S100B, 
S100A4, S100A6, S100A7, S100A11, S100A12, S100A13 and S100P interact with the cell 
surface receptor for advanced glycation end products (RAGE) to transduce their 
extracellular effects (Figure 1.5), although relatively high concentrations of protein are 
generally required to activate the receptor (Donato, 2003). Binding of RAGE is thought to 
primarily activate a pro-inflammatory response and in neurons, initiates production of 
moderate amounts of reactive oxygen species and activates the caspase cascade leading to 
apoptosis (Huttunen et al., 2000).   
1.6.3. Antimicrobial S100 proteins 
1.6.3.1 S100A7 protein 
S100A7 has been identified as a primary antimicrobial protein of the human skin, and 
provides a major defence against E.  coli infection (Gläser et al., 2005). It is also an important 
protective protein in the female genital tract and increases wound resistance to bacterial 
infection (Lee and Eckert, 2007, Mildner et al., 2010).  The protein has also been found in 
the bovine udder, and while it is absent from healthy teat cisterna and parenchyma, teat 
cistern expression is activated by E. Coli infection (mastitis) of the udder (Regenhard et al., 
2010, Regenhard et al., 2009). The S100A7 gene is also upregulated in the human lung in 
response to Staphylococcus aureus, and is believed to be involved in mucosal airway 
immunity (Andresen et al., 2011). Antibacterial action of S100A7 protein was first suggested 
to be zinc dependent, and the mechanism of action was thought to require zinc 
sequestration (Gläser et al., 2005). More recently, studies have found that only amino acids 
35-80 are required for full antibacterial function, and mutation of the zinc binding HXXXH 
42 
 
motif at the C-terminal only slightly reduces antibacterial activity (Lee and Eckert, 2007). 
More recent research has shown that S100A7 disrupts the bacterial membrane by forming 
pores at pH<6, however at neutral pH, E. coli is killed without membrane disruption 
(Michalek et al., 2009). Hence, the mechanism of antimicrobial activity is unclear. In addition 
to its antimicrobial ability, S100A7 may also contribute to innate immunity by enhancing 
neutrophil host defence activities in areas of inflammation or infection (Zheng et al., 2008). 
The protein has been shown to activate neutrophils, causing the production of cytokines, 
chemokines and reactive oxygen species, and also cause an increase in the expression of 
alpha-defensin mRNA to subsequently induce their release (Zheng et al., 2008).  
1.6.3.2. S100A7a protein 
The closely related human S100A7a also displays antimicrobial activity against E. coli both in 
vivo and in vitro, and it’s expression is thought to be modulated through E. coli’s interaction 
with the Toll-like receptor 4 (TLR4) (Büchau et al., 2007).  
  1.6.3.3. Calprotectin protein 
Calprotectin, a non-covalent hetrodimer consisting of S100A8 and S100A9 protein, also has 
broad spectrum antibiotic activity (Miyasaki et al., 1993, Murthy et al., 1993, Sohnle et al., 
1991, Steinbakk et al., 1990).  Both S100A8 and S100A9 have two calcium binding domains 
within their EF hands, and the heterodimer is known to bind four calcium ions (Vogl et al., 
2006).  Calprotectin’s activity is mostly microbistatic, although it does have microbicidal 
activity under certain conditions (Sohnle and Hahn, 2000), increasing cell resistance to 
cytoplasmic bacterial growth, reducing bacterial binding to cells, and decreasing bacterial 
invasion (Nisapakultorn et al., 2001). It has been suggested that calprotectin exerts its 
43 
 
activity by chelating zinc ions via its HXXXH motif (common to many S100 proteins) as well 
as the HHH motif at the C-terminal (Loomans et al., 1998, Sohnle and Hahn, 2000). In vitro, 
however, synthetic peptides containing the HXXXH and HHH domains were not sufficient to 
effect antimicrobial inhibition (Sohnle and Hahn, 2000). More recently, data has confirmed 
that deletion of amino acids 113-114 or 100-114 at the C-terminus of S100A9 actually 
increases resistance of calprotectin-expressing cells to bacterial invasion. Amino acid Thr-
113 is the only phosphorylation site of calprotectin, and is involved in translocation to the 
plasma membrane and membrane binding (van den Bos et al., 1996, Kerkhoff et al., 1999), 
and hence disruption of the Thr-113 may prevent membrane binding and effect cytoskeletal 
events that are essential for the internalisation of bacteria (Champaiboon et al., 2009).  It 
seems the formation of the heterodimer is necessary for antimicrobial activity, however 
dimerization is not dependant on the extended C-terminal domain (Champaiboon et al., 
2009).  
1.6.3.4 S100A12 protein  
S100A12 protein, also known as calgranulin C,  is an antimicrobial (McFarland et al., 2008) 
and Cole et. al. (2001) discovered an S100A12 peptide fragment with antimicrobial 
properties in human airway secretions (Cole et al., 2001). They named the peptide 
‘calcitermin’ as it originates from the final 15 amino acid residues of the S100A12 C-terminal 
as follows: VAIALKAAHYHTHKE. This peptide also contains the HXXXH zinc-binding consensus 
sequence described above. Increased quantities of S100A12 protein have been found in the 
milk of S. aureus infected bovine udders, and recombinant bovine S100A12 also inhibits the 
growth of E. coli in culture (Strandberg Lutzow et al., 2008).   
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It is thought that both calprotectin and S100A12 may act in a calcium-dependent 
chaperone/anti-chaperone-like manner, assisting the aggregation of some proteins and 
suppressing the aggregation of others (Hatakeyama et al., 2004, Champaiboon et al., 2009). 
The structural changes of S100 proteins resulting from Ca2+ binding influence a series of 
complex downstream events which are not well understood, and hence the mechanism of 
antibacterial activity of has not been elucidated (Champaiboon et al., 2009).  
1.6.4. The S100A7/S100A15 subfamily 
S100A7 (or psoriasin) is a small protein belonging to this family and was first discovered as 
an over-expressed secretary protein found in psoriatic skin (Madseti et al., 1991).  It is 
typically a secretory protein (Jinquan et al., 1996), but is also observed in the cytoplasm and 
nucleus of malignant phenotypes (Hagens et al., 1999, Enerback et al., 2002, Al-haddad et 
al., 1999, Jinquin et al., 1996). Overexpression of S100A7 in human breast cancer cells 
results in activation and nuclear redistribution of Jun activation domain-binding protein-1 
(Jab1) (Emberley et al., 2003a), a component of the CSN/COP9 signalosome involved in 
signal transduction, including the regulation of E3 ubiqitin ligases and the JUN/AP1 
transcription factors, and protein degradation (Schwechheimerb and Deng, 2001, Chamovitz 
and Glickman, 2002, Emberley et al., 2003a). Overexpression of S100A7 also enhanced 
tumorgenesis and metastasis in vivo, suggesting a role in tumour progression and invasion in 
breast cancer (Emberley et al., 2003a). Studies have also demonstrated increased 
expression of this gene in atopic dermatitis, mycosis fungoides, Darier's disease, 
inflammatory lichen sclerosus et atrophicussquamous, abnormally differentiating 
keratinocytes, squamous cell carcinomas of several organs including the oral cavity and 
lung, as well as in a subset of breast tumours (Emberley et al., 2004c, Alowami et al., 2003, 
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Al-haddad et al., 1999, Moog-Lutz et al., 1995, Leygue et al., 1996, Zhang et al., 2008, 
Algermissen et al., 1996). S100A7, located on human chromosome 1q21 within the 
epidermal differentiation complex (Donato, 2001), is involved in both Ca2+-dependent and 
independent processes, regulating  a variety of intracellular and extracellular activities. The 
human S100A7 gene has been implicated in inflammation (Webb et al., 2005) and also 
shown to be highly and more frequently expressed in ductal carcinoma in situ (DCIS) when 
compared with invasive breast carcinomas, suggesting a role in tumour progression (Krop et 
al., 2005, Emberley et al., 2004c, Enerback et al., 2002, Leygue et al., 1996). Psoriasin 
expression in breast tumours was also associated with increased angiogenesis and poor 
clinical outcome (Krop et al., 2005). Expression was undetectable in exponentially growing 
mammary epithelial cells (immortalised MCF-10A), but was up-regulated during growth 
factor deprivation, prolonged confluency and loss of attachment to the extracellular matrix 
(Enerback et al., 2002, Watson et al., 1998). However, MDA-MB-468 cells expressed very 
high levels of psoriasin protein and mRNA even when grown in standard culture conditions 
(Enerback et al., 2002, Emberley et al., 2003a). While over expression of S100A7 during 
tumourgenesis of the breast and skin implied an oncogenic role for psoriasin in tumour 
development, more recent studies on the psoriasin expression profile during tumour 
progression suggest greater complexity in functional roles with regards to development of a 
malignant growth. Analysis showed that S100A7 gene expression was comparatively low or 
undetectable in normal tissue, benign and atypical hyperplastic proliferative ductal lesions. 
However, there was a considerable increase in expression levels in the ductal epithelial cells 
of premalignant, pre-invasive DCIS (Leygue et al., 1996). Expression of the S100A7 gene was 
then reduced when carcinomas became invasive (Leygue et al., 1996, Emberley et al., 
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2003b). The S100A7 gene expression pattern implied that overexpression of psoriasin 
impacts on differentiation in glandular epithelium of DCIS and may accelerate early breast 
tumour progression (Watson et al., 1998). The downregulation of S100A7 gene expression in 
tumours prior to invasion suggests that psoriasin may have an inhibitory role on the 
migration of epithelial cells; reduced S100A7 gene expression may be required for successful 
invasion (Watson et al., 1998).  
Further evidence consistent with a role in tumour progression is the chromosomal 
location of the S100A7 gene. The gene is located in a region of chromosome 1 that 
frequently loses heterozygosity in invasive tumours (Munn et al., 1995, Watson et al., 1998). 
Microarray data from 89 breast carcinomas identified genes most highly correlating with the 
expression of psoriasin. A surprising 26% of the 50 highest ranked genes were localised on 
chromosome 1q, the chromosomal arm where psoriasin and a cluster of other S100 genes 
are located, suggesting possible co-regulation of genes or a potential underlying genetic 
change (Wang et al., 2004, Krop et al., 2005). Down-regulation of psoriasin in invasive breast 
cancer cells increased anchorage-independent growth, cell motility and invasion in vitro, 
while decreasing tumourgenicity in vivo (Krop et al., 2005). A cell line engineered to lack 
psoriasin expression showed no difference in cell proliferation and survival when compared 
to control cells, however the cells exhibited increased migration and invasion in vitro and 
reduced tumourgenicity in nude mice (Krop et al., 2005). When psoriasin expression was 
down regulated using short hairpin RNA (shRNA), matrix metalloproteinase-13 (MMP-13) 
expression was increased, and vascular endothelial growth factor (VEGF) was decreased 
both in culture and in vivo (Krop et al., 2005).  
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In agreement with these findings, another study focusing on the psoriasin’s activity 
in squamous cell carcinomas of the oral cavity (SCCOC) found that while S100A7 gene 
expression is increased in preinvasive and well-differentiated early stage carcinomas, little 
or no expression was noted in poorly differentiated later stage invasive tumours. 
Comparison of three orthotopic SCCOC nude mouse models with varying levels of 
malignancy was consistent with these findings. High levels of S100A7 gene expression were 
detected in the mouse model with low malignancy, and no S100A7 gene expression was 
evident in the most malignant mouse model. Hence, the conclusion was drawn that S100A7 
inhibits SCCOC cell proliferation in vitro and tumour growth and invasion in vivo (Zhou et al., 
2008). This study also demonstrated an association between S100A7 and the β-catenin 
complex, inhibiting β-catenin signalling by inducing β-catenin degradation.  The mechanism 
is non-canonical and independent of GSK3β-mediated phosphorylation. It was also found 
that β-catenin signalling negatively regulates S100A7 gene expression, suggesting an 
important role in tumour development and progression. Downregulation of the S100A7 
gene in the later stages of tumourgenesis allows an increase in β-catenin signalling, resulting 
in promotion of tumour growth and progression (Zhou et al., 2008).  
S100A7 has also been shown to interact with BRCA1 and c-Myc. Kennedy et al. 
(2005) identified S100A7, S100A8 and S100A9 as downstream targets of BRCA1, and showed 
that BRCA1 was required for repression of these family members. BRCA1 and c-Myc formed 
a complex on the S100A7 promoter, and BRCA1 repression of S100A7 was dependent on 
functional c-Myc. Hence, S100A7 is a potential marker to aid in the early diagnosis of BRCA1 
negative tumours (Kennedy et al., 2005).   
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Psoriasin also acts as a chemotactic factor for CD4+ lymphocytes in the skin (Jinquin 
et al., 1996), and more recently it has been proposed to be involved in the antibacterial 
defence mechanism of the skin (Gläser et al., 2005).  
1.6.4.1 Structure of S100A7 
The structure of S100A7 differs from most other S100 proteins (structure shown in Figure 
1.7).  Although it has most of the residues required for calcium binding at the C-terminal EF 
hand, it has an extended lysine residue where most of the other proteins in the family have 
either a glutamine or glutamate. The N-terminal of the S100A7 protein differs significantly 
from other proteins of the family (Brodersen et al., 1998). When aligned with the other S100 
protein sequences, there is a three residue gap within S100A7 at the C-terminal EF hand.  
This gap changes the conformation of the protein and is the likely cause of the predicted 
loss of N-terminal calcium binding functionality. However, if the complete S100A7 protein is 
aligned with S100A6 and S100B (other members of this protein family whose structure has 
been investigated), the overall confirmation and shape is almost identical, suggesting it is 
the subtle changes in amino acid sequence that result in S100 functional variability 
(Brodersen et al., 1998). The crystal structure of S100A7 protein, solved by Brodersen et al. 
(1999), and the subsequent observation that the zinc binding site is located at the surface of 
the S100A7 dimer adjacent the putative receptor molecule cleft, implies that zinc binding is 
not simply a structural feature but is involved in the physiological function of the protein 
(Brodersen et al., 1999). 
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Figure 1.7: 3D structure of zinc- and calcium-bound human S100A7 dimer.  
The S100A7 protein commonly exists as a homodimer with the ability to bind one calcium 
ion by each of the canonical EF hand motifs, and two zinc ions simultaneously on the dimer 
interface. Image from Brodersen et al. (1999).  
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   1.6.4.2 Duplications and inversions in the S100A7 region of human 
chromosome 1q21 
A number of duplication events have occurred on the human chromosome 1q21 in the 
S100A7 region. The region has three functional genes, S100A7, S100A7a and S100A7L2, as 
well as two are fragmented genes which are thought to be non-functional, and are likely to 
have diverged earlier from an evolutionary perspective. According to Kulski et al. (2003), the 
duplications seem to have also involved an inversion. The duplications and rearrangements 
within this highly active chromosomal region are the cause of such a large and diverse 
family of S100 genes. However, S100A7 appears to be the only gene in the family to have 
undergone recent duplications, occurring during the divergence of primates (Kulski et al., 
2003). Comparative genomic analysis shows that there is no similarity between other 
intergenic regions of the S100 cluster, suggesting they evolved far earlier in evolutionary 
history (Kulski et al., 2003).   
1.6.4.3 Comparison between hS100A7 and hS100A7a 
Human S100A7 and S100A7a are the two functional forms of human S100A7 and share 93% 
sequence identity (Wolf et al., 2010). These two proteins differ in only seven residues; four 
of which are located in a zinc binding region and three of which form part of a proposed 
receptor binding face. Like S100A7, as mentioned above, S100A7a is an antimicrobial 
protein of the skin (Büchau et al., 2007). However, the proteins have distinct expression 
locality in inflammatory conditions of the epidermis. The S100A7a gene is expressed in the 
basal and granular layer (Wolf et al., 2007), while the S100A7 gene is expressed only in the 
upper epidermis (Madsen et al., 1991, Gläser et al., 2009). These highly similar proteins also 
have distinct signalling methods; while S100A7 depends on zinc to interact with RAGE, 
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Figure 1.8: Subtle differences between human S100A7 and S100A7a amino acid sequence 
and binding surface. 
The differences in amino acid residues between hS100A7 and hS100A7a are localised to the 
predicted receptor binding surface, resulting in the alteration depicted above. Acidic 
regions are coloured red and basic regions are blue. Note the reduced acidity in the 
S100A7a receptor binding surface. Image modified from Murray et al. (2012).   
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S100A7a signals through a G-protein coupled receptor, independently of zinc (Emberley et 
al., 2004d, Murray et al., 2012), which can be explained by the slight conformational 
difference in the receptor binding surface (Figure 1.8) (Murray et al., 2012).  
1.6.4.4. S100A15 protein 
There is considerable confusion regarding the naming of the S100A15 gene. There have 
been several S100A7 duplication events on the human chromosome, resulting in 4 S100A7  
“like” genes. In addition, there is another highly homologous gene at location 153,388,945-
153,395,701 (plus strand) on human chromosome 1, ensemble id ENSG00000184330. This 
gene had initially been named “S100A15”, however it has recently been renamed 
“S100A7a” due to its high homology to the S100A7 gene (Marenholz et al., 2006). Other 
species such as the chimpanzee, cow, horse and opossum, however, do have genes named 
“S100A15”, to which the human S100A7a or S100A15 is not orthologous, although closely 
related. The S100A15 gene is highly conserved between species possessing this gene (see 
chapter 2, Figure 2.4). While the human does not have a true S100A15 gene orthologous to 
these species, there does appear to be a pseudo-gene consisting of only the second exon at 
153,369,069-153,369,270 on chromosome 1, named AL591704.7 (ENSG00000224784; see 
Chapter 2 of this thesis). Published data refer to the mouse S100A15 as the ortholog of 
human S100A7 (Webb et al., 2005, Wolf et al., 2006), but detailed bioinformatics analysis of 
the protein and transcript sequences shows this to be unlikely. Although the hS100A7 genes 
are more closely related to the mouse S100A15 gene than any other mouse gene, there is 
relatively little homology between the species. Analysis shows (please refer to chapter 2) 
that the gene named S100A7a (ENSMUSG00000063767) in the mouse (Kulski et al., 2003) is 
orthologus to the true S100A15 genes of other species, and not to the human S100A7a 
53 
 
(which is a duplicate of the S100A7 gene) as claimed by Wolf et al.(2006). The mouse gene 
will therefore be referred to as “mS100A15” in this thesis. The mS100A15 gene has only 33% 
identity (calculated with EMBOSS Needle) to the best functional human match, S100A7a, 
which is much lower than the average for the comparison of S100 genes between human 
and mouse, which stands at 84% (Wolf et al., 2006).  The second exon coding region of 
mS100A15 however, does have 74.5% (or 85.9% excluding the first 27 bp gap in sequence) 
homology with the non-functional human S100A15 pseudo-gene AL591704.7 (see Figure 
2.4c). Published data describing the human S100A7a/A15 gene is readily available; however 
data on either genes or proteins belonging to the true S100A15 group is very limited, with 
the exception of a few articles describing the distribution and expression of mS100A15 
(Wolf et al., 2006, Nasser et al., 2012, Webb et al., 2005, Schonthaler et al., 2009). Like 
human S100A7, mS100A15 shows similar genomic organisation to the human S100A7 
subfamily and is expressed in keratinocytes in vivo (Wolf et al., 2006). Its expression is also 
increased  in a mouse model of psoriasis (Schonthaler et al., 2009) and it is localised to the 
epidermal granular and cornified layers, as well as the maturing layers of the hair follicle 
(Wolf et al., 2006). In vitro, S100A15 gene expression is inducible by increasing extracellular 
calcium concentration, but upregulation can be blocked by inhibition of protein kinase C 
(PKC), which forms part of a signalling pathway involved in epidermal differentiation. 
Induction of PKC also stimulated by mS100A15 protein (Wolf et al., 2006).  
Although the mS100A15 gene shows  greater sequence homology with hS100A7a, 
it’s expression patterns are more similar to that of hS100A7 (Webb et al., 2005), with 
upregulation in mammary tumourgenesis and skin inflammation. Like hS100A7, it also 
contains the Jab1 binding sight, which is absent from hS100a7a (Webb et al., 2005). Even 
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the closely related hS100A7 and hS100A7a proteins exhibit functional dissimilarities; both 
are present in human psoriatic skin (Madsen et al., 1991, Wolf et al., 2003) but only S100A7 
is detectable in neoplasia of the mammary gland (Emberley et al., 2004c) and human skin 
(Webb et al., 2005). 
In summary, the mouse S100A15 gene shows similar genomic organisation and 
sequence, localisation, expression patterns and regulation during normal epidermal 
differentiation when compared with human S100A7, but the primordial gene is not known 
(Regenhard et al., 2009). Due to the number of gene duplications, rearrangements, and the 
complexity of the S100A7/A15 region, the origin of this subfamily is unclear.  
1.6.4.5 S100A19 protein 
Studies characterising wallaby stomach development identified a previously un-annotated 
wallaby S100-like gene (Kwek, 2009). The gene was found to be developmentally regulated 
in the forestomach and mammary gland of the tammar, and the protein predicted to have a 
function in these tissues. The biological role of protein was not explored, although it was 
hypothesised to have a developmental role in the maturation process of the wallaby 
stomach. The gene was expressed in the forestomach during the initial 200 days of pouch 
young development, but undetectable after this period coinciding with loss of the parietal 
cells and the adoption of the adult forestomach phenotype (Kwek et al., 2008, Waite et al., 
2005).  
The gene was identified as the marsupial ortholog of the eutherian S100A7 gene 
(Kwek, 2009).  This convention is challenged in chapter 2 of this thesis; the gene has been 
renamed S100A19, the gene loci and structure examined and further phylogenetic analysis 
performed. Due to the early evolutionary divergence of marsupial and monotreme species, 
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the comparison of eutherian S100 genes with marsupial and monotreme genes also 
provides greater insight into the evolutionary origin of the S100 family (Messer et al., 1998, 
Killian et al., 2001).  
 
1.7 Aim and scope of this study 
The marsupial neonate enters the external environment as an exposed foetus, is hairless, 
unable to control its own body temperature, and has little immunity. The marsupial 
provides an exceptional model for the study of neonatal development and the methods 
used to protect the vulnerable pouch young allowing such extraordinary survival. These 
include the delivery of immune cells and peptides in the milk, and the chemical and 
mechanical cleaning of the pouch and pouch young. This thesis focuses on antimicrobial 
activity in the wallaby pouch and examines expression of the novel marsupial S100A19 gene 
and the antibacterial scope of the subsequent protein. The regulatory mechanisms 
facilitating the marsupial’s unique lactation strategy are also of interest in order to better 
understand mammary gland function. The wallaby mammary gland undergoes periods of 
significant change throughout the lactation cycle, and provides highly specialised milk for 
the pouch young which changes in composition according to age of the young. Hence, this 
thesis also examines in detail the expression of the wallaby S100A19 gene in mammary 
tissue, and additionally explores the biological function of the protein in the mammary 
gland.  
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Hypotheses 
S100A19 protein is secreted into the pouch of the tammar wallaby to protect the immune-
incompetent neonate through control of pathogenic bacteria.  
S100A19 is expressed in the wallaby mammary gland to aid proliferation of mammary 
epithelial cells in preparation for lactation, and to provide resistance to bacterial invasion in 
the mammary gland during periods of vulnerability.  
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CHAPTER 2 
Identification, Bioinformatic Exploration and Phylogenetic 
Analysis of an Ancient Marsupial S100 Gene  
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Chapter 2 
Identification, Bioinformatic Exploration and Phylogenetic Analysis of a Marsupial S100 
Gene  
2.1 Summary 
A novel marsupial S100 gene was recently identified in the tammar wallaby gut and 
mammary gland by Dr. Joly Kwek in 2009 (Kwek, 2009). The gene was thought to be the 
marsupial ortholog of the S100A7 gene, encoding a small calcium binding protein, due to 
the degree of homology with the eutherian S100A7 group. However, the current study 
shows the formation of a separate phylogenetic clade and poor alignment with S100A7 gene 
and protein suggest that, although related, the marsupial gene is most likely a new member 
of the S100 protein family. This chapter examines the gene structure and origin of the gene 
in more detail using a bioinformatics and a phylogenetic approach with comparison to the 
S100 family in other well studied species.  
2.2 Introduction 
The S100 proteins are the largest subgroup among the EF-hand family of Ca2+ binding 
proteins. They are vertebrate-specific and have undergone significant diversification during 
the evolution of vertebrates resulting in at least 20 highly specialised proteins with a 
plethora of functions (Salama et al., 2008, Donato, 2001, Sedaghat and Notopoulos, 2008). 
Their involvement in various cellular processes such as cell growth and differentiation, cell 
cycle regulation and motility is vital for the maintenance of a healthy intracellular and 
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extracellular environment, with changes in expression linked to numerous types of illness 
including cancer (Marenholz et al., 2004). 
The majority of the human S100 genes are located on human chromosome 1q21 
within the S100 cluster (Donato, 2001, Schäfer et al., 1995). Most of these genes can be 
identified in other vertebrate species since the S100 genes have considerable sequence 
conservation, and although chromosomal organisation is variable, the gene loci are typically 
conserved with regard to surrounding genes (Marenholz et al., 2004).  
In humans, the intron/exon structure of the S100 genes are also highly conserved, 
characteristically consisting of two introns and three exons, with the first exon containing 
only non-coding sequence (Heizmann et al., 2002, Pietas et al., 2002). The mouse S100 
genes also show comparable structure (Marenholz et al., 2004). While the purpose of the 
non-coding exon is not understood, it seemed likely that the novel marsupial and 
monotreme S100 gene of interest, which we will refer to as S100A19, would also include 
this sequence.  Hence, the intron/exon structure of S100A19 is examined in this chapter. 
Many of the S100 proteins have multiple names and symbols which has resulted in 
confusion in the past (Schäfer et al., 1995), and the nomenclature of the S100A7a/S100A15 
genes remains uncertain.  While the approved HGNC name for the mouse member of this 
subfamily remains ‘S100A7a’, we show here that the murine gene shows much greater 
homology to the eutherian S100A15 genes, and although related and perhaps sharing the 
same origin, S100A15 and S100A7 differ significantly and both present remarkable 
conservation across species. In this chapter, phylogenetic analysis allows the exploration of 
S100 family relationships, and bioinformatics analysis at a genomic level gives further insight 
into the origin of these genes and evolutionary events which may have been involved in 
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either gene creation or loss. These methods are employed together to generate a 
hypothesis for the origin and evolution of the S100A7/S100A15/S100A19 subfamily.  
 
2.3 Materials and Methods 
2.3.1 Phylogenetic trees 
2.3.1.1 Protein trees 
The S100 protein sequences were obtained from NCBI and Ensembl Genome database 
(appendix 1), correct as of October 2012. Sequences were aligned with ClustalX Version 
2.0.11 (Larkin et al., 2007), and the PHYLIP package Version 3.69 (Felsenstein, 1989) was 
used to compute the distance matrix (ProtDist) for protein sequences based on the Jones-
Taylor-Thornton matrix and 100 bootstrap replicates. The distance matrix was used to 
construct a rooted tree using the Neighbour Joining tree building method with 100 
bootstrap replicates. Trees were drawn using iTOL (Letunic and Bork, 2006). 
2.3.1.2 Gene transcript trees 
The S100 nucleotide sequences were obtained from NCBI and Ensembl Genome database 
(appendix 2). Sequences were aligned with ClustalX Version 2.0.11 (Larkin et al., 2007), and 
the PHYLIP package Version 3.69 (Felsenstein, 1989) was used to compute the distance 
matrix for nucleotide sequences (DNADist) using the F84 distance method. The distance 
matrix was used to generate a tree based on the Fitch-Margoliash tree building method and 
1000 bootstrap replicates, and a subsequent consensus tree generated. Trees were drawn 
with TreeView Version 1.6.6. 
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2.3.1.3 Exon trees 
The S100 protein sequences and exon structure were obtained from NCBI and Ensembl 
Genome database, correct as of October 2012. The sequence of the first and second exon 
were aligned separately using Bioedit V. 7.1.3.0 (Hall, 1999), and the PHYLIP package 
Version 3.69 (Felsenstein, 1989) was used to compute the distance matrix (ProtDist) for 
protein sequences based on the Jones-Taylor-Thornton matrix and 100 bootstrap replicates. 
The distance matrix was used to construct rooted trees using the Neighbour Joining or Fitch-
Margoliash tree building method using 100 bootstrap replicates. Trees were drawn using 
iTOL (Letunic and Bork, 2006). 
2.3.2 Genome loci analysis 
The Ensembl database (Flicek et al., 2012) was used to extract the genome sequence of the 
region between the S100A8 and S100A6 genes for human, mouse and short-tailed opossum 
(monodelphis domestica). The S100A2 and S100A15 genes were not annotated on the 
opossum chromosome, so the sequences obtained from NCBI were aligned with the 
opossum genome to locate the genes on chromosome 2. All alignments were performed 
using the Ensembl Blast tool (Flicek et al., 2012). The location of the opossum ortholog of 
the wallaby S100A19 gene was determined by aligning the wallaby S100A19 sequence (from 
Kwek, 2009) with the opossum genome. A Fast-Dots 2.0 analysis (Lefèvre and Ikeda, 1994) 
compared the human and bovine and human and mouse genomic region of the S100 
cluster.  Genome sequences were then used to perform GeVo genome evolution analysis 
(Lyons and Freeling, 2008). The (B)LastZ: Large Regions algorithm was used and parameters 
as follows:  word size = 8, gap start penalty = 400, gap extend penalty, score threshold = 
3000, mark threshold= 0. 
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The wallaby and opossum S100A15 genes were identified by aligning the mouse S100A15 
gene sequence against their respective genomes, retrieving opossum 
ENSMODG00000017402  and a previously unidentified gene on the wallaby chromosome, 
located on  Scaffold 42740 at position 9991 to 10140 (exon 1)  and  13621 to 13797 (exon 2) 
on the positive strand. The opossum S100A6 and S100A8 sequences were aligned against 
the wallaby genome. The wallaby and opossum S100A15 and S100A19 proteins were 
aligned using ClustalX Version 2.0.11 (Larkin et al., 2007) and the Needleman-Wunsch 
algorithm was implemented using EMBOSS Needle (http://emboss.bioinformatics.nl/cgi-
bin/emboss/needle) to determine the percentage identity and similarity between the 
wallaby and opossum S100A15 and S100A19 proteins.  
2.3.3 RNA extraction and reverse transcription 
Total RNA was extracted from tammar wallaby mammary tissue at day 24 of gestation using 
a QIAGEN® RNeasy® minikit (#74104) according to manufacturer’s protocol. A total of 32.4 
μg of RNA was extracted, with quantity and quality assessed using a nanodrop 
spectrophotometer (NanoDrop 1000, Thermo Scientific). Reverse transcription was 
performed from 1μg of RNA incubated at 65°C for 5 min with 2 μL of 10mM dNTP mix 
(#18427-088, Invitrogen) and 2 μL of oligo DT primer at 0.05 μg/μL (Sigma), made up to 24 
μL with nuclease-free water, then placed on ice for 2 min. The prepared RNA mixture was 
then combined with 8 μL of 5 x First Strand Buffer (#y02321, Invitrogen), 4 μL of 0.1M DTT 
(#y00147, Invitrogen), 2 μL RNaseOut at 40U/μL (#100000840, Invitrogen), 0.5 μL 
Superscript IIITM Reverse Transcriptase at 200U/μL (#56575, Invitrogen), and 1.5μL nuclease-
free water. Template- and enzyme-free reactions were included. Reactions were then 
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placed in a thermocycler (Eppendorf Mastercycler®) at 42°C for 50 min, 70°C for 15 min, 
followed by 4°C for 5 min and samples stored at -20°C until analysed.  
2.3.4 Determination of S100A19 non-coding sequence and gene structure in the 
wallaby, opossum and platypus 
The wallaby S100A19 coding sequence was reported by Dr. Joly Kwek (Kwek, 2009). To 
predict the wallaby non-coding exon, we used the known consensus splice sites for 5’ donor 
splice site (C/A)AG/GTAAGT and 3’ acceptor splice site (C/T)AG/G. Primers used for both 
amplification and sequencing of the S100A19 non-coding exon (gene located on Ensembl 
scaffold 63159: 10,413- 14,571) were designed using Primer3Plus (Untergasser et al., 2007) 
and synthesised by Macrogen (Korea) as follows: Upstream 5’ 
CACTCATCTGACTCTTTCCTCTTG 3’ and downstream 5’ CCAGCACAGTCACAAACTC 3’. The PCR 
reaction (20μL volume) contained 1 x GoTaq® Green Master Mix (#M7122, Promega), 0.5μM 
upstream and downstream primer, 0.5μg DNA template and nuclease-free water. Reaction 
conditions (Eppendorf Mastercylcer®) were 94°C for 2 min initial denaturation, followed by 
35 cycles of 94°C for 30 sec, 60°C for 30 sec, and 72°C for 45 sec, with a final extension of 
72°C for 5 min. The PCR reaction was then run on a 2% agarose gel using electrophoresis, 
band visualised (Molecular Imager® ChemiDoc™ XRS+, Bio-Rad) and DNA band extracted 
using PureLink Quick Gel Extraction Kit (#K210012, Invitrogen) as per manufacturer’s 
protocol. Purified product was then sent to Macrogen (Korea) for sequencing. The 
confirmed wallaby sequence was then used to predict the opossum and platypus S100A19 
gene sequences by alignment with the respective genomes. Exon structure information 
from a selection of S100A15 and S100A7 genes was extracted from Ensembl (Flicek et al., 
2012) and compared with the sequence of the newly defined wallaby and opossum S100A19 
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gene.  Platypus was not included due to gaps in the sequence. The 3’ non-coding sequence 
was estimated in relation to the poly A stretch and subsequent dissociation of RNA 
polymerase. 
2.4 Results 
 2.4.1 Phylogenetic analysis  
In order to explore the relationship between S100 genes from a variety of species and the 
marsupial and monotreme S100A19 genes, phylogenetic analysis was performed using 
derived protein sequences (Figure 2.1). Due to the high similarity between S100 proteins, 
some branches within the phylogram display bootstraps below 50, demonstrating the 
difficulty in defining evolutionary relationships between proteins of this family. The S100A19 
protein sequences form their own clade but show most relatedness to the S100A7/S100A15 
subfamily. To further examine the S100A7/S100A15/S100A19 relationship, phylogenetic 
analysis was performed using nucleotide sequences (exons only) (Figure 2.2). When 
nucleotide sequences were compared, S100A19 groups with S100A15. However, a low 
bootstrap value of 539 (out of 1000) suggests that S100A19 has almost equal similarity to 
both S100A7 and S100A15 genes.  
It is generally recognised that the S100 gene family arose through numerous 
duplication, inversion and recombination evolutionary events. Therefore, to explore the 
origin of the S100A19 gene, we generated phylogenetic trees from the translated sequences 
of the first and second exons separately (Figure 2.3). The first exon of S100A19 shows 
greatest homology to S100A15 and S100G first exon sequences, which form a clade. The 
first exon of the S100A7 group shows little homology to S100A19 or S100A15, and groups 
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separately with S100A10. The second exon tree shows that the second exon of S100A19 is 
most similar to the second exon of S100A7, while also showing likeness to S100A15 and 
S100G second exons which form a neighbouring clade.  
2.4.2 Examination of gene structure and loci 
As discussed in chapter one, there has been considerable confusion regarding the nature 
and nomenclature of the S100A15 gene. Due to the close relationship between S100A19 
and S100A15 genes, clarity regarding the gene is important. We examined the human 
‘S100A15’ or S100A7a by comparing the coding region of the gene structure to the S100A15 
genes from other species (Figure 2.4a). The gene structure comparison shows that the 
length of the coding sequence of the S100A15 genes is highly conserved, with exon one at 
150 nucleotide and exon two at 177 nucleotides in all species shown. An alignment of all 
S100A15 proteins (Figure 2.4b) shows high levels of identity between all species with the 
exception of the chimpanzee and human. The chimpanzee and human proteins, however, 
align well with the S100A7 protein family. The rhesus macaque (macaca mulatta) is the only 
primate shown here possessing a true S100A15 gene. The individual translated exons of the 
mouse S100A15 gene sequence were aligned with the human genome to identify any 
remnants of the S100A15 gene. The first exon of mouse S100A15 aligned poorly with the 
human genome, while the second exon aligned with the human pseudo-gene AL591704.7 
(ENSG00000224784), with 85.9% identity (Figure 2.4c).  
The S100A15/S100A7 loci were compared between mouse and human (Figure 2.5) to 
demonstrate the significant change that has occurred in this highly active chromosomal 
region. The human S100A7 locus has two functional genes on the reverse strand and one on 
the forward strand, as well as an additional pseudo-gene on each strand. As expected, the 
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Figure 2.1: Relationships between proteins of the S100 family. 
Rooted neighbour joining phylogenetic tree of S100 proteins was generated using 10 
species as follows: homo sapiens (hs), mus musculus (mm), bos taurus (bt), sus scrofa (ss), 
pan troglodytes (pt), equus callibus (ec), gallus gallus (gg), monodelphis domestica (md), 
ornithorhynchus anatinus (oa) and macropus eugenii (me).  The novel marsupial S100A19 
gene (black) forms a clade of its own and is only present in monotremes and marsupials. 
Bootstraps (100 replicates) are displayed on branches. Glucosidase beta acid (GBA) was 
used as an outgroup.  
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human pseudo-gene AL591704.7 is at a similar chromosomal location to the mouse 
S100A15 gene. To examine the relationship between the S100A7 and S100A15 genes and 
confirm a loss of the S100A7 gene in the mouse, a program for nucleotide sequence 
comparison was employed. Fast-dots 2.0 analysis (Lefèvre and Ikeda, 1994) identifies 
sequence similarity through the direct comparison of large sections of DNA. When the 
human and mouse S100 loci of chromosome 1 and 3 respectively were compared (Figure 
2.6) a clear break in the diagonal line showed a segmental deletion in the mouse 
chromosome, resulting in the loss of the S100A7 gene. The human S100A7 loci were then 
compared to the bovine loci on chromosome 3 in an attempt to examine the origin of the 
primate S100A7 duplications more closely. Similar to the evaluation of the mouse S100 loci, 
the human/bovine sequence comparison (Figure 2.7) showed alignment of the bovine 
S100A15 and human pseudo-gene AL591704.7. The bovine S100A7-like gene (located on the 
reverse strand) showed similarity to the human S100A7a on the forward strand, and also 
S100A7 and S100A7L2, located on the reverse strand (data not shown). The bovine S100A7 
gene on the forward strand showed likeness to the human S100A7 and S100A7L2 genes on 
the reverse strand, and also the human S100A7a on the reverse strand. Only two S100A7-
like genes were detected in the bovine genome. Chromosomal sequence from both 
upstream and downstream of the bovine region shown in Figure 2.7 on both the forward 
and reverse strands had no further detectable similarity to the human S100A7 genes, 
suggesting further duplications of the S100A7 genes most likely occurred after the 
divergence of primates.  
To further investigate the relationship between S100A7 and S100A19 genes, we 
examined gene loci. As the wallaby genome scaffolds have not been assembled into 
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chromosomes due to low sequence coverage, the chromosome of the closely related 
monodelphis domestica was studied. Due to the evolutionary distance between the 
eutherians and opossum, a FastDots alignment of the S100 clusters showed no significant 
similarity. The more sensitive GeVo analysis aligned genes and repeats within the human 
and opossum regions stretching from S100A8 to S100A6 (Figure 2.8a). As expected, the 
opossum S100A15 gene showed sequence similarity to the human pseudo-gene 
AL591704.7, and the S100A6 genes of both species also aligned. There was no detectable 
sequence similarity between the human sequence and opossum S100A19, although the 
human S100A7 gene resides at a similar location.  
An attempt was made to assemble the wallaby scaffolds within these loci (Figure 
2.8b), however this was not possible as each scaffold contained only one gene. The 
eutherian S100A8 gene did not align with the wallaby genome, most likely due to 
sequencing gaps in the genome. A search for the opossum S100A6 gene returned an 
alignment with the wallaby pseudo-gene ENSMEUG00000007062. Interestingly, the 
opossum has two S100A6-like genes, one within the S100 cluster, annotated S100A6 
(ENSMODG00000017400), and another on chromosome 2 at 67,189,598-67,604,597, 
annotated calcyclin binding protein (ENSMODG00000004383), which is conserved in the 
wallaby (ENSMEUG00000010725). While the wallaby and opossum S100A15 genes are well 
conserved with 90.7% identity between species (Figure 2.8c), the S100A19 is more divergent 
with only 47.2% identity.  
2.4.3 Evolution of the gene 
The collective data was used to generate a tentative evolutionary model describing the 
evolution of the S100A7/A15/A19 subfamily. The subfamily is predicted to have arisen from 
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Figure 2.2: Transcript tree showing relationship between S100A7, S100A15 and S100A19. 
FITCH phylogenetic tree was generated using the mRNA sequences of all known S100A7, 
S100A15 and S100A19 genes, as well as the wallaby S100A15 and human pseudo-S100A15 
found using blast alignment. Species included are homo sapiens (hs), pan troglodytes (pt), 
macaca mulatta (mac), mus musculus (mm), rattus norvegicus (rn), bos taurus (bt), sus 
scrofa (ss), canis lupus familiaris (cf), oryctolagus cuniculus (oc), equus callibus (ec), 
monodelphis domestica (md), ornithorhynchus anatinus (oa) and macropus eugenii (me). 
The tree was rooted to the more distantly related S100A1. The gene annotated as human 
S100A15 groups with the S100A7 transcripts, while the pseudo gene has 93% homology 
with the second exon of the rhesus macaque (macaca mulatta) S100A15. Bootstraps values 
calculated on 1000 replicates are displayed.   
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Figure 2.3: Exon trees showing relationship between the individual exons  
Rooted neighbour joining phylogenetic trees were generated using the translated first and 
second coding exon sequence separately. Species included are homo sapiens (hs), mus 
musculus (mm), bos taurus (bt), sus scrofa (ss), pan troglodytes (pt), equus callibus (ec), 
gallus gallus (gg), monodelphis domestica (md), ornithorhynchus anatinus (oa) and 
macropus eugenii (me).  The first exon of S100A7, S100A15 and S100A19 group together 
with S100G, and while the second exon of S100A15, S100A19 and S100G also group 
together, S100A7 groups separately with S100A10. Glucosidase beta acid (GBA) was used as 
an outgroup. Bootstraps values calculated on 100 replicates are indicated.   
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Figure 2.4: Gene structure and amino acid sequence comparison between the S100A7 and 
S100A15 genes. 
(a) Schematic diagrams of S100A15 gene structures in different species. Comparison shows 
that coding regions are highly conserved across orders, however human ‘S100A15’ does not 
show the conserved gene structure (shown in red). Non-coding exons are not shown.  (b) 
Clustal alignments of human (hs) and chimpanzee (pt) S100A15/S100A7a (boxed in red) 
with both S100A7 and S100A15 amino acid sequences from other species. The human and 
chimpanzee S100A15/7a protein shows much greater homology to the S100A7 group, while 
the translated human pseudogene aligns well with amino acid 39 to 108 of S100A15 from 
other species. Mouse (mm) S100A15/A7a (also boxed in red) aligns well with the S100A15 
proteins from other species. (c) EMBOSS Needle alignment and percentage identity 
calculations of the human (h) and mouse (mm) S100A7a genes. Parameters as follows, 
Matrix: EDNAFULL, gap penalty 10.0, extend penalty 0.5. 
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Figure 2.5: Comparison between human and mouse S100A7/S100A15 chromosomal region  
Inspection of the human 1q21 and mouse 3qF1 regions containing the S100 cluster show a 
number of duplication and inversion events have occurred in the human, as well as a loss of 
the functional S100A15 gene. The mouse chromosome appears to have undergone a 
deletion in the S100A7 region, while retaining the functional S100A15 gene. 
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Figure 2.6: Dot-plot alignment human and mouse S100 loci supporting a deletion on the 
mouse chromosome. 
The genome sequence at the S100 chromosomal cluster was compared between the human 
and mouse. The mouse reverse strand was aligned to the human forward strand. A clear 
diagonal line showing an interruption at the S100A7 loci supports the theory of a deletion 
on the mouse chromosome resulting in the loss of the S100A7 gene. Parameters set as 
follows: K-tuple 30, mismatch 9. Positive alignments of genes are indicated by broken green 
lines, and pseudogenes shown in purple.  
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Figure 2.7: Dot-plot alignment of human and cow S100A7/S100A15 chromsomal region. 
Alignment of the human and cow S100A7/S100A15 cluster shows that only two S100A7-like 
genes are present within the region. The cow reverse strand was aligned to the human 
forward strand. Parameters were set as follows: K-tuple 35, mismatch 9. Positive 
alignments of genes are indicated by broken green lines and repeats are boxed in red.  
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Figure 2.8: Genome sequence analysis of the human and opossum 
S100A7/S100A15/S100A19 subfamily. 
 (a) GEVo alignment of human and opossum chromosomal regions flanking the 
S100A7/S100A15 genes. Other genes are shown in blue and opossum S100A19 in red. 
Positive hits (pink bars) show likeness of the S100A8 and S100A6 genes, and the opossum 
S100A15 gene aligns with the human pseudogene AL4.7 as expected. Large repeats also 
align. There is no significant likeness in the hsS100A7/mdS100A19 regions. Un-sequenced 
regions are show in green. (b) Unassembled wallaby scaffolds taken from Ensembl. The 
wallaby appears to have lost functional S100A6, with a pseudogene ENSMEUG00000007062 
(Ensembl) taking its place. A Blast alignment for S100A8 returned no significant results in 
the wallaby, likely due to the gaps in coverage during sequencing. (c) Clustal alignment of 
opossum and wallaby S100A15 and S100A19 proteins and EMBOSS Needle identity 
calculations showing significantly greater conservation of the S100A15 protein.  
 
83 
 
 
 
 
84 
 
 
Figure 2.9: Schematic representation of the evolution of the S100A7/S100A15/S100A19 
subfamily.  
The possible evolution of the S100A7/S100A15/S100A19 subfamily involves an early 
duplication giving rise to S100A15 and S100A19. The S100A7 gene appeared before the 
divergence of euarchontoglires and laurasiatheria. There have since been simultaneous 
S100A7 deletions on the rodent and canine lines, and S100A7 duplication on the bovine and 
primate lines. The S100A15 gene appears to have been lost only in the late primates.  
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Figure 2.10: Human versus dog dot-plot and bovine alignment data supporting the proposed 
evolutionary model.  
(a) Alignment of the human and dog S100 cluster shows a clear interruption in the diagonal 
alignment at the S100A7 loci, supporting the theory of a deletion on the dog chromosome 
resulting in the loss of the S100A7 gene. The dog reverse strand was aligned to the human 
forward strand. 
(b) An alignment between the two S100A7-like genes in the cow shows only 15 base pair 
changes in the coding sequence with an identity of 95.1%, suggesting a recent duplication 
of S100A7 independent of the primate duplication events.  
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one common ancestor, which has undergone an early duplication. The ancestor is expected 
to be most closely related to the S100A19 gene, given that the monotremes and marsupials 
are the most ancient species, having diverged prior to the other orders. FastDots analysis 
shows a deletion in the dog S100A7 chromosomal region, and an Emboss alignment of the 
cow S100A7 and S100A7-like genes shows high identity value of 95.1% supporting a late 
duplication on the bovine lineage.     
2.4.4 Determination of the S100A19 5’ non-coding exon 
The first and second coding exons of the S100A19 gene in the tammar wallaby were 
previously determined by Kwek (2009) to be 159 bp and 183 bp respectively, and protein 
predicted at 13 kDa. Examination of the gene structure of the S100 family brought to 
attention the conserved 5’ non-coding exon, leading to the supposition that the marsupial 
and monotreme S100A19 gene is also likely to include this exon. To determine that wallaby 
5’ non-coding sequence, PCR was performed on cDNA from the wallaby mammary gland. 
Results confirmed a non-coding exon of at least 37 base pairs (due to primer constraints, 
with actual length predicted 40 bp), comprising a 620 bp intronic region with splice sites at -
22/-23bp and -643/-642bp upstream of the ATG start codon (Figure 2.11). The newly 
defined wallaby sequence was then used to predict the non-coding sequence and splice 
sites in the opossum and platypus. The proposed opossum non-coding exon sequence is also 
40 bp with splice sites predicted at -22/-23bp and 635/-634bp, and an intronic region of 
612bp (Figure 2.12). Gaps in sequencing of the platypus genome did not allow sufficient 
sequence to determine the first intron splice site, but a tentative splice site is predicted at -
18/-19bp upstream of the ATG (Figure 2.13). 
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Comparison of eutherian S100A7 and murine S100A15 genes with marsupial 
S100A19 showed a similar but distinct gene structure (Figure 2.14). Coding regions are 
similar in length, although slightly longer in marsupials, with exon 1 ranging from 141 to 
159bp and exon 2 from 165 to 213 bp in eutherians and marsupials respectively. The 
intronic regions, however, are up to 1600 bp shorter in marsupials, although mature 
transcript length is comparable to other species.  
2.5 Discussion  
2.5.1 Clarification of human and mouse S100A7a/S100A15 nomenclature 
Close examination and comparison of the S100A15 and S100A7 gene structure and amino 
acid sequence show that the human gene with multiple names of S100A15 and S100A7a is a 
recently duplicated copy of the S100A7 gene. It therefore should not be referred as 
S100A15, as the S100A15 genes are, although related, a distinct group present in marsupials 
and monotremes, rodents, lagomorphs and eutherians including some primates. It is clear 
that the mouse gene, also known by the multiple names of S100A15 and S100A7a, on the 
other hand belongs to the S100A15 subfamily, and the accepted MGI (Mouse Genome 
Informatics) and HGNC names should be changed to S100A15 to avoid confusion.  
 2.5.2 Origin and evolution of the S100A7/S100A15/S100A19 subfamily 
Phylogenetic analysis demonstrates that the mostly closely related proteins to the marsupial 
S100A19 are those of the S100A7/S100A15 subfamily. Although previous analysis by Kwek 
(2009) suggested that S100A19 was the marsupial equivalent of S100A7, sequence analysis 
here shows a relatively equal likeness to both S100A7 and S100A15. In the protein tree, 
S100A19 branches as a distinct clade before both S100A7 and S100A15, and while the 
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Figure 2.11: Full S100A19 gene and protein sequence in the wallaby. 
Non coding exons are shown in red font, introns in green font and coding exons in blue font 
with amino acid sequence below. Splice sites are underlined and predicted TATA box is 
highlighted in red.  
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Figure 2.12: Full S100A19 gene and protein sequence in the opossum. 
Non coding exons are shown in red font, introns in green font and coding exons in blue font 
with amino acid sequence below. Splice sites are underlined and predicted TATA box is 
highlighted in red.  
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Figure 2.13: S100A19 gene and protein sequence in the platypus. 
Non coding exons are shown in red font, introns in green font and coding exons in blue font 
with amino acid sequence below. Splice sites are underlined. The full 5’ non-coding 
sequence or predicted TATA box could not be determined due to gaps in sequence 
coverage.  
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Figure 2.14: Gene structure comparisons between the marsupial S100A19 and the eutherian 
S100A7 and murine S100A15 genes.   
Schematic diagrams of the marsupial S100A19 and eutherian S100A7 and murine S100A15 
genes show conservation of gene structure between species, including a 3’ non-coding exon 
and an interrupted 5’ non-coding exon. Limited species are shown due to the lack of 
availability full exon structure information for other species.   
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 transcript tree shows a grouping with S100A15, a bootstrap value of only 539 suggests that 
for every 1000 trees generated, S100A19 may group with S100A7 up to 461 times. The 
S100G protein also appears to have a close relationship to the S100A7/A15/A19 subfamily, 
with trees consistently presenting S100G as a neighbouring clade. It seems likely that these 
proteins share the same origin, and that evolution, duplication and rearrangement events 
involving a common ancestor have given rise to this subset of proteins. While the S100A7, 
S100A15 and S100A19 genes are located within the S100A cluster, the S100G gene is found 
on a different chromosome. The S100A group is located on chromosome 1, 3 and 2 in the 
human, mouse and opossum respectively. In contrast, the S100G gene is located on the X 
chromosome in humans and mice, and on chromosome 7 in the opossum. Due to the 
presence of all 3 members S100A7, S100A15 and S100G in various species, it seems likely 
that these genes originated from a common ancestral gene through duplication prior to 
divergence of mammals.  
When the translated amino acid sequences of the first and second coding exon are 
analysed separately, the second exon of S100A19 shows a slightly closer relationship to that 
of S100A7 while S100A15 branches with S100G in a neighbouring clade. The first exon of 
S100A19 groups with S100A15 and S100G, while S100A7 proteins groups with the S100A10 
proteins some distance from their relatives, but again low bootstrap values give low 
confidence of these relationships. The groupings may, however, give some insight into the 
evolution of this subfamily of genes. This result, together with the absence of the S100A7 
gene in the marsupials and monotremes, may suggest that while exon 2 of S100A7, 
S100A15, S100A19 and S100G share the same origin, the S100A7 gene possibly arose from a 
recombination event between the second exon of the S100A19 gene or the ancestral gene 
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of this subfamily, and the first exon of S100A10 (or a precursor). These events are the 
presumed method by which the S100 protein family arose during the speciation of 
vertebrates.  
The S100 proteins are thought to be a relatively young family of proteins in 
evolutionary terms, as to date they have been isolated only from vertebrates (Shang et al., 
2008). Analysis of the genomes of non-vertebrate eukaryotes such as insects, nematodes 
and protozoa showed no S100-like sequences (Marenholz et al., 2004). At least five sub-
groups of S100 proteins are evident from phylogenetic analysis; the first four identified by 
Marenholz et al. in 2004. These subgroups are thought to have arisen via multiple 
duplications and other evolutionary events such as rearrangements resulting in gene 
creation. It seems that the sub-groups of related proteins may also share some 
characteristics such as sub-cellular localisation and function. The first sub-group is formed 
by S100A1, S100B, S100P and S100Z, with S100A10 and S100A11 included although forming 
their own branch. The proteins S100A2, S100A3, S100A4, S100A5 and S100A6 form the 
second subgroup. The third subgroup, consisting of S100A8, S100A9 and S100A12 have all 
been isolated from the extracellular space, where they act as chemotactic molecules and 
mediate pro-inflammatory signals (Marenholz et al., 2004, Hofmann et al., 1999). S100A13, 
S100A14, S100A16 make up the fourth subgroup. The fifth subgroup, defined here, consists 
of S100A7, S100A15, S100G and S100A19. S100A7 was previously thought to stand alone 
with S100G (formerly known as calbindin 3) some distance from the primary four 
subgroups, potentially due to earlier divergence or comparatively more significant changes 
over evolutionary time. Although S100A7 itself has much lower than standard homology 
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when compared pairwise with other S100 proteins (Kulski et al., 2003), it appears to fit well 
within in the S100G/S100A5/S100A19 subgroup. 
The limitations of phylogenetic analysis leave a question as to whether the S100A19 
gene is an early form of S100A7 as previously suggested by Kwek (2009), or whether it 
stands alone as a novel member of the S100 family. Gene loci analysis shows that while the 
S100A7 and S100A19 genes appear in approximately the same locus, the alignment pattern 
of repeats shows a shift to the left in the human, suggesting a possible deletion in the 
human chromosome surrounding the S100A7/A19 loci. This could mean that the ancestral 
S100A19 gene has been deleted in eutherians following a duplication rearrangement event 
resulting in the creation of S100A7. However, the presence of multiple S100A7-like genes in 
the human also suggests that significant change has occurred in this region, which may 
imply that either S100A19 or S100A7, or perhaps both, have simply undergone such 
significant change through evolution resulting in the formation a separate clade. While the 
S100A15 gene is highly conserved between the opossum and wallaby, the S100A19 gene is 
poorly conserved by comparison with almost half the sequence identity. The reason for such 
poor conservation is unclear; a possible cause may be highly specialised species specific 
function. 
The evolutionary model of the S100A7/A15/A19 subfamily was generated through 
careful consideration of both data generated in the present study and that described in 
published literature (Wolf et al., 2006, Shang et al., 2008, Kulski et al., 2003, Marenholz et 
al., 2004). It is supported by phylogenetic and genome sequence analysis, and is in line with 
the published Bayesian phylogenetic molecular tree of evolution (Murphy et al., 2001). The 
model shows simultaneous duplications and deletions on separate evolutionary lineages 
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demonstrating that this region is somewhat unstable. It appears that the human paralogs 
S100A7, S100A7a and S100A7L2 have emerged through duplications after the divergence of 
the primates. Although a second ‘S100A7-like’ paralog is present in the bovine, a duplication 
event appears to have occurred separately on the bovine lineage, quite recently in 
evolutionary terms.  
It is hypothesised that S100A15 evolved from a duplicate copy of the ancestral gene, 
while S100A19 has endured significant change and divergence, perhaps through 
recombination with a contemporary or ancestral S100A10 duplicate, to become S100A7 in 
rodentia, lagomorpha and primates. By definition, orthologs are genes related via 
speciation, that is, through vertical decent, and paralogs are genes related via duplication 
(Koonin, 2005). Both duplication (likely multiple counts) and change through speciation 
appear to have occurred. As we cannot fully understand the details of the evolutionary 
pathways which led to the emergence or divergence of these genes, it would be 
unreasonable to attempt to define S100A7 and S100A19 as either orthologous or 
paralogous genes. In general terms, insufficient information is available to effectively 
determine the nature and timing of gene duplication or speciation events that gave rise to 
the species of today (Jenson, 2001). S100A7 might therefore be more reasonably termed 
broadly as a homolog of both S100A19 and S100A15, indicating their common origins. 
2.5.3 Conserved structure of the 5’non-coding exon 
The S100A7/A15 subfamily exhibit a conserved exon structure, including two coding exons, 
with flanking untranslated regions (UTR’s) as well as a 5’ non-coding exon. This structure is 
also evident in the marsupial S100A19 gene and transcript, and most likely the monotreme 
gene also. Most S100 genes show similar organisation, with few exceptions such as S100A5 
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which has four exons and three introns (Wicki et al., 1996, Engelkamp et al., 1993). It is 
understood that the 5’ UTR contains regulatory elements such as sequences either 
promoting or inhibiting the initiation of translation, protein binding sites, iron responsive 
elements which regulate gene expression in response to iron in eukaryotes and also the 
ribosome binding site (RBS) or Shine Delgarno sequence in prokaryotes (Cenik et al., 2010). 
Both 5’ and 3’ UTRs enhance mRNA stability (Misquitta et al., 2001). However, little is 
known about the role of non-coding exons, but their frequent occurrence in vertebrate 
transcriptomes suggests an important function (Cenik et al., 2010). The synthesis of 
differential transcripts has been observed in the mouse Prkar1b gene, with the use of 
different promoters resulting in alternative transcript isoforms with varying 5’ non-coding 
exons. The resulting transcripts show tissue specific expression, suggesting varied regulatory 
mechanisms or functions (Banday et al., 2012). The most common and likely role for the 
S100 family  5’ UTR is translational regulation (Araujo et al., 2012), although no such 
function has been established in the S100 protein family to date.  
2.6 Conclusion  
The S100A19 gene described here belongs to a large family of EF-hand calcium binding 
proteins involved in many intracellular and extracellular processes. Analysis of phylogenetic 
relationships and evolution of the gene locus offers insight into possible functional roles for 
S100A19 protein through comparison with closely related proteins and scrutiny of predicted 
evolutionary events. Gene structure analysis indicates the importance of structural aspects 
such as conserved coding and non-coding regions and binding domains, and provides clues 
as to how the gene expression may be regulated. We found that S100A19 is closely related 
to S100A7 and S100A15 proteins, and S100G to a lesser extent. The S100A7 protein has 
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been studied extensively in the human and bovine, and a review of the related literature 
provides clues as to the functional role of the marsupial and monotreme gene, in particular 
antibacterial activity. The confirmed presence of a 5’ non-coding exon may also indicate the 
involvement of post-transcriptional regulatory mechanisms controlling gene expression.  
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Chapter 3 
Functional Properties of S100A19 protein in the Tammar Wallaby (Macropus eugenii): 
Microbial Protection and Proliferation of Mammary Epithelial Cells 
 
3.1 Summary 
This study examines the function of the marsupial S100A19 protein. Results show that 
S100A19 has a similar secondary structure to S100A7 protein, although in contrast with 
S100A7 it appears to have a functional N-terminal Ca2+ binding domain and an extended 
Zn2+ coordinating motif. Like the human S100A7 protein, S100A19 protein has antibacterial 
activity. The S100A19 gene shows greatest expression in the tammar wallaby mammary 
gland during periods of increased susceptibility to infection (pregnancy and involution) and 
in the pouch only during early lactation when the pouch young is immunologically 
incompetent, providing protection against pathogenic bacteria. The protein also exhibits 
mitogenic activity, stimulating mammary epithelial cell proliferation in culture and is likely 
to aid cell growth during pregnancy, preparing the mammary gland for lactation.   
3.2 Introduction 
The distinguishing feature of mammals is the ability to provide complete nutrition to the 
infant through secretions from the mammary gland. In contrast with the eutherian 
reproductive strategy in which the foetus is dependent on the maternal placenta for the 
delivery of nutrients and biochemical signals for a large proportion of development, the 
marsupial strategy is unique in that it involves the birth of highly altricial young which is 
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solely dependent upon the mother’s milk from an early stage of development (Nicholas et 
al., 1997, Tyndale-Biscoe and Janssens, 1988). After a short period of intrauterine 
development, the neonate is born and crawls unassisted into the maternal pouch, which 
provides physical protection and temperature homeostasis (Baudinette et al., 1988). The 
newborn young of marsupials do not have lymphoid tissue and are unable to mount an 
adaptive immune response (Old and Deane, 2000, Baudinette et al., 1988). They are born 
into a non-sterile environment in an undeveloped, foetus-like state and are highly 
vulnerable, and they therefore depend on the mother for protection via a number of 
maternal strategies (Ambatipudi et al., 2007). Recognised maternal protective mechanisms 
include the prenatal transfer of immunoglobulins, the passive transfer of immunoglobulins 
and immune cells via the milk (Deane and Cooper, 1984, Young et al., 1997, Young and 
Deane, 2001, Old and Deane, 2000). The chemical or mechanical cleaning of both the pouch 
interior and the pouch young by maternal licking is also a likely protective mechanism 
(Edwards et al., 2012). It has also been postulated that the pouch epithelium may secrete 
specific compounds which act to protect the immunologically incompetent neonate, either 
by reducing bacterial population to a safe level or eliminating harmful species completely 
and therefore maintaining suitable pouch conditions for the young (Yadav et al., 1972, 
Ambatipudi et al., 2007, Old and Deane, 1998).  
Epithelial surfaces are continually exposed to a host of bacterial species, but rarely 
succumb to infection. The dead, desiccated layer of epidermal cells on the stratum corneum 
forms a physical barrier, which is difficult for microbes to penetrate (Gläser et al., 2005). 
Mammalian epithelia produce many innate immune effector molecules including lysozyme 
(Klenha and Krs, 1967), RNase 7 (Harder and Schroder, 2002), antileukoprotease (Wiedow et 
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al., 1998) and dermcidin (Schittek et al., 2001) which are commonly secreted by either the 
keratinocytes or sweat ducts of healthy skin. Other molecules such as β-defension and 
cathelicidin are inducible by either inflammation or contact with bacteria (Gläser et al., 
2005).  
The warm, moist environment of the marsupial pouch is favourable for bacteria, and 
it hosts a variety of microflora including a number of potentially pathogenic species (Old and 
Deane, 1998, Chhour et al., 2010, Osawa et al., 1992). A study by Old and Deane (1998) 
found that the greatest diversity of bacteria were present in wallaby pouches not containing 
pouch young. A total of 25 species of bacteria were identified in empty pouches, 15 of which 
were found exclusively in pouches without young. In 2010, Chhour et al. reported similar 
findings, showing a greater variety of microbes in empty pouches, and fewer present in 
pouches one day post-partum. This suggests that the pouch environment in adult 
marsupials approaching parturition is regulated by maternal mechanisms that either reduce 
or exclude harmful bacteria. While there is no current evidence for any ill effects resulting 
from the bacterial colonisation of the tammar wallaby pouch (Old and Deane, 1998), the 
presence of pathogenic bacteria in the koala pouch has been linked to increased mortality 
rates of young (Osawa et al., 1992). Washes from the inside of the wallaby pouch have 
exhibited antimicrobial activity, with the greatest activity observed in washes from females 
during oestrous when compared with pre- and post-oestrous females (Ambatipudi et al., 
2008). Washes from the koala and wallaby pouch have demonstrated antibacterial effects 
against E. coli, a Gram negative species, but did not inhibit the growth of the Gram positive 
S. aureus (Bobek and Deane, 2002, Ambatipudi et al., 2008). It is likely that antimicrobial 
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secretions from the pouch epithelium exhibit bacterial specificity, perhaps selecting for 
potentially harmful species.  
The wallaby pouch epithelium is thought to secrete many proteins, and the 
secretome undergoes qualitative changes throughout the reproductive cycle (Ambatipudi et 
al., 2007). Some proteins such as dermcidin, α-lactalbumin, β-lactoglobulin and casein 
isolated from the wallaby pouch by Ambatipudi et al. (2007) are known to have 
antimicrobial activity or antibacterial derivatives in other species. A folding variant of α-
lactalbumin found in human milk (Håkansson et al., 2000), β-lactoglobulin fragments from 
bovine milk (Miyabe et al., 1981, Hernández-Ledesma et al., 2008), casein peptides from 
rabbit (Baranyi et al., 2003) and bovine (Hayes et al., 2006) milk, and dermcidin from the 
human sweat glands (Schittek et al., 2001, Lai et al., 2005) have all been shown to have 
antibacterial activity. However, since the isolated proteins included a number of milk 
proteins, it is difficult to determine whether those antibacterial proteins identified to date 
originate either from the mammary gland secretions, pouch secretions, the maternal saliva, 
from the pouch young excrement or pouch young skin secretions. Antimicrobial secretions 
originating from the pouch epithelium had not been confirmed prior to this study.  The 
molecular approach utilised here provides greater insight into the secretion of antimicrobial 
proteins in the pouch.  
A number of secretory S100 proteins display antimicrobial functions including 
S100A7, S100A8, S100A9 and S100A12. A hetrodimer consisting of S100A8 and S100A9 
protein, known as calprotectin, is a potent antimicrobial (Miyasaki et al., 1993, Murthy et 
al., 1993, Sohnle et al., 1991, Steinbakk et al., 1990).  S100A12 protein gives rise to an 
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antimicrobial peptide of the human airway secretions (McFarland et al., 2008, Cole et al., 
2001) and concentrations of S100A12 are increased in the S. aureus -infected bovine udder 
(Strandberg Lutzow et al., 2008).  The S100A7 protein is secreted by the keratinocytes and 
sebaceous glands and is one of the human skin’s main defences against E. coli infection 
(Gläser et al., 2005). It also protects the female genital tract (Mildner et al., 2010), increases 
the resistance of wounds to bacterial infection (Lee and Eckert, 2007), is upregulated in the 
human lung in response to S. aureus infection, and is thought to be involved in microbial 
defense of the airways (Andresen et al., 2011). The bovine ortholog of the S100A7 gene is 
upregulated during mastitis infection, a bacterial infection of the breast most commonly 
caused by E. coli (Regenhard et al., 2010, Regenhard et al., 2009). The closely related human 
S100A7a has also been implicated in E. coli defense (Büchau et al., 2007).          
In chapter 2, we showed that the marsupial and monotreme S100A19 protein shares 
significant homology and genetic origin with S100A7. The S100A8, S100A9 and S100A12 
proteins belong to a closely related neighbouring subgroup and may also share common 
functions.  This chapter explores the function of S100A19, and results show that the protein 
shares some structural characteristics with S100A7 and other members of the S100 protein 
family, is differentially expressed in wallaby tissue at different stages of the reproductive 
cycle, and exhibits mitogenic and selective antimicrobial activity. The S100A19 protein is 
identified as a maternal defence mechanism, secreted into the pouch during early lactation 
to either reduce or inhibit specific bacterial strains to provide an appropriate environment 
for the growth and development of the neonate. Furthermore, the S100A19 gene is 
upregulated in the mammary gland at times of significant morphological transformation; 
during pregnancy as the gland prepares for milk synthesis and during involution as the gland 
109 
 
reverts back the non-lactating state (Kass et al., 2007). These periods of intense change 
leave the mammary gland vulnerable to bacterial infection (Neave et al., 1950, Oliver and 
Mitchell, 1983, Sordillo et al., 1987), and upregulation of the S100A19 gene and production 
of the subsequent protein may provide antimicrobial protection. Additionally, this study 
shows a new function for S100A19 protein; it has mitogenic activity and therefore likely 
influences mammary epithelial cell proliferation, which occurs rapidly in the mammary 
gland during gestation as the milk ducts extend throughout the stroma and alveolar buds 
form (Hennighausen and Robinson, 2005).  
3.3 Materials and Methods 
3.3.1 Secondary structure, structural domain, and protein disorder prediction 
The SOPMA Secondary Structure Prediction Method (online server, http://npsa-
pbil.ibcp.fr/cgi-bin/npsa_automat.pl?page=/NPSA/npsa_sopma.html) was used to predict 
wallaby S100A19 secondary structure (Geourjon and Deleage, 1995). ClustalX Version 2.0.11 
(Larkin et al., 2007) was employed for sequence alignments and ANCHOR (online server, 
http://anchor.enzim.hu) used to predict binding sites (Bálint et al., 2009). IUPred (online 
server, http://iupred.enzim.hu/) was utilised for the prediction of structural domains 
(Dosztányi et al., 2005), and Poodle-S web application (http://mbs.cbrc.jp/poodle/poodle-
s.html) used to predict disordered regions (Shimizu et al., 2007). 
3.3.2 Animals 
Tissue for gene expression studies was collected from the mammary glands of 37 female 
tammar wallabies at various stages of lactation. Animals included 2 non-pregnant, 9 
pregnant, 10 phase 2A lactating, 7 phase 2B lactating, 5 phase 3 lactating and 4 involuting 
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females. Animals were euthanised and mammary glands excised and dissected into 0.1g – 
0.15g portions. Pouch skin biopsies were taken from 4 animals post-oestrus, 8 animals 
between 1 and 40 days post-partum (Phase 2A, kindly provided by J. E. Deakin Laboratory, 
Australian National University) and 3 animals between day 136 and 151 post-partum (Phase 
2B). When mammary gland tissue was not required, pouch skin was sampled from live 
animals under general anaesthetic (isofluorane) using a biopsy punch and curved surgical 
scissors (sample weight 0.1g - 0.2g), and incisions closed with 1 – 2 sutures. All samples 
were placed on dry ice immediately after excision and stored at -80°C until use.  
3.3.3 RNA extraction and reverse transcription 
Tissue was homogenised using a rotor-stator (Polytron® PT-MR2100, Kinematica AG) and 
RNA extracted using a PureLink RNA mini kit (#121830018A, Ambion) as per manufacturer’s 
protocol. RNA quantity and quality were assessed using a nanodrop spectrophotometer 
(NanoDrop 1000, Thermo Scientific), and reverse transcription was performed from 1μg of 
RNA from each sample. RNA was incubated at 65°C for 5 min with 1 μL of 10mM dNTP mix 
(#18427-088, Invitrogen) and 1 μL of oligo DT primer at 0.05 μg/μL (Sigma), made up to 12 
μL with nuclease free water and then placed on ice for 2 min. To each prepared RNA mix, 4 
μL of 5 x First Strand Buffer (#y02321, Invitrogen), 2 μL of 0.1M DTT (#y00147, Invitrogen), 1 
μL RNaseOut at 40U/μL (#100000840, Invitrogen), 0.25 μL Superscript IIITM Reverse 
Transcriptase at 200U/μL (#56575, Invitrogen), and 0.75 μL nuclease free water was then 
added. Template- and enzyme-free controls were included. Reactions were placed in a 
thermocycler (Eppendorf Mastercycler®) at 42°C for 50 min, 70°C for 15 min, followed by 
4°C for 5 min and samples then kept at -20°C until use.  
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Table 3.1 DNA oligo probes used in qPCR 
Gene ID GenBank ID Primer sequences (5’ to 3’ orientation) Product Size (bp) 
S100A19 EU682765 
F: CACTCATCTGACTCTTTCCTCTTG 
R: CCAGCACAGTCACAAACTC 
315 
BLG X15212 
F: GCATGTGCCCACTATGTCAG 
R: AGGGGGATAACTTCGTCTGC 
154 
GAPDH EF654515 
F: GACTCATGACTACAGTCCATGCCAT 
R: GGACATGTAGACCATGAGGTCCAC 
479 
18S AJ311676 
F: CGGCTACCACATCCAAGGAA 
R: GCTGGAATTACCGCGGCTAGCCGCGGTAA 
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3.3.4 Quantitative PCR 
S100A19 and BLG gene expression were normalised against 18S rRNA and Glyceraldehyde-3-
phosphate dehydrogenase (GAPDH) housekeeping genes. Intron-spanning oligo probes 
(Table 3.1) were chosen to minimise the chance of amplifying contaminating genomic DNA. 
Probes were synthesised by Macrogen Korea. Reactions were performed in a Bio-Rad 
CFX96™ Real-Time Detection System. Each reaction consisted of 10 μL SsoFast™ Evagreen® 
Supermix (#172-5202, Bio-Rad), 0.5 μL forward and reverse primers at 10μM, and 0.5 μg 
template made up to 20 μL with nuclease-free water. Conditions were initial denaturation 
of 3 min at 94° C, followed by 39 cycles of 1 min denaturation at 94° C, 1 min annealing at 
60° C, and 30 sec extension at 72° C, with a final 5 min extension. All samples were assayed 
in triplicate, and template-free controls included. Relative expression levels of S100A19 and 
112 
 
BLG were calculated using Bio-Rad CFX Manager™ software (Version 3.0), ∆∆Cq normalised 
expression method.   Melting curve analysis was employed to confirm the amplification of a 
single PCR product.  
3.3.5 S100A19 gene constructs and transformation of E.coli 
Primers were designed to amplify the full length tammar wallaby S100A19 cDNA. The 
reverse primer was designed at the stop codon and included a sequence for FLAG-Tag which 
was added with the intention of subsequent protein purification. Primer sequences were as 
follows: Upstream primer 5’ GGTCCTCCCTGATACACTGA 3’ and downstream primer 5’ 
TCActtgtcatcgtcatccttgtaatcATGGTGGTGACCATGTGTGTG 3’ where the lower case letters are 
the FLAG sequence. Template cDNA was from day 5 involution (5 days post-weaning) 
wallaby mammary gland.  The PCR conditions included an initial denaturation at 94 °C for 
3 min, followed by 39 cycles of 94 °C 1 min, 60 °C 1 min and 72 °C 30 sec followed by a final 
extension of 72 °C for 5 min performed in an Eppendorf Mastercycler®. The reaction 
products were then run on a 1.2% agarose gel using electrophoresis, visualised using SYBR®-
Safe DNA Gel Stain (#S33102, Invitrogen) under UV light and extracted using PureLink Quick 
Gel Extraction Kit (#K210012, Invitrogen) as per manufacturer’s instructions. Purified DNA 
was then ligated into pTargeT™ Mammalian Expression Vector System (#A1410, Promega) 
with T4 DNA ligase (#15224-017, Invitrogen) following the manufacturer’s protocol.  
Electrocompetent E.coli cells were thawed briefly on ice, combined with ligated S100A19-
plasmid, added to an electroporation tube and pulsed briefly in an electroporator 
(MicroPulser Electroporator™, BioRad). The contents of the tube were then transferred to a 
sterile LB-agar plate supplemented with ampicillin (reagents #L2897 and #A0166 
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respectively, Sigma), spread with a glass rod beneath a Bunsen burner flame, and incubated 
overnight at 37°C. The following day, 5 colonies were each transferred to separate pre-
warmed tubes containing 3mL LB broth supplemented with Ampicillin (#L3022, and #A0166, 
Sigma) and incubated at 37°C for approximately 15 hours with shaking. Plasmid DNA was 
then purified using QIAprep Spin MiniPrep Kit (#27104, Qiagen) as pre manufacturer’s 
protocol. Aliquots of each of the 5 preparations were sent to Macrogen Korea for 
sequencing to ensure correct ligation and orientation of S100A19.  
3.3.6 HEK-293T cell transfection for conditioned media 
HEK-293T cells (a human embryonic kidney cell line) were cultured in Dulbecco’s Modified 
Eagle Medium (DMEM) high glucose media supplemented with 10% FBS (#IVT3008403, 
Invitro Technologies) and 1% L-glutamine (#25030, Gibco), and incubated at 37 °C (5% CO2). 
Lipofectamine® 2000 reagent (#11668-019, Invitrogen) was used to carry out transfections 
as per manufacturer’s protocol using the S100A19 construct (2500ng DNA per 1 x 106 cells). 
Ligated empty pTarget expression vector was transfected into cells as a negative control. 
Cells were seeded at 1 x 106 cells/mL and incubated overnight. The following day media was 
removed and cells carefully washed with phosphate buffered saline (PBS) (#E404, Amresco) 
to removed traces of serum, and media was replaced with Opti-MEM® Reduced Serum 
Media (#31985, Gibco). Transfections with the fluorescent marker Green Fluorescent 
Protein (GFP) cloned in pTargeT™ were included to assess transfection efficiency. Cells 
transfected with the GFP construct were imaged 24 h post-transfection to confirm effective 
transfection. Conditioned media was collected 48 h post-transfection and centrifuged at 
5000 x g for 5 min to remove cell debris, and supernatant stored at −80 °C until use. 
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3.3.7 Antibacterial assays 
Antibacterial assays were performed using alamarBlue® Cell Viability Reagent (#DAL1025, 
Invitrogen) as per manufacturer’s protocol. Overnight cultures of ATCC25923 
Staphylococcus aureus, ATCC43971 Salmonella enterica, ATCC27853 Pseudomonas 
aeruginosa, and ATCC10100 Enterococcus faecalis and Escherichia coli 0157:H7 
ATCC43895 were prepared in Iso Sensitest™ broth (#CM0473, Oxoid) and incubated 
overnight at 37 °C with shaking. To obtain log phase cultures, a 200 μl aliquot of each 
overnight preparation was added to 1.8 ml ISA broth and incubated at 37 °C with shaking for 
3h. Initial cell number was determined by absorbance measurement on a 
spectrophotometer at 600 nm (SmartSpec™ Plus Spectrophotometer, Bio-Rad). To assess 
antibacterial activity, 96-well assay plates (#3603, Corning Incorporated) were loaded with 
10 μl alamarBlue®, 40 μl conditioned media (S100A19 or negative control) and log-phase 
bacterial preparations to a concentration of 1 × 104 cells/ml (total volume 100μL per well). 
Plates were incubated at 37 °C with shaking and absorbance measured every hour on a UV-
Vis spectrophotometer (xMark™ Microplate Spectrophotometer, Bio-Rad) at 570nm, with 
the exception of the E. coli strain for which fluorescence was measured on a fluorescence 
spectrophotometer (Glomax Multi Detection System, Promega) using excitation 560nm and 
emission 590nm filter settings. All assays were performed in triplicate and repeated at least 
three times. 
3.3.8 Cell proliferation assays 
A culture base media (2x) was prepared by dissolving 10 x Medium 199 (final conc. 
0.0095g/mL, #31100-035, GIBCO) and 10 x HAMS F12 (final conc. 0.00106g/mL, #21700-026, 
GIBCO), HEPES (final conc. 0.00476g/mL, #H4034, Sigma), sodium bicarbonate (final conc. 
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0.0075g/mL, #S5761, Sigma) and anhydrous sodium acetate (final conc. 328μg/mL, #S8750, 
Sigma) in milliQ water. The pH of the solution was measured (Denver Instrument pH Meter, 
Model 215) and adjusted to pH 7.55 at room temperature with 1M NaOH. The solution was 
then filter sterilised with a 0.2 μM filtration system (#431097, Corning Incorporated). The 1 x 
growth media was prepared by adding 20% (final conc.) horse serum (#16050, GIBCO), 5% 
(final conc.) foetal calf serum (FCS) (#3008403, Invitro Technologies), 1mM 
Penicillin/Streptomycin (#15140-122, GIBCO), epidermal growth factor (EGF) (10ng/mL, 
#E4127, Sigma), bovine insulin (0.1μg/mL, #I-5500 Sigma), and cortisol (F) (1μg/mL, #H-4001 
Sigma), to 50mL culture base and solution made up to 100mL with milliQ and again filter 
sterilised with a 0.2 μM filtration system. Wallaby mammary epithelial cells (WallMECs), 
extracted from day 15 pregnant mammary tissue by Stephen Wanyonyi as per  Wanyonyi et 
al. (2011), were seeded at 2000 cells/well in 96 well plates (#3599, Corning®) in a solution of 
1:1  growth media and conditioned media and incubated at 37oC (5% CO2). Conditioned 
media from HEK293T cells transfected with Empty pTARGET™ vector was used as a control. 
Cells were monitored and counted each day for 7 days using the Trypan Blue (0.4%, #T8154, 
Sigma) staining method, 1 x trypsin-EDTA (0.5%, #15400-054, Gibco) for cell dissociation, 
and a hemocytometer. Media in remaining wells was changed at day 3. Treatments were 
performed in triplicate and experiment repeated twice.  
3.3.9 RNA sequencing  
RNA from the pouch skin of one female at day 6 post-partum, extracted as per section 3.3.3, 
was sent to BGI China for Illumina GAII poly-A-selected paired-end RNA sequencing (45 nt+). 
Sequencing data was processed using a three step method. Raw sequences were cleaned 
using fastQ (http://www.bioinformatics.babraham.ac.uk/projects/fastqc/) and fastx 
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Figure 3.1: Prediction of wallaby S100A19 protein secondary structure.  
Secondary structure of tammar wallaby (me) S100A19, human (hs) and bovine (bt) S100A7 
and mouse (mm) and bovine S100A15 proteins as determined by the SOPMA Secondary 
Structure Prediction Method. Alpha-helices and shown in blue, loops or random coils in 
purple and beta-turns in green. S100A19 and S100A7 have a 4-helix structure, while 
S100A15 appears to comprise a fifth helix.   
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Figure 3.2: S100 subfamily alignment and prediction of binding domains. 
(a) A sequence alignment of the S100A7, S100A15 and S100A19 subfamily shows 
positioning of the S100 and canonical EF-hands, calcium binding domains and HXXXH 
motifs. (b) A binding domain is predicted with approximately 70% likelihood within the N 
terminal EF-hand, and 90% likelihood within the C terminal EF-hand of the S100A19 
protein.    
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programs 
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(http://hannonlab.cshl.edu/fastx_toolkit/). The paired-end raw reads were then aligned 
using the TopHat version 2.0.3 with default settings. The aligned reads were assembled into 
genes and transcripts using cufflinks version 2.0.2 using Ensembl genome annotations. 
3.3.10 Statistical analysis 
Quantitative PCR and fluorescence data were presented as mean ± standard error of the 
mean (SEM). Statistical comparisons were made using paired t-tests assuming unequal 
variances between means. In all statistical tests a p value of less than 0.05 was considered 
significant.  
3.4 Results 
 3.4.1 S100A19 secondary structure and binding domains 
  3.4.1.1 SOPMA prediction 
In order to gain insight into the function of the S100A19 protein, the secondary structure 
was examined. The secondary structure of wallaby S100A19 protein was compared to 
secondary structure of human and bovine S100A7 and mouse and bovine S100A15 proteins 
(since the human genome lacks the S100A15 gene) (Figure 3.1). The S100A19 secondary 
structure appears very similar to that of S100A7 protein, consisting of 4 helices and an 
extended C-terminal random coil. Like the bovine S100A7, S100A19 also appears to have a 
beta-turn within the loop between the third and fourth helices, but lacks the beta-turn 
which closely follows the fourth helix in both human and bovine S100A7 proteins. 
Interestingly, the S100A15 proteins appear to have a fifth helix separated from the fourth 
only by a short beta-turn region, and also a beta–turn in the first loop between helices one 
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Figure 3.3: S100A19 protein lacks Jab1 binding domain. 
The Jab-1 binding domain previously identified in human (hs) S100A7, human leukocyte-
function-associated antigen-1 (LFA-1) and human p27 is not conserved in wallaby (me) 
S100A19, human (hs) S100A7a, bovine (bt) S100A7 or bovine (bt) S100A15 proteins. The 
first essential residue for Jab1 binding (boxed red) is changed from a negatively charged 
(E/D) amino acid to a neutral polar (N/S/Q/T, shaded green) amino acid. In addition, 
btS100A7 and meS100A19 proteins also have a positively charged H residue (shaded blue) 
where others contain neutral polar amino acids (boxed green). Wallaby S100A15 protein 
also has a valine (shaded purple) in place of leucine (boxed yellow). Adapted from Webb et 
al. (2005).  
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Figure 3.4: S100A19 tertiary structure: protein disorder and structural domains.  
(a) Disordered regions were detected at the N and C terminals with approximately 70% and 
90% probability respectively, and within the hinge region at a probability of 50%. (b) A large 
globular domain was predicted downstream of the hinge region.  
 
123 
 
and two. In terms of secondary structure, S100A19 correlates more closely to S100A7 than 
to S100A15 proteins.   
3.4.1.2 Protein alignment comparison and ANCHOR prediction of binding 
domains 
The S100A19 protein sequences were aligned with those of S100A7 and S100A15 to 
compare sequence characteristics which may play a role in function (Figure 3.2a). S100A15 
and S100A19 proteins align well and appear to have functional N-terminal Ca2+ binding 
motifs comprising the aspartate and glutamate residues required for ion binding (Brodersen 
et al., 1998, Marenholz et al., 2004). Like many S100 proteins, all members of the 
S100A7/S100A15/S100A19 subfamily contain the HXXXH motif thought to be involved in 
zinc chelation and antimicrobial activity (Loomans et al., 1998, Sohnle and Hahn, 2000). 
Similar to S100A9 protein (Kwek, 2009), S100A19 also has an extended His-rich tail. To 
further support the presence of functional binding domains, the wallaby S100A19 protein 
sequence was submitted to ANCHOR, an online server for binding region prediction. The 
model predicts operational binding regions in both the N- and C-terminal domains (Figure 
3.2b).  
  3.4.1.3 Assessment of Jab1 binding domain 
The wallaby S100A15 and S100A19 protein sequences were compared to other protein 
sequences with identified Jab1 domains, as well as the cow S100A7 and S100A15 sequences 
(Figure 3.3).  Both wallaby S100A15 and S100A19 proteins lack the motif, as do both the 
cow proteins. A negatively charged residue is thought to be required 22 amino acids 
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upstream of a leucine residue, and a neutral polar amino acid 10 amino acids downstream 
(Webb et al., 2005). Each of the cow and wallaby proteins have significant variations, 
presumably rendering the Jab1 domain inactive. The cow S100A7, S100A15 and wallaby 
S100A15 and S100A19 proteins have neutral polar residues in place of the required 
negatively charged residue, and cow S100A7 and wallaby S100A19 also have positively 
charged amino acids in place of the required neutral polar residue. In addition, wallaby 
S100A15 has a valine in place of the required leucine. Since the two amino acids are both 
side-branched amino acids with similar properties, this is a conservative change and may 
not have caused motif inactivation if the first required residue had been intact. Human 
S100A7a was also included in the analysis and has previously been described as a protein 
lacking the Jab1 binding domain (Webb et al., 2005). 
3.4.1.4 Poodle-S disorder and IUPred binding domain predictions 
To increase knowledge regarding the structural properties of S100A19, the tertiary structure 
was explored. The phenomena of ‘natively unfolded’ or ‘intrinsically disordered’ protein 
regions under physiological conditions is common. These regions serve fundamental roles in 
various biological activities such as cell signalling, cell cycle control and target recognition 
(Wang et al., 2011a), and thus recognising the presence of disordered regions is important 
for understanding protein function. It is predicted that the N- and C- terminal of the wallaby 
S100A19 protein are disordered, and there is also possible disorder within the hinge region 
(Figure 3.4a). Disorder in the hinge region is commonly required for target recognition 
(Permyakov et al., 2011). Human and bovine S100A7 and mouse and bovine S100A15 
proteins showed comparatively less overall disorder, with low probabilities of disorder (30-
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40%) at the hinge region (Data not shown). All sequences assessed for disorder did, 
however, show probable disorder at the C-terminal (60-80%).  
Globular domains effect protein shape and binding, and therefore significantly 
impact on function. The region between amino acids 47 and 91 spanning the canonical EF-
hand in wallaby S100A19 comprises a predicted globular domain (Figure 3.4b), which is 
likely to be important for ligand binding and may indicate a role in signalling or regulation.  
3.4.2 Temporal regulation of S100A19 gene in the wallaby mammary gland 
Kwek (2009) reported temporal expression of the S100A19 gene in the wallaby mammary 
gland using a limited number of animals and showed upregulation of gene expression during 
pregnancy and involution (shown in Figure 3.5b). This data, in combination with the 
knowledge that eutherian S100A7 protein exhibits antimicrobial activity (Gläser et al., 2005) 
and is expressed by epithelial cells of the mammary gland and nipple during mastitis in the 
bovine (Regenhard et al., 2010, Regenhard et al., 2009) and human (Dr. Julie Sharp, data 
unpublished) prompted further investigation of the S100A19 gene expression profile in the 
mammary gland using a larger sample size. Quantitative PCR was used to analyse gene 
expression, and tissue from a total of 37 animals from various stages throughout pregnancy, 
lactation and involution. Data showed that the S100A19 gene is temporally expressed 
throughout lactation, with highest levels present in the non-pregnant and pregnant gland, 
low levels during lactation, and an increase during involution (Figure 3.5a). The BLG gene, 
used for comparison, is expressed exclusively during the phase 2A, 2B and 3 of lactation and 
declines rapidly during involution as expected.  
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Figure 3.5: Temporal expression of the S100A19 gene in the tammar wallaby mammary 
gland 
(a) Gene expression levels of the S100A19 and BLG genes in tammar wallaby mammary 
tissue from 37 animals at various stages throughout the lactation cycle, normalised against 
GAPDH and 18S housekeeping genes. S100A19 gene expression is high in the non-pregnant 
mammary gland, is downregulated during the lactation period and expression increases 
again at involution. Results are consistent with data previously generated by Kwek (2009) 
(b). Data are presented as mean ± SEM. The BLG gene expression profile is used for 
comparison, with relative expression levels shown on the secondary axis (right on both 
graphs). 
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Figure 3.6: Cell viability assays showing antimicrobial activity of recombinant wallaby 
S100A19 protein. 
Antibacterial assays show effective inhibition of microbial growth by recombinant wallaby 
S100A19 protein. S100A19 protein inhibited growth of S. aureus (a), S. enterica (c), P. 
aeruginosa (d) and E. coli (e), but no effect on E. faecalis was observed (b). Conditioned 
media from cells transfected with empty plasmid vector was used as a negative control. 
Asterisk shows a statistically significant difference when P < 0.05. Each assay was 
performed in triplicate, and data are presented as mean ± SEM.  
 
 
 
 
129 
 
 
 
 
 
 
130 
 
3.4.3 Selective bacteriostatic effects of recombinant wallaby S100A19 
The upregulation of the S100A19 gene at involution, the presence of the zinc binding motif 
and the close relationship with S100A7 together suggest that S100A19 protein has 
antimicrobial activity. Recombinant wallaby S100A19 protein was tested for antibacterial 
activity on a selection of bacterial strains. The Gram positive S. aureus and Gram negative 
S. enterica and P. aeruginosa and E. coli species are pathogenic and known to cause 
infection in the stomach, respiratory system and/or mammary gland (Doymaz et al., 1988, 
Stetcher et al., 2007, Daly et al., 1999, Regenhard et al., 2010, Garmendia et al., 2005, 
Andresen et al., 2011, Argudín et al., 2010, Wesselkamper et al., 2008). A commensal 
bacterial species E. faecalis has been identified in the tammar wallaby gut (Yadav et al., 
1972), and was therefore chosen to test the selectively of the S100A19 protein.  Cell viability 
assays were performed using conditioned media from HEK293T cells transfected with 
wallaby S100A19 and compared with empty plasmid vector (negative control) treatment. 
Results showed that wallaby S100A19 had statistically significant antibacterial activity 
against the pathogenic S. aureus, S. enterica, P. aeruginosa  and E. coli species (Figure 
3.6). No significant effect was seen against E. faecalis, suggesting that S100A19 protein 
has selective activity against harmful bacterial strains  (P < 0.05).   
3.4.4 Proliferative effects of S100A19 protein on WallMECs 
Following the observation of the high expression levels of the S100A19 gene in the 
mammary gland during pregnancy, S100A19 protein was examined for either mitogenic 
activity or an influence on epithelial cell differentiation, processes which are essential in the 
mammary gland as it prepares for lactation. Conditioned media generated from HEK293t 
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cells transfected with either S100A19 or empty vector (control) constructs was applied to 
WallMECS to test the effect of S100A19 protein on cell proliferation. The addition of media 
containing S100A19 protein resulted in an increase growth rate, and significantly greater cell 
numbers (P <0.05) were seen after 4, 6 and 7 days when compared with the control 
treatment (Figure 3.7a). Although the difference in cell number at day 5 was not significant, 
proliferation of MECs was consistently greater in the presence of S100A19 protein when 
compared with the control. Cells were visually assessed each day and acini counted and 
measured using a light microscope at x 40 magnification; cell morphology appeared 
unchanged and acini formation occurred at the same rate in treatment and control groups, 
and spheres were of comparable size (Figure 3.7b). 
3.4.5 Differential regulation of the S100A19 gene in the wallaby pouch 
Due to the newly defined antimicrobial property of S100A19, it was predicted that it may 
also be secreted by the pouch epithelia to protect the pouch young from harmful bacteria. 
To explore the expression pattern of the S100A19 gene in the wallaby pouch, quantitative 
PCR was performed on samples obtained from the pouch of tammar wallabies at selected 
stages of the reproduction cycle. Expression of the S100A19 gene by the pouch epithelia 
was normalised against the housekeeping GAPDH and 18S genes, and found to be 
significantly greater (P< 0.05) in females during early phase 2A lactation when compared to 
phase 2B and non-lactating females (Figure 3.8).  
3.4.6 RNA sequencing data analysis 
RNA sequencing was utilised to examine the transcriptome of pouch epithelium during early 
lactation when the S100A19 gene is highly expressed. Illumina sequencing returned a total 
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Figure 3.7: Proliferative effects of S100A19 on WallMECs 
(a) Conditioned media from HEK293T cells transfected with wallaby S100A19 construct or 
empty vector control construct (EV) were examined for effect on proliferation of WallMECs. 
Cell number was significantly increased after 4, 6 and 7 days when compared with the 
control.  Data are presented as mean ± SEM, and considered statistically significant when P 
< 0.05. (b) Cells at 40 x magnification on day 4, 5, 6 and 7 of culture with control (EV) or 
S100A19 conditioned media.  
 
133 
 
 
134 
 
 
Figure 3.8: S100A19 gene expression in the wallaby pouch. 
Real-Time PCR analysis of S100A19 gene expression in wallaby pouch skin collected from 
tammars during phase 2A lactation (P2A), phase 2B lactation (P2B) or post-oestrus (pouch 
empty/PE). The expression of the gene was significantly upregulated during phase 2A. 
Housekeeping genes GAPDH and 18S were used for normalisation. Data are presented as 
mean ± SEM. Significant differences (P<0.05) were seen between groups PE and 2A, and 
groups 2A and 2B.  
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Table 3.2: RNA Sequencing results summary. Number 
Total gene transcripts 48548 
Discarded gene transcripts (FPKM <10) 35581 
Gene transcripts >100 FPKM 1959 
            Pre-annotated gene transcripts >100 FPKM 48 
            Novel gene transcripts >100 FPKM 2911 
 
Table 3.3: Top 5 expressed transcripts. 
Gene ID Locus FPKM FPKM conf_lo 
FPKM 
conf_hi 
CUFF.42192 Scaffold 557948:723-805 8.53E+07 6.70E+07 1.04E+08 
CUFF.28986 Scaffold 21833:7052-7132 3.40E+07 1.52E+07 5.29E+07 
CUFF.45222 Scaffold 69138:5197-5279 1.76E+07 9.32E+06 2.60E+07 
CUFF.36204 Scaffold 391734:2153-2240 3.95E+06 2.43E+06 5.47E+06 
CUFF.17561 Scaffold 8098:22075-22164 3.88E+06 2.78E+06 4.97E+06 
* ‘conf_lo’ represents the lower bound of the 95% confidence interval of the abundance of this 
transcript, as a fraction of the transcript abundance, and ‘conf_hi’ the upper bound. 
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of 48,548 gene transcripts, 35,581 of which were considered insignificant due to low FPKM 
values of less than 10 (FPKM: Fragments Per Kilobase of exon per Million fragments 
mapped) (Table 3.2). A total of 1959 genes were expressed with FPKM values greater than 
100, of which only 48 were annotated. The majority of highly expressed genes were 
unannotated, and the top 5 most highly expressed genes are listed in table 3.3. These 
sequences were aligned with the human and mouse genome using Ensembl blast, which 
returned no hits, except for CUFF.17561 which appears to be leucine-rich repeat-containing 
protein 20 (LRRC20). The primary function of the leucine-rich repeat proteins is thought to 
be the provision of a versatile structural framework for the establishment of protein-protein 
interactions. Table 3.4 lists all the annotated genes with FPKM values greater than 100 
together with their functions according to the NCBI and/or UniProt databases 
(www.ncbi.nlm.nih.gov and www.uniprot.org respectively), and indicates the expression 
level of the S100A19 transcript. As expected, a high proportion of the expressed transcripts 
originated from ribosomal and mitochondrial sources, typical of RNA sequencing methods 
(Raz et al., 2011). The S100A19 transcript was particularly highly expressed with an FPKM 
value of 1923.27 and another member of the S100 calcium binding family, S100A10, was 
also highly expressed with an FPKM value of 977.407. The transcript encoding the calcium 
binding matrix Gla protein was also detected at significant levels with an FPKM value of 
270.068.  Also worth noting is the presence of the transcript encoding the epidermal protein 
psoriasis susceptibility 1 candidate 2.  The dataset was examined for the expression of 
previously identified antimicrobial genes listed on the Antimicrobial Peptide Database 
‘APD2’ (aps.unmc.edu/AP/main.php) and Dragon Antimicrobial Peptide Database DAMPD 
(http://apps.sanbi.ac.za/dampd) using the Ensembl database and the Ensembl Blast tool. 
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Due to the poor coverage of the wallaby genome and the lack of annotation, few 
antimicrobial genes were identified. The FPKM values of transcripts detected by this method 
as well as the previously identified antimicrobial wallaby cathelicidin (Wanyonyi et al., 2011) 
and S100A15, the close relative of S100A19, are listed in Table 3.5. It must be noted that all 
genes in this table have FPKM values below 10 and are not considered to be active in the 
sample.  
3.5 Discussion 
3.5.1 Structural characteristics of S100A19 
The marsupial S100A19 protein has a secondary structure which closely resembles S100A7, 
and contains two EF hand motifs separated by a hinge region. The S100A19 protein appears 
to have two functional binding domains, most likely binding Ca2+ ions, as well as an HXXXH 
motif and a His-rich tail. These domains are attributes generally considered to interact with 
zinc and possibly contribute to antimicrobial activity (Loomans et al., 1998, Sohnle and 
Hahn, 2000). This contrasts with the structure of S100A7, which is thought to have only one 
functional binding domain due to the lack of aspartate (D) and glutamate (E) residues in the 
N-terminal EF-hand,  believed to be important for calcium binding (Marenholz et al., 2004, 
Brodersen et al., 1998). S100A7 is also a highly non-globular protein, while S100A19 is 
shown here to have a globular C-terminal domain (Brodersen et al., 1998).   
The human S100A7 gene is highly expressed in some cancer types and is associated 
with the alteration of cellular functions relating to malignancy, including increased growth 
and invasiveness, and decreased adhesion (Emberley et al., 2003a). Emberley et al. (2003) 
reported that Jun activation domain-binding protein-1 (Jab1) interacted with S100A7, and 
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postulated that the stimulation Jab1 by S100A7 increases malignancy. Jab1 is part of a 
multimeric protein complex called the CSN/COP9 signalosome, which is involved in signal 
transduction and protein degradation. It was found that the Jab1 binding motif is not 
present in either cow S100A7 and S100A15 or wallaby S100A15 and S100A19 proteins. The 
presence of the Jab1 binding domain in mouse S100A15 and absence in human S100A7a 
had previously been identified by Webb et al. (2005). Results from the current study suggest 
that S100A19 protein may not interact with Jab1 and either has altered functions or acts via 
different mechanisms to the closely related eutherian S100A7 protein.  In addition, Jab1-
S100 protein interactions are not common across species, suggesting that the S100A7 
protein effect on cell cycle regulation and cell adhesion (Webb et al., 2005, Emberley et al., 
2004b, Emberley et al., 2003a, Cope et al., 2002, Emberley et al., 2004a) may not be a 
primary role (and reason for persistence throughout evolution), or perhaps that the protein 
exerts effects by more than one mechanism.  
By definition, intrinsically unstructured or disordered proteins do not have a single 
well-defined tertiary structure in their native, functional state (Dyson and Wright, 2005). 
The S100 proteins are functionally diverse due to their ability to interact with various 
targets; a common characteristic of intrinsically disordered proteins (or IDPs). Although 
none of the S100 proteins are recognised as disordered proteins, they are predicted to be 
enriched in intrinsic disorder. According to Permyakov (2011), 62% of S100 proteins are 
predicted to be disordered by one or more of the IDP prediction servers, 31% are recognised 
as molten globules, and 15% are in extended disordered form. Surprisingly, the disorder of 
these regions is more highly conserved among the S100 proteins when compared to the 
more structured regions, suggesting a critical functional role for such disorder (Permyakov 
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et al., 2011, Uversky et al., 2000, Khan and Kumar, 2009). It may be the disordered regions 
of the S100 proteins which allow the formation of heterodimers, since dimer formation 
depends on flexibility of one monomer combined with rigidity of another. Moreover, these 
disordered regions, often located in the hinge region and N-terminal end of helix III, play a 
crucial role in target recognition (Permyakov et al., 2011).  
The S100A19 protein shares considerable structural similarity with both S100A7 and 
S100A15. These comparisons provide clues to the possible functions of S100A19 protein. 
However, S100A19 protein also has some novel characteristics and functional properties 
which were subsequently explored.  
3.5.2 Multifunctional S100A19 gene is temporally expressed in the wallaby mammary 
gland during the lactation cycle 
The mammary gland undergoes significant change and remodelling throughout the 
reproductive cycle (Kass et al., 2007, Monks et al., 2008) and the transcriptome changes 
accordingly, reflecting the current physiological state and providing clues regarding gene 
function (Yoon et al., 2013, Adams, 2008). It was postulated that upregulation of the 
S100A19 gene and secretion of S100A19 protein provides microbial defence during times 
when the mammary gland is most at risk of infection. This includes periods of immense 
change such as gestation, which involves rapid proliferation and differentiation of mammary 
epithelial cells (O'Donoghue, 1911, Hennighausen and Robinson, 2005). In addition, during 
involution the mammary gland undergoes epithelial cell apoptosis, milk is held static and 
the tissue is remodelled to resemble the pre-pregnant state. The susceptibility of the 
mammary gland to bacterial invasion at these times of transition has been well documented 
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(Sordillo et al., 1987, Neave et al., 1950, Oliver and Mitchell, 1983), and risk of mastitis at 
involution is estimated to increase seven-fold when compared with mid-lactation (Neave et 
al., 1950). After involution is complete, the gland is highly resistant to infection, but 
susceptibility increases again during the subsequent reproductive cycle as the animal nears 
parturition (Sordillo et al., 1987). Mastitis is usually caused by either E. coli (Eberhart, 1977, 
Smith et al., 1985) or S. aureus (Le Maréchal et al., 2011, Doymaz et al., 1988), species 
against which S100A19 protein showed growth inhibition. In contrast, S100A19 did not 
inhibit growth of the commensal E. faecalis species, suggesting specificity of the protein for 
pathogenic species. 
S100A7, a protein closely related to S100A19, is known to kill E. coli on human 
epithelial surfaces (Gläser et al., 2005) and is expressed at increased levels in response to S. 
aureus infection of the lung (Andresen et al., 2011). This gene is also upregulated during 
mastitis infection of the bovine udder (Regenhard et al., 2010) and human breast (Dr. Julie 
Sharp, data unpublished), demonstrating its defensive function against bacteria in the 
mammary gland. Therefore it is proposed that like eutherain S100A7, the marsupial and 
monotreme S100A19 gene is upregulated at pregnancy and involution for the purpose of 
antimicrobial protection of the mammary gland. The expression level of the S100A19 gene 
in the non-pregnant mammary gland was elevated, but included data from only two animals 
due to the limited tissue available. Therefore further investigation of the expression levels in 
the virgin or non-pregnant animal is required.    
The current study has shown that S100A19 protein stimulated proliferation of 
mammary epithelial cells. Substantial proliferative activity is observed in the mammary 
gland  during pregnancy as ducts extend throughout the stroma and alveolar buds begin to 
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form, and later differentiate into milk secreting alveoli tissue prepares for lactation 
(Hennighausen and Robinson, 2005, O'Donoghue, 1911). In the wallaby, the lobular alveolar 
pattern is visible by day 10 of pregnancy and by day 15 the alveoli structure is well defined 
with small lumina evident, and alveolar diameter increases steadily until parturition at day 
27 (Findlay, 1982). The presence of high levels of S100A19 protein in the mammary gland 
during pregnancy may be one of the factors influencing proliferation during this time. DNA 
synthesis is greater in the phase 2 wallaby mammary gland when compared with phase 3 
(Nicholas, 1988b), an occurrence likely associated with the expression of whey acidic protein 
(WAP) gene (Topcic et al., 2009). The WAP gene is primarily expressed in phase 2B of 
lactation in the wallaby, and the protein has previously been shown to stimulate 
proliferation of mammary epithelial cells, increase DNA synthesis and promote the 
formation of alveolar-like structures in culture (Topcic et al., 2009). The downregulation of 
the S100A19 gene in phase 2A precedes the upregulation of WAP, which is a milk 
constituent ingested by the young (Nicholas et al., 1997).  
Other factors involved in mammary epithelial cell proliferation include hepatocyte 
growth factor (HGF, also known as scatter factor) and oestrogen receptors α and β. HGF has 
been shown to stimulate mammary epithelial cell growth, increasing proliferation in a 
collagen gel culture model (Soriano et al., 1995). HGF is a polypeptide originating from 
fibroblasts which appears to interact with corticosteroid hormones to enhance mitotic 
activity. HGF also appears to have morphogenic activity, with HGF conditioned medium 
influencing ductal formation and extension (Soriano et al., 1995, Brinkmann et al., 1995). 
The oestrogen receptors EFα and EFβ are also factors eliciting mammary epithelial cell 
proliferation, mediated by oestrogen (Cheng et al., 2004). The exact mechanism of induction 
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is unclear, although it seems that EFα receives the proliferation signal from oestrogen while 
EFβ regulates EFα expression (Cheng et al., 2004). Both oestrogen and progesterone play 
important roles cell proliferation in mammary gland. Oestrogen controls ductal elongation 
during puberty, and influences lobuloalveolar development during pregnancy, and 
progesterone stimulates synthesis of DNA and as well alveolar development (Zeps et al., 
1999, Bocchinfuso et al., 2000, Olsson et al., 1996). It is possible that S100A19 protein acts 
as a paracrine regulator of proliferation in the pregnant mammary gland, perhaps 
participating in cooperative interactions with endocrine factor/s such as progesterone or 
oestrogen.  
The S100A19 gene is also upregulated during involution, a time during which the 
mammary gland undergoes significant apoptosis and remodeling (Monks et al., 2008, Hovey 
et al., 2002, Jahchan et al., 2012), which contrasts with the processes of proliferation and 
differentiation that occur during pregnancy (Hennighausen and Robinson, 2005, 
O'Donoghue, 1911). During involution, it is likely that the ECM signals mammary epithelial 
cells to enter apoptosis, overriding the proliferative effects of S100A19 protein. A study by 
Schedin et al. (2004) demonstrated the dominant influence of the micro-environment and 
the ability of ECM from mid-stage involuting mammary glands to induce epithelial cell 
death.  
 3.5.3 Expression of the S100A19 gene is upregulated in the wallaby pouch during 
early lactation to protect the immunologically incompetent neonate.   
The warm and humid marsupial pouch is an opportune environment for microbial growth 
(Old and Deane, 1998, Osawa et al., 1992) and therefore requires innate immune 
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mechanisms to maintain appropriate bacterial populations. Control of microflora within the 
pouch is critical, especially during early development of the tammar pouch young, at a time 
when it is immunologically incompetent and therefore extremely vulnerable to infection 
(Old and Deane, 1998, Yadav et al., 1972). The secretion of antimicrobial proteins by the 
epithelium plays a central role in first-line host defence in various species (Schonwetter et 
al., 1995), and during a time when the marsupial neonate is contained within the pouch 
environment, the maternal pouch epithelial secretions also directly impact the infant 
(Ambatipudi et al., 2008). This study has shown that S100A19 gene expression is 
upregulated in the wallaby pouch during phase 2A of lactation (day 0 to 100 post-partum), 
and has antimicrobial activity with specificity for pathogenic strains of bacterial. Results 
suggest that the secretion of S100A19 protein by the marsupial pouch is a maternal 
protective strategy to reduce numbers of harmful bacterial in the pouch during the time 
when the infant is most at risk to infection prior to the development of its immune system 
(Old and Deane, 2000, Basden et al., 1997).  
RNA sequencing data presented in Table 3.4 and 3.5 shows that the S100A19 gene is 
expressed at significant levels by the pouch epithelium during early lactation when 
compared with other annotated genes, and constituted one the most abundant transcripts 
(when ordered from most abundant to least abundant, S100A19 was listed at 281 out of the 
total 48,548 transcripts identified). The high expression levels are also reflected in 
quantitative PCR data shown in Figure 3.8. In contrast, wallaby cathelicidin which has been 
identified as an antimicrobial and innate immune molecule protecting the mammary gland 
and neonate (Wanyonyi et al., 2011, Zanetti, 2004, Carman et al., 2009, Daly et al., 2008) 
was detected in the pouch skin at very low levels with an FPKM value of only 5.58267 (Table 
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3.5). Another previously identified antimicrobial protein of the wallaby mammary gland, 
WFDC2 (Watt et al., 2012), was undetectable, suggesting expression of the gene may be 
specific to the mammary gland. The large FPKM value corresponding to the wallaby 
S100A10 gene suggests that the protein plays an important role in the pouch skin; assays 
testing the activity of wallaby S100A10 protein against pathogens may be beneficial. Due to 
the large FPKM value for S100A19, it is reasonable to assume that S100A19 protein is a 
primary defence molecule protecting the pouch young during early life. Figure 3.8 shows 
that by phase 2B of lactation, S100A19 gene expression has been down regulated 
significantly and is unlikely to be secreted at effective levels. It appears that the protein is no 
longer required to limit bacterial populations in the pouch at this stage of pouch young 
development, perhaps due to the establishment of the pouch young’s own immune system.  
The newborn wallaby pouch young has a limited number of defence mechanisms. 
The outer layer of the developing epidermis called the periderm provides physical a barrier 
(Krause et al., 1978), which is lost approximately 1 week post-partum as the epidermis 
thickens (Lyne et al., 1970).   At parturition, the liver appears to be the only site of 
haematopoiesis, and no sign of haematopoietic activity is evident in the bone marrow until 
2 weeks post-partum (Basden et al., 1996). No mature lymphoid tissue is apparent and 
significant numbers of immature erythroblasts and leucocytes were detected in the blood 
(Basden et al., 1996, Basden et al., 1997).  However, relatively high levels of neutrophils 
have been isolated from the blood of wallaby pouch young during the days following birth 
(Basden et al., 1996). These cells persist over the first 2 weeks of life before levels decline, 
and are likely to play a role in non-specific defence against pathogens (Basden et al., 1996). 
Other possible innate defence mechanisms including antimicrobial peptides, vacuolated 
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cells and lipids are also thought to be involved in bacterial protection of the newborn 
marsupial, although very limited data is available (reviewed in Edwards et al. 2012). While 
the timing of immune development and establishment of immune competence are yet to be 
defined (Old and Deane, 2000), immune capabilities of the pouch young are likely to 
increase rapidly during the initial 4-8 weeks post-partum, and immunological maturity most 
likely coincides with the progressive relaxation of protective pouch secretions (Basden et al., 
1997, Old and Deane, 2000, Ambatipudi et al., 2008).  
The S100A19 protein, like its close relative S100A7 and other antimicrobial proteins 
such as the cathelicidins (Frohm et al., 1997, Gläser et al., 2005), is mostly likely secreted by 
the keratinocytes and sebaceous glands. Charlick et al. (1981) predicted that the sebaceous 
and sweat glands in the dermal layer of the pouch may be responsible for the secretion of 
compounds with antimicrobial activity. In other species, sebaceous glands secrete sebum 
consisting of lipids, which repel water and act as surfactants of eccrine secretions. Charlick 
et al. (1981) made the link between the antimicrobials and the sebaceous glands after 
identifying a corynebacterium species, usually associated with these glands, in the pouch of 
the quokka. Both cathelicidins and defensins have been identified as antimicrobial defence 
molecules secreted by the skin of various mammalian species (Schonwetter et al., 1995). 
While defensins and cathelicidins are inducible peptides secreted in response to the 
presence of bacteria (Bobek and Deane, 2002, Gudmundsson and Agerberth, 1999), 
S100A19 appears to be regulated differently. The continual presence of bacteria in the 
pouch is apparent (Charlick et al., 1981, Old and Deane, 1998, Osawa et al., 1992); however 
there is temporal upregulation of the S100A19 gene in the pouch during early lactation 
when the pouch young in most vulnerable (Ambatipudi et al., 2008, Baudinette et al., 2005, 
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Old and Deane, 1998). According to prior studies by Ambatupudi et al. (2008) and Bobek 
and Deane (2002) on the wallaby and koala, the greatest antimicrobial activity was obtained 
from the pouch washes from animals around the time of birth. The findings from these 
groups support the argument presented in this thesis that S100A19 protein is the principle 
effector in the pouch and was most likely a major antibacterial in the washes collected by 
these groups. Therefore it is assumed that the upregulation of the S100A19 gene begins 
around the time of parturition, which correlates with the greatest antibacterial activity 
reported in the previous studies. Experiments described in chapter 4 take the initial steps in 
identifying the mechanism/s which allow the timely regulation of S100A19 in the wallaby.  
3.6 Conclusion 
This chapter demonstrates that the S100A19 gene is differentially regulated in both the 
wallaby mammary gland and pouch skin throughout the lactation cycle. The protein 
increased proliferation of mammary epithelial cells in culture. It is likely to function as a 
stimulant of cell proliferation during pregnancy as the mammary gland prepares for 
lactation. S100A19 protein also has antimicrobial activity, and is selective for pathogenic 
strains. Pregnancy, like involution, is a time when the mammary gland is susceptible to 
bacterial infection, and it is suggested that upregulation of S100A19 gene expression and 
subsequent protein production protects the mammary gland during these periods. Perhaps 
the most significant finding presented in this chapter is the substantial upregulation and 
abundance of the S100A19 transcript in the pouch during early lactation.  The protein 
appears to be a major participant in antimicrobial protection of the pouch young.  
 
150 
 
 
 
 
 
 
 
 
151 
 
CHAPTER 4 
Pre- and Post- Transcriptional Regulation of the S100A19 
Gene in the Tammar Wallaby (Macropus eugenii) Mammary 
Gland 
 
 
 
 
 
 
 
 
 
 
 
 
 
152 
 
Chapter 4 
Pre- and Post- Transcriptional Regulation of the S100A19 Gene in the Tammar Wallaby 
(Macropus eugenii) Mammary Gland 
 
4.1 Summary  
Wallaby S100A19 is a secretory protein with antimicrobial activity and the capacity to 
stimulate cell proliferation. Expression levels of the S100A19 gene are increased in the 
wallaby pouch epithelia during early lactation when the neonate is at the highest risk of 
infection, and the gene also exhibits temporal expression in the mammary gland throughout 
lactation, with high levels present in the pregnant mammary gland, a marked 
downregulation during lactation followed by an increase in expression at the onset of 
involution. To examine the mechanisms that may control S100A19 gene expression, pre- 
and post-transcriptional regulatory elements were explored and the transcription factor 
C/EBPβ identified as a possible regulatory participant. Tissue and cell culture experiments 
were employed to test the effect of lactogenic hormones and extracellular matrix on 
S100A19 gene expression with no obvious effect, and small RNA sequencing data did not 
generate strong evidence for miRNA interactions. This study has taken the initial steps in 
identifying the mechanisms which regulate the marsupial S100A19 gene.  
4.2 Introduction 
Mammary gland development throughout the life of a mammal is regulated by intricate 
interplay between the female endocrine system, and the mammary gland epithelium and 
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stroma. It has long been known that differentiation of mammary tissue, milk synthesis and 
secretion cannot occur in the absence of hormones including prolactin, oestrogen, 
progesterone, transforming growth factors (TGFs), cortisol and insulin (Topper and 
Freeman, 1980, Ono and Oka, 1980, Nagamatsu and Oka, 1983). However, evidence has 
suggested that hormones alone do not control changes in milk protein gene expression and 
composition; other influencing factors include the extracellular matrix (ECM) (Bissell et al., 
1982, Wicha et al., 1982) and milk proteins such as α-lactalbumin  (Sharp et al., 2008, 
Baltzer et al., 2004, Håkansson et al., 1999, Håkansson et al., 1995), WAP (Topcic et al., 
2009) and cathelicidin (Wanyonyi et al., 2011) which can provide feedback to the mammary 
gland.  
The processes of growth and development of the mammary gland from infancy to 
maturity, and differentiation into the functional state capable of milk secretion occur in a 
discontinuous manner with discrete phases reflecting the functional state of the animal 
(Topper and Freeman, 1980). Mammary gland development in the eutherians generally 
begins during foetal development with the formation of the mammary crest and teat 
anlage, and growth continues throughout the neonatal and pre-pubertal phases of growth 
(Topper and Freeman, 1980). Ducts elongate and branch during the pre-pubertal phase, and 
branching proceeds throughout the fat-pad until sexual maturity when alveolar buds are 
established (Brisken and Rajaram, 2006). Differentiation of mammary epithelial cells into 
functional milk secreting cells occurs during pregnancy in preparation for lactogenesis 
(Topper and Freeman, 1980). Mature differentiated cells are capable of the manufacture 
and secretion of significant quantities of protein, fat and carbohydrate made possible by 
well-developed cellular machinery (Topper and Freeman, 1980). Milk production in the 
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mammary gland persists until weaning and the commencement of involution, whereby 
alveolar cells undergo apoptosis and remodelling of mammary gland occurs, returning to 
morphological structure resembling the pre-pregnancy gland (Jahchan et al., 2012, Hovey et 
al., 2002). These general processes are common to most mammals, although there is some 
variation between species. For example in marsupials including the experimental model 
used here, the tammar wallaby, the teat anlage forms shortly after birth and unlike the 
eutherians in which the  teats develop from a mammary cell line, each teat of the marsupial 
forms from a separate anlage as a result of local proliferation (Bresslau, 1920), and epithelial 
cell proliferation predominantly occurs following ovulation in marsupials, before the embryo 
is attached (O'Donoghue, 1911).  
Minimal hormone requirements for ductal outgrowth in most circumstances are 
oestrogen in combination with either prolactin or growth hormone; none of which are 
sufficient alone (Topper and Freeman, 1980), while the addition of insulin, prolactin and 
adrenal steroid appears sufficient to produce mature differentiated secretory alveoli in 
culture (Elias, 1959, Elias, 1957). In addition, the processes of mammary cell replication and 
ductal growth require tissue specific matrix in vivo (Topper and Freeman, 1980), the 
composition of which alters according to the functional stage of the lactation cycle to 
support correct cell behaviour and gene expression in the mammary gland (Schedin et al., 
2004). The influence of mammary ECM on growth and differentiation in the mammary gland 
was explored by Schedin et al. (2004), who found that the culture of mammary epithelial 
cells on matrix derived from the mammary glands of virgin mice promoted the formation of 
ducts, while matrix isolated from involuting tissue induced apoptosis.  The matrix from mice 
at day 8 and day 10 of involution restored glandular development supporting the formation 
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of duct-like structures. In contrast, matrix from parous animals suppressed the organisation 
of cells into ductal structures. While the changes in ECM composition were initially 
presumed to be driven by endocrine signals, the publication by Wanyonyi et al. (2013a) 
focusing on the tammar wallaby shows that mammary ECM regulates changes in expression 
of milk protein genes which are independent of hormones. While hormones are required for 
the expression of milk protein genes, they do not appear to regulate the temporal changes 
in these genes during the lactation cycle. In this study Wanyonyi et al. (2013a) showed that 
mammary epithelial cells isolated from early lactation acquire the late lactation phenotype 
when cultured on the ECM prepared from mammary tissue from late lactation, expressing 
milk proteins specific to the late phase.  
Data presented in chapter 3 demonstrated that the wallaby S100A19 gene, a 
member of the S100 calcium binding family, is differentially regulated in the tammar 
wallaby; S100A19 gene expression levels in the mammary gland peak during pregnancy and 
involution and are noticeably downregulated during lactation. The stimuli and mechanisms 
controlling S100A19 gene expression were examined in this study, including the effects of 
hormones and ECM and subsequently an analysis of putative transcriptional and post-
transcriptional regulatory mechanisms. 
Previous studies examining S100 gene expression have identified a role for the 
transcription factors CCAAT/enhancer binding proteins (C/EBPs) in S100 gene regulation. 
C/EBP -alpha and -beta have been shown to regulate S100A9 gene expression in myeloid 
cells (Henkel et al., 2002, Klempt et al., 1998, Kuruto-Niwa et al., 1998), and are also thought 
to regulate S100A8 gene expression (Németh et al., 2009). The C/EBPs are leucine zipper 
transcription factors with a diverse range of functions (Robinson et al., 1998). They bind to 
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gene promoters as homodimers or heterodimers, regulating proliferation, differentiation 
and programmed cell death in the mammary gland (Zahnow, 2002). Gene deletion in mice 
has confirmed the critical role of C/EBPβ in normal mammary gland development, evident in 
C/EBPβ deficient mice which experienced disrupted ductal growth and branching (Robinson 
et al., 1998). Overexpression of C/EBPβ in mouse mammary epithelial cells showed that the 
transcription factor regulates genes involved in the proliferation of mammary epithelial cells 
(Zahnow et al., 2001). This transcription factor is thought to be a participant in hormonal 
signalling cascades which regulate cell proliferation and early differentiation in the 
mammary gland in preparation for lactation (Robinson et al., 1998). C/EBPβ is present in 
multiple isoforms including truncated dominant negatives, which are generated either 
during translation of the C/EBPβ transcript or by proteolytic cleavage of the full length 
protein (Zahnow, 2002).  Low levels of expression of the C/EBPβ gene are detectable in the 
virgin mouse mammary gland, increasing during pregnancy, declining during lactation and 
then increasing again at the onset of involution (Gigliotti and DeWille, 1998). Due to the 
similar expression profile of the S100A19 gene throughout the lactation cycle, together with 
the evidence for C/EBPβ regulation of other S100 genes, we hypothesised that binding of 
C/EBPβ to the S100A19 promoter may activate transcription of the gene during pregnancy 
to effect cell proliferation and/or mammary epithelial cell differentiation.  
Following successful transcription of a gene, the mRNA transcript may be modified 
by splicing, degraded, silenced or translated to protein. These complex processes involve 
the participation cellular machinery such as spliceosomes and endonucleases, but also short 
sequences of nucleic acid called short interfering RNA (siRNA) and microRNA (miRNA) 
(Valencia-Sanchez et al., 2006). Recent studies have resulted in considerable advances in 
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knowledge regarding the significance of miRNA in development and function of the 
mammary gland and secretion in milk. The miRNAs have been found to play a central role in 
the regulation of developmental processes and immunity in both the maternal mammary 
gland and suckling young (Zhou et al., 2012, Gu et al., 2012, Wang et al., 2012, Avril-Sassen 
et al., 2009, Tanaka et al., 2009, Kosaka et al., 2010, Xiao and Rajewsky, 2009, Chen et al., 
2013). These findings prompted exploration of miRNA in the mammary gland of the tammar 
wallaby, and raised interest in the possibility of a role for miRNA in control of the S100A19 
gene.  
The miRNAs are expressed in a tissue-specific manner and act to regulate protein 
expression by binding to complementary sequences in target mRNA transcripts, generally 
repressing translation (Bartel, 2009, Berezikov, 2011, Cannell et al., 2008). MiRNAs play an 
important role in the control of gene expression in the mammary gland (Avril-Sassen et al., 
2009), and the presence of some miRNAs is crucial for normal mammary gland development 
and function. For example, miR-212 and miR-132 are essential for ductal outgrowth. 
Expressed exclusively by stromal cells, miR-212 and miR-132 target metalloproteinase-9, 
control collagen deposition and are primary regulators of epithelial-stromal interactions 
(Ucar et al., 2010). The milk protein β-casein is regulated by miR-101, and overexpression of 
this miRNA supresses milk production as well as epithelial cell proliferation (Tanaka et al., 
2009). Therefore, we predicted that miRNAs may play a role in S100A19 gene regulation in 
the mammary gland, by suppressing translation of the protein during lactogenesis. 
Transcript structure of the S100 family of genes is highly conserved, typically containing a 5’ 
non-coding sequence of unknown function. A sequencing approach in combination with 
bioinformatic analysis is used here to investigate the possibility that the conserved 5’ UTR is 
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involved in post-transcriptional regulation, binding to miRNA and preventing translation. 
This miRNA interaction may begin to explain the conservation of the 5’ non-coding exon in 
the S100 protein family.  
4.3 Materials and Methods 
4.3.1 Animals 
Tissue for S100A19/C/EBPβ gene expression studies was collected from the mammary 
glands of female tammar wallabies at various stages of lactation over a period of 10 years. 
Tissue for miRNA extraction was collected from the mammary glands of two females in each 
phase of lactation including gestation (phase 1), phase 2A, phase 2B, phase 3, involution and 
non-pregnant/post-oestrus. All samples were stored at -80°C until use.  
For mammary explant culture, tissue was excised from 3 tammars at day 24 of 
pregnancy. Approximately 16 hours after giving birth, tammar wallabies experience 
postpartum oestrus (Tyndale-Biscoe et al., 1983), but development of the resulting corpus 
luteum and embryo are arrested after 8 days and remain quiescent throughout lactation 
(Nicholas and Tyndale-Biscoe, 1985). Removal of the pouch young initiates reactivation of 
pregnancy and birth occurs 26 or 27 days later. For this study, pouch young were removed 
and pregnant animals were sacrificed 24 days later. Pregnancy was confirmed from foetal 
development.  
4.3.2 Explant tissue culture  
Media was prepared by adding 10 x Medium 199 (9.5g) (#31100-035, GIBCO) and 10mL 
Penicillin/Streptomycin (#15140-122, GIBCO) to approximately 900mL of sterile milliQ and 
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the pH of the solution measured (Denver Instrument pH Meter, Model 215) and adjusted to 
pH 7.55 at room temperature with 1M NaOH. The solution was then made up to 1L with 
milliQ, and filter sterilised with a 0.2 μM filtration system. For the lactogenic hormone 
treatment group (IFP), media was prepared by adding bovine insulin (I), (1μg/mL, #I-5500 
Sigma), cortisol (F) (0.05μg/mL, #H-4001 Sigma) and ovine prolactin (P) (1μg/mL, Nation 
Hormone and Pituitary Program USA NIDDK-oPRL-21, #AFP-10677C) to an aliquot of the 1 x 
media. Lens paper for supporting explants was prepared by soaking sheets of lens paper 
(Grade No. 105, #CMC-750-012X, Whatman) in a 1 in 100 dilution of AquaSil™ siliconising 
fluid (#42799, Thermo Scientific) in water for 6 h. Lens paper was then washed 6 times in 
water, dried and then cut into 2 cm x 2 cm squares and sterilised by heating at 150°C for 1 h. 
Excised mammary glands were dissected into small pieces of approximately 2mm x 2mm (1-
2mg) under sterile conditions within a biosafety cabinet (SAFEMATE Series Class II). Explants 
were placed on sterile lens tissue and floated on 5mL media in 6-well plates, and incubated 
at 37°C (5% CO2). Explants were maintained in 1 x growth media either without the addition 
of growth factors and hormones (no hormone: NH) or with a combination of IFP, and media 
changed at 48 hour intervals over 4 days. Mammary explants were collected daily and 
frozen at -80°C for RNA extraction. Experiments were performed in triplicate.  
4.3.3 ECM preparation 
ECM preparation was carried out by Stephen Wanyonyi at Deakin University (Wanyonyi et 
al., 2013a). Mammary tissue (100mg) was homogenised, RNA purified and reverse 
transcription performed as described in section 4.3.5 below.  Tissue integrity was confirmed 
by RNA quality assessment, and mammary ECM was then extracted as described by O'Brien 
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et al. (2010) and Wanyonyi et al. (2013a). Briefly, from each of the indicated phases of 
lactation, 3g of  mammary tissue was pulverised to a fine powder in liquid nitrogen and 
homogenised in a high salt buffer consisting of 2 mM n-ethylmaleimide (NEM) (#E1271, 
Sigma), 200 μg/ml phenylmethylsulfonyl fluoride (PMSF) (#P7626, Sigma) and 2x protease 
inhibitor cocktail (#P8340, Sigma). The tissue preparations were then enriched for insoluble 
extra-cellular matrix proteins through several centrifugations and high salt and urea 
extractions (O'Brien et al., 2010). The resulting ECM preparation was frozen in aliquots at -
20oC until required. 
4.3.4 Wallaby MEC culture  
A culture base media (2x) was prepared by dissolving 10 x Medium 199 (final conc. 
0.0095g/mL, #31100-035, GIBCO) and 10 x HAMS F12 (final conc. 0.00106g/mL, #21700-026, 
GIBCO), HEPES (final conc. 0.00476g/mL, #H4034, Sigma), sodium bicarbonate (final conc. 
0.0075g/mL, #S5761, Sigma) and anhydrous sodium acetate (final conc. 328μg/mL, #S8750, 
Sigma) in milliQ water. The pH of the solution was measured (Denver Instrument pH Meter, 
Model 215) and adjusted to pH 7.55 at room temperature with 1M NaOH. The solution was 
then filter sterilised with a 0.2 μM filtration system (#431097, Corning Incorporated). The 1 x 
growth media was prepared by adding 20% (final conc.) horse serum (#16050, GIBCO), 5% 
(final conc.) foetal calf serum (FCS) (#3008403, Invitro Technologies), 1mM 
Penicillin/Streptomycin (#15140-122, GIBCO), epidermal growth factor (EGF) (10ng/mL, 
#E4127, Sigma), bovine insulin (0.1μg/mL, #I-5500 Sigma), and cortisol (F) (1μg/mL, #H-4001 
Sigma), to 50mL culture base and solution made up to 100mL with milliQ and again filter 
sterilised with a 0.2 μM filtration system.  For the prolactin (P) treatment group, ovine 
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prolactin (1μg/mL, Nation Hormone and Pituitary Program USA NIDDK-oPRL-21, #AFP-
10677C) was added to an aliquot of the 1 x growth media.  
The MECs from mid pregnant wallabies (day 15) at passage 3 (isolated by Stephen 
Wanyonyi, Wanyonyi et al. (2011)) were cultured in 24 well plates (#143982, Nunc) on ECM 
from pregnant, early (phase 2A), mid (phase 2B) and late (phase 3) lactation mammary 
glands as earlier described (Wanyonyi et al., 2013a), RNA extracted (section 4.3.5) and 
assayed for changes in S100A19 gene expression (section 4.3.6). When prolactin was added, 
β-lactoglobulin (BLG) gene expression was examined to assess the hormonal response and 
validate the experimental model. Briefly, 80μl of ECM was added to each well and incubated 
at 37oC for 1 h to create an ECM coat. Cells were then seeded at 5 x 104 cells per well in 
growth media. The cells were incubated at 37oC (5% CO2) for 3 days and RNA extracted on 
the fourth day. Control wells without ECM coating were included, and all treatments 
performed in triplicate.  
4.3.5 RNA extraction and reverse transcription 
Tissue was homogenised using a rotor-stator (Polytron® PT-MR2100, Kinematica AG) and 
RNA extracted from both tissue and WallMECs cells using a PureLink RNA mini kit 
(#121830018A, Ambion) as per manufacturer’s protocols. Reverse transcription was 
performed from 1μg or 0.5 μg of RNA from tissue samples and cells respectively. RNA was 
incubated at 65°C for 5 min with 1 μL of 10mM dNTP mix (#18427-088, Invitrogen) and 1 μL 
of oligo DT primer at 0.05 μg/μL (Sigma), made up to 12 μL with nuclease free water and 
then placed on ice for 2 min. To each prepared RNA mix, 4 μL of 5 x First Strand Buffer 
(#y02321, Invitrogen), 2 μL of 0.1M DTT (#y00147, Invitrogen), 1 μL RNaseOut at 40U/μL 
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(#100000840, Invitrogen), 0.25 μL Superscript IIITM Reverse Transcriptase at 200U/μL 
(#56575, Invitrogen), and 0.75 μL nuclease free water was then added. Template- and 
enzyme-free controls were included. Reactions were placed in a thermocycler (Eppendorf 
Mastercycler®) at 42°C for 50 min, 70°C for 15 min, followed by 4°C for 5 min and samples 
then kept at -20°C until use.  
4.3.6 Quantitative PCR 
The oligo probe sequences and amplicon size can be found in Table 4.1. S100A19 and 
C/EBPβ gene expression was normalised against 18S rRNA and Glyceraldehyde-3-phosphate 
dehydrogenase (GAPDH) housekeeping genes. Intron-spanning oligo probes were chosen to 
minimise the chance of amplifying contaminating genomic DNA. Probes were synthesised by 
Macrogen Korea, and reactions performed in a Bio-Rad CFX96™ Real-Time Detection 
System. Each reaction consisted of 10 μL SsoFast™ Evagreen® Supermix (#172-5202 Bio-
Rad), 0.5 μL forward and reverse primers at 10μM, and 0.5 μg template made up to 20 μL 
with nuclease-free water. Conditions were initial denaturation of 3 min at 94° C, followed by 
39 cycles of 1 min denaturation at 94° C, 1 min annealing at 60° C, and 30 sec extension at 
72° C, with a final 5 min extension.  Relative expression levels of the S100A19 and BLG genes 
were calculated using Bio-Rad CFX Manager™ software (Version 3.0), ∆∆Cq normalised 
expression method. All samples were assayed in triplicate, and template-free controls 
included. Melting curve analysis was employed to confirm the amplification of a single PCR 
product for each primer pair. Expression values are presented as fold of expression at time 
zero (before culture was initiated).  
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Table 4.1 Oligo probes used in qPCR 
Gene ID GenBank ID Primer sequences (5’ to 3’ orientation) Product Size (bp) 
S100A19 EU682765 
F: CACTCATCTGACTCTTTCCTCTTG 
R: CCAGCACAGTCACAAACTC 
315 
GAPDH EF654515 
F: GACTCATGACTACAGTCCATGCCAT 
R: GGACATGTAGACCATGAGGTCCAC 
479 
18S AJ311676 
F: CGGCTACCACATCCAAGGAA 
R: GCTGGAATTACCGCGGCTAGCCGCGGTAA 
187 
BLG X15212 
F: GCATGTGCCCACTATGTCAG 
R: AGGGGGATAACTTCGTCTGC 
154 
CEBPB 
Nil  
(obtained from Ensembl) 
F: AACCTGTCCACGTCGTCTTC 
R: GGCTTTGTCGCGACTCTTAC 
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4.3.7 Microarray analysis  
Microarray data from RNA extracted from human milk cells at various stages of lactation 
was obtained from Dr. Julie Sharp (data unpublished). Briefly, samples were collected from 
healthy volunteer mothers during the colostrum period (24 h pre-partum, n=2), milk at peak 
lactation (days 24, 48 and 101 after birth, n=5) and at involution (day 7 and 14 after 
cessation of feeding, n=2). Cells were extracted from the fresh or frozen (-80°C) milk by 
centrifugation at 2000 x g, 5 min at 4°C. RNA was extracted from cell pellets using an RNeasy 
Lipid Tissue Mini Kit (#74804, QIAGEN) as per manufacturer’s protocol. Total RNA (3μg) was 
used to generate biotin-labelled cRNA which was hybridised to Human Genome 2.0 
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Affymetrix genechips, and data was analysed by Genespring. Mouse microarray data from 
RNA extracted from mouse mammary gland at various time points across lactation was 
obtained from previous published research by the University of Cambridge, United Kingdom 
(Clarkson and Watson, 2003).  
4.3.8 Computer analysis of transcription factor binding sites  
The University of California, Santa Cruz (UCSC) Genome Bioinformatics website 
http://genome.ucsc.edu/ was employed for investigation of transcription factor binding 
sites in the human S100 gene promoters, and ALGGEN Promo (Messeguer et al., 2002) used 
for identification of C/EBPβ binding sites in the wallaby S100A19 promoter.  
4.3.9 Determination of miRNA candidates for post-trancriptional regulation of 
S100A19 in the wallaby 
To determine if the tammar 5’ non coding exon interacts with miRNA to regulate S100A19 
gene expression in the mammary gland, the Mamsap online server was employed 
(http://mamsap.it.deakin.edu.au). We focused on the complete 5’ non-coding exon plus the 
first 20 base pairs of the first coding exon as follows: 
5’GTTCACTCATCTGACTCTTTCCTCTTGCAGCTTCCTCCAGGTCCTCCCTGATACACTGAGTCATGGCA
TCCACAAAGTACAC3’. Since miRNAs  have not yet been described in the wallaby, all known 
miRNAs identified previously in the grey short-tailed opossum Monodelphis domestica 
(Devor and Samollow, 2008) were queried against the wallaby S100A19 sequence above to 
identify low-energy interactions. Opossum data was employed due to the high degree of 
conservation between the opossum the tammar wallaby (Rens et al., 2001). An energy cut-
off of -20kcal/mol gave 23 opossum miRNAs which target the wallaby S100A19 sequence. 
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The miRNA precursors of the 23 mature opossum miRNAs (obtained from mirBASE 
http://www.mirbase.org) were aligned with the wallaby genome using Ensembl Blast. Of 
those miRNA candidates above, 10 miRNAs with high sequence identity to the confirmed 
opossum sequence (up to 3bp mismatch, no more than one deletion, and unlikely change to 
mature miRNA) and strong hairpin probability (determined by rnaFold 
http://rna.tbi.univie.ac.at/cgi-bin/RNAfold.cgi) were chosen for experimental investigation.  
4.3.10 miRNA extraction  
Tissue was derived from the mammary glands of tammar wallabies, using one animal per 
phase of lactation (gestation, phase 2A, phase 2B, phase 3 and involution). Tissue was 
homogenised using a rotor-stator (Polytron® PT-MR2100, Kinematica AG) and total RNA 
extracted using a mirVana miRNA Isolation kit (#AM1560, Ambicon) as per manufacturer’s 
protocol. RNA integrity was confirmed using an Agilent 2100 Bioanalyser (Small RNA chip, 
Agilent Technologies). 
4.3.11 miRNA sequencing and data processing 
RNA extracted as per section 4.3.10 was sent to BGI China for Illumina GAII gel-selected 
sequencing (18-40 nt). Raw fastq sequences were cleaned and adaptors were trimmed using 
FastQ (http://www.bioinformatics.babraham.ac.uk/projects/fastqc/) and fastx programs 
(http://hannonlab.cshl.edu/fastx_toolkit/). miRNA annotation tool miRanalyzer (Hackenberg 
et al., 2011) was used to identify the miRNA populations in small RNAs from mammary 
gland samples by aligning first to miRNAs from marsupial opossum Monodelphis domestica 
gene assembly (MonDom5) (http://www.ncbi.nlm.nih.gov/assembly/237648/).  
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4.3.12 Statistical analysis 
Data were presented as mean ± standard error of the mean (SEM). Statistical comparisons 
were made using paired t-tests assuming unequal variances between means. In all statistical 
tests a p value of less than 0.05 was considered significant.  
4.4 Results 
4.4.1 Effect of lactogenic hormones on S100A19 gene expression 
Due to the negative correlation between the level of S100A19 gene expression and 
lactogenesis, it was predicted that the addition of the lactogenic hormone complex of 
insulin (I), cortisol (F) and particularly prolactin (P) to culture media may reduce S100A19 
transcript abundance in mammary explants from pregnant wallabies. Mammary explants 
were cultured in media with lactogenic hormones over four days, and examined for changes 
gene expression. Genes of interest were normalised against the housekeeping GAPDH and 
18S genes and a P value of < 0.05 was considered significant. Since β-lactoglobulin (BLG) 
gene expression is prolactin dependent (Collet et al., 1991), BLG mRNA levels were assessed 
to confirm that the mammary explants were responding to hormone treatment. BLG gene 
expression in the IFP treatment group was significantly greater at day 4 of culture when 
compared with the NH control (Figure 4.1b). The change in S100A19 gene expression was 
not statistically significant after either 2 or 4 days (Figure 4.1a). 
4.4.2 Effect of ECM on S100A19 gene expression 
It is known that significant changes in the ECM composition occur throughout lactation, and 
stromal-epithelial interactions play an important role in control of mammary regulation and 
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Figure 4.1: The effect of lactogenic hormones on S100A19 gene expression in wallaby 
mammary explants.  
(a) S100A19 gene expression in wallaby mammary tissue after 2 and 4 days of culture in the 
presence of either IFP or no hormone (NH). No significant change in S100A19 gene 
expression was observed at day 2 or 4 of culture (n=3). To confirm tissue response to 
hormones, changes in BLG gene expression was examined (b). A significant difference in 
BLG gene expression was observed between treatment and control groups at day 2 and 4 of 
culture (P < 0.05). All values are presented as mean ± SEM. 
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Figure 4.2: The effect of ECM on S100A19 gene expression in WallMECs.  
Expression levels of S100A19 in wallaby primary mammary epithelial cells derived from a 
pregnant animal were examined after 3 days of culture on ECM.  Initial culture experiment 
performed on ECM from gestation, phase 2A (P2A), phase 2B (P2B) and phase 3 (P3) tissue 
with hormones I and F showed no significant change in S100A19 gene expression (a). The 
experiment was repeated with the addition of P (shown in b and c). Although S100A19 gene 
expression appears greater on ECM derived from pregnant tissue, changes were not 
statistically significant (b). BLG gene expression is significantly greater in the presence of P 
(c). All values are presented as mean ± SEM. P values  < 0.05 were considered significant.  
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Figure 4.3: S100 gene expression during lactation in the human and mouse mammary gland 
(a) Microarray data of human milk cells from various stages throughout lactation showed 
temporal expression for S100A4, S100A6, S100A10 and S100A11 genes, with expression 
levels decreasing during early lactation and remaining low throughout the lactation cycle, 
with a marked increase at the onset of involution. (b) Microarray data from mouse 
mammary gland (Clarkson and Watson, 2003) showed a similar expression profile for 
S100A6, S100A10, S100A11 and S100A13 genes, with expression levels high in the virgin 
gland, expression maintained during pregnancy, followed by down-regulation during 
lactogenesis, and then an increase at the onset of involution. 
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Figure 4.4: Expression of the transcription factor C/EBPβ gene during the lactation cycle in 
the human and mouse mammary gland. 
(a) Microarray data from human milk showed expression of the C/EBPβ gene mimicked that 
of the S100 genes in Figure 4.4, with a decrease in expression levels during early lactation, 
low expression levels remaining low throughout lactation, followed by an increase at the 
onset of involution. (b) A similar relationship was seen in the mouse microarray data 
(Clarkson and Watson, 2003), with C/EBPβ levels correlating with the S100 gene expression 
profile. 
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Figure 4.5: The tammar wallaby S100A19 promoter comprises the CCAAT box. 
The wallaby S100A19 promoter has a C/EBPβ binding site of the consensus sequence 
5’TTGCNNAA3’ 109 bp upstream of the transcription start site. The position of non-coding 
exons (NC Exon), TATA box, intron and start sign are shown.  
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cell differentiation (Cunha et al., 1995). Wanyonyi et al. (2013a and b) have recently 
demonstrated that the ECM of the tammar wallaby mammary gland acts as a local 
regulatory mechanism controlling the expression of a number of mammary and milk protein 
genes. Since there is a marked downregulation in wallaby S100A19 gene expression as the 
gland enters lactogenesis, it was postulated that culturing S100A19-expressing MECs 
extracted from pregnant tissue on ECM from the lactating gland may downregulate 
S100A19 gene expression. A primary cell culture model was used to investigate ECM-
induced changes in S100A19 gene expression, normalised against the housekeeping GAPDH 
and 18S genes. Figure 4.2 (a) shows expression levels of the S100A19 gene in cells after 3 
days of culture on ECM extracted from mammary tissue at each phase of lactation. The 
difference in S100A19 gene expression was not statistically significant (P< 0.05) between 
any of the treatment groups. The experiment was then repeated with the addition of 
prolactin to the media (media contained insulin and cortisol in all treatment groups) (Figure 
4.2b and c). Expression of the BLG gene was quantitated to test effectiveness of the 
experimental model and cell response to the addition of hormone (Figure 4.2c). The 
expression of the BLG gene was significantly greater in the presence of IFP when compared 
to IF only. Insufficient phase 2B and phase 3 mammary tissue was available for ECM 
extraction therefore these treatment groups were not included in the second culture (Figure 
4.2b and c). Again the difference in S100A19 gene expression between treatment groups 
was not statistically significant. 
4.4.3 A putative role for C/EBPβ in the regulation of S100A19 gene expression 
Transcription factors are critical participants in the regulation of gene transcription (Liu et 
al., 1997). Existing microarray data from the mouse mammary gland and human milk cells 
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Figure 4.6: Expression profile of the C/EBPβ and S100A19 genes in the tammar wallaby 
mammary gland.  
Expression of the C/EBPβ gene correlates with that of the S100A19 gene throughout the 
lactation cycle, with highest levels evident during gestation, involution and in the non-
pregnant animal, and low levels of gene expression during days 2 to 220 of lactation 
(phases 2A, 2B and 3).  
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derived from various time points throughout the lactation cycle was examined to gather 
information regarding potential regulatory elements involved in controlling expression of 
the S100 gene family. Data was examined for S100 gene expression patterns and 
correlations between the expression levels of transcription factors and S100 genes. It was 
noted that a number of S100 genes in eutherian species had similar expression profiles to 
that of the wallaby S100A19 gene, including human and mouse S100A6, S100A10, S100A11, 
as well as human S100A4 and mouse S100A13 genes (Figure 4.3). It was hypothesised that 
these genes may be controlled by the same regulatory elements as the tammar S100A19 
gene, and therefore subsequent analysis utilised the Encyclopedia Of DNA Elements 
(ENCODE project) (Raney et al., 2011) data available on http://genome.ucsc.edu/ to search 
for transcription factor binding sites common to all of the promoters of the S100 genes 
mentioned above. ENCODE is a project which was launched in 2003 by The National Human 
Genome Research Institute (NHGRI) with the objective of identifying all functional elements 
in the human genome sequence. The transcription factors C/EBPβ, tata box binding protein 
(TBP), MYC binding protein 2 (MYCBP2) and Polymerase (RNA) II Polypeptide A (POLR2A) 
have been identified by the ENCODE project to bind to the promoter regions upstream of all 
of the above human genes.  Hence, it was predicted that one or more of these regulatory 
elements may participate in the regulation of these S100 genes. Human and mouse 
microarray data was revisited and queried for expression levels of the above transcription 
factors, which were plotted in Microsoft Excel (Figure 4.4). C/EBPβ gene expression was 
found to correlate with the eutherian S100 gene expression profiles in Figure 3, provoking 
further exploration of an S100A19-C/EBPβ relationship in the wallaby.  
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The online server ALGGEN Promo (Messeguer et al., 2002), which uses TRANSFAC 
Version 8.0 matrices for binding prediction, was then used to identify C/EBPβ binding sites 
in the putative wallaby S100A19 promoter. The consensus sequences for C/EBPβ binding, 
5’TTGCNNAA3’ (Osada et al., 1996) was identified 109 bp upstream of the predicted 
transcription start site (Figure 4.5) .  
A quantitative PCR approach was used to examine the expression profile of the 
C/EBPβ gene in the wallaby mammary gland, normalising against the house keeping genes 
18S and GAPDH, and comparing expression to that of the S100A19 gene (Figure 4.6). 
Expression of the C/EBPβ gene correlated with S100A19 gene expression, with highest levels 
of S100A19 mRNA present during pregnancy, low expression levels throughout phase 2A 
(day 1-100 of lactation), phase 2B (day 100-200 of lactation) and phase 3 (up to day 220 of 
lactation), followed by an increase late in phase 3 (from day 260 lactation) and at the onset 
of involution. Findings therefore support the hypothesis that this transcription factor may 
play a role in activating expression of the wallaby S100A19 gene and the aforementioned 
eutherian S100 genes with C/EBPβ binding sites within their promoters. 
4.4.4 miRNA interactions with the S100A19 gene transcript 
Since miRNAs are differentially expressed throughout the lactation cycle and are known to 
be important regulators of gene expression in the mammary gland (Avril-Sassen et al., 
2009), the involvement of miRNAs in the control of S100A19 gene expression was explored. 
While miRNAs commonly bind to the 3’ untranslated region of mRNA transcripts (Cannell et 
al., 2008), association at any position on the target mRNA appears to exert translational 
repression effectively (Lytle et al., 2007). Hence, miRNA may interact with the 5’ UTR of the 
178 
 
S100A19 transcript, which could explain the conservation of a 5’ noncoding exon in the S100 
proteins. To determine which miRNAs may be of involved, the Mamsap server was 
employed to identify monodelphis miRNA species which have the theoretical ability to bind 
to the N-terminal region of the wallaby S100A19 transcript, and 23 candidate miRNAs were 
identified (Table 4.2). The precursor sequences of the 23 mature monodelphis miRNA 
candidates were then examined for conservation in the wallaby, and a subset of 10 miRNAs 
were chosen for experimental examination. The miRNAs chosen for further examination 
were selected using a cut-off of 3 bp mismatch when aligned with the orthologous 
monodelphis sequences as well as strong hairpin probability determined by the rnaFold 
server (Figure 4.7).  
Generated miRNA sequencing data from wallaby mammary tissue was then used to 
examine changes in expression levels of miRNA throughout the lactation cycle. Initially, the 
10 most abundant miRNAs from each library (gestation through to involution) were plotted 
and compared. The Let-7 miRNAs (a, b, d, f, g and i) were strongly represented in the top 10 
from each library, in particular Let-7a and Let-7f which were the two most highly expressed 
miRNAs in all libraries with the exception of Phase 2B, which showed a contrasting stacked 
bar when compared with the other phases, although both miRNAs were included in the top 
10 category (Figure 4.8). The expression patterns of this category during lactation were then 
examined and several were found to exhibit phase specific expression, shown in Figure 4.9. 
The expression of two miRNAs, miR-10b and miR-143, was greatly increased during phase 
2B of lactation, while miR-1 and miR-26 were highly expressed during pregnancy, although 
they were also present at increased levels during involution and phase 3 respectively (Figure 
4.9 (c) and (d)). 
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Table 4.2: Mamsap output showing monodelphis domestica miRNAs targeting wallaby 
S100A19 mRNA 5’ region, free energy required for miRNA-target binding and position the 
mature miRNA binds on the target. 
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Figure 4.7: Predicted wallaby miRNAs potentially regulating S100A19 gene expression in the 
mammary gland.  
Predicted miRNA sequences are shown, beside predicted pre-miRNA hairpin structure 
generated by RNAFold and projected miRNA/Target hybridisation determined by 
RNAHybrid.  
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Figure 4.8: Top 10 lactation-related miRNAs exhibiting highest expression levels in 
mammary tissue libraries. 
Stacked bar graph showing normalised expression levels of the 10 most highly expressed 
miRNAs in each library.   
 
 
182 
 
 
 
Figure 4.9: Phase specific expression of lactation-related miRNA in the wallaby mammary 
gland during the lactation cycle. 
Normalised expression levels of highly expressed phase specific miRNAs are shown as 
determined by gel-selected sequencing.  
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Figure 4.10: Candidate S100A19-binding miRNAs’ expression profiles in the wallaby 
mammary gland during the lactation cycle. 
Normalised expression levels of the selected miRNAs are shown as determined by gel-
selected sequencing.  
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The expression profiles of the 10 identified miRNA candidates (Figure 4.7) were then 
examined in the tammar mammary gland during the lactation cycle. Of the 10 miRNA 
candidates, 7 were expressed at detectable levels in the mammary gland, with significant 
variations in transcript counts between miRNA species. Let-7b was the most highly 
expressed miRNA of interest with a maximum normalised expression value of 14.7 in 
involuting mammary tissue, a slightly lower value of 13.8 during phase 2A, reduced 
expression during gestation and phase 3 with values of 4.7 and 4.8 respectively, and the 
lowest expression value of 0.12 occurring in the phase 2A mammary gland (Figure 4.10a). 
Levels of Let-7d peaked at 3.07 in the phase 3 mammary gland, and showed similar 
expression levels in the pregnant, phase 2A and involuting glands with values ranging from 
1.1 to 1.6, while a lower level of expression (value 0.1) was present in the phase 2B gland 
(Figure 4.10b). miR-152 and miR-184 appear most important in the milk secreting stages 
during phase 3 and phase 2A respectively, with expression levels at least 60% higher when 
compared with the other phases (Figure 4.10f and g). miR-22 had a more consistent 
expression pattern, with levels fluctuating between 0.21 and 0.86 (Figure 4.10 (c)). Although 
miR-31 and miR-122 were expressed at much lower levels in the mammary gland, they too 
appear phase specific, peaking at 0.04 (gestation) and 0.06 (involution) respectively, while 
levels in all other phases values were less than 0.01 with the exception of miR-122 in the 
phase 3 mammary gland which had an expression value of 0.03 (Figure 4.10d and e).  
4.5 Discussion 
Throughout the reproductive cycle, the fate of epithelial cells is characterised by 
phases of growth, differentiation and apoptosis (Groner, 2002), processes which are 
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modulated by complex interactions between regulatory factors such as hormones, growth 
factors, cytokines (Nagamatsu and Oka, 1983, Ono and Oka, 1980, Topper and Freeman, 
1980), extracellular matrix (Wang et al., 2011b, Streuli, 2009, Bissell et al., 1982, Wanyonyi 
et al., 2013a) and milk compounds (Ucar et al., 2010, Sharp et al., 2008). These components 
relay their effects on gene expression via transcriptional regulation through specific 
receptors and intracellular signalling molecules, effecting shifts in the transcriptome 
comprising both qualitative and quantitative changes (Groner, 2002, Rosen et al., 1999, 
Rosen et al., 1998). This study explored some potential regulatory mechanisms controlling 
wallaby S100A19 gene expression, though the experimental models used here did not 
generate convincing evidence for hormonal or ECM manipulation of the gene. 
Mammary explants responded to treatment with lactogenic hormones, increasing 
BLG gene expression in the presence of prolactin, consistent with the literature (Collet et al., 
1991, Nicholas et al., 1991, Nicholas and Tyndale-Biscoe, 1985). S100A19 gene expression, 
however, was unchanged. The experimental model did not include all endocrine and growth 
factors involved in the initiation and maintenance of lactation, such as oestrogen and 
thyroid hormone. It is possible that the specific combination of hormones and growth 
factors that regulate S100A19 gene expression were lacking from the current experiments.   
The thyroid hormones are known to control the level of prolactin binding in the 
mouse mammary gland (Bhattacharya and Vonderhaar, 1979), and appear necessary in 
maintaining the responsiveness of mammary tissue to growth hormone and prolactin 
(Capuco et al., 1999). The expression of whey acidic protein (WAP) in eutherians is generally 
under the control of prolactin, insulin and cortisol (Devinoy et al., 1991). In the tammar 
wallaby, however, thyroid hormone and oestrogen are also required for the induction of 
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tammar WAP gene expression (Simpson et al., 2000). Therefore, while prolactin, insulin and 
cortisol are primary regulators of milk protein gene expression in the mouse and wallaby, 
the lack of thyroid hormone and/or oestrogen in culture can result in an altered 
physiological response. Consequently, a lack of these or other necessary growth factors or 
hormones may have affected S100A19 gene expression data produced here. Repetition of 
the wallaby explant experiment with the inclusion of combinations of oestrogen and thyroid 
hormones in addition to prolactin, insulin and cortisol may provide further insight into the 
endocrine regulation of S100A19 gene expression. 
Recent studies by Wanyonyi et al. (2013a and b) have described the effect of ECM on 
MEC morphology and function.  The ECM was shown to regulate expression of the 
MaeuCath1a, a splice variant of the cathelicidin gene which is translated into a secretory 
milk protein providing antimicrobial protection to the newborn young (Wanyonyi et al., 
2013b). Subsequent studies used phase specific gene markers of wallaby lactation to 
demonstrate the ability of ECM to regulate phenotypic changes in MECs. The culture of 
phase 2B wallaby MECs on ECM derived from phase 3 mammary gland resulted in MECs 
expressing late-lactation protein (LLP), a protein specific to phase 3 of lactation (Wanyonyi 
et al., 2013a). In addition, Wanyonyi et al. (2013a) showed that compositional changes in 
the ECM are characteristic of the lactation phases and that these progressive changes most 
likely contribute to a local regulatory mechanism for milk protein gene expression. The 
wallaby ECM culture model used by Wanyonyi et al. (2013a) was replicated in the present 
study to examine the effects of ECM on wallaby S100A19 gene expression; however no 
significant change in S100A19 gene expression was detected. Since gene regulation in the 
mammary gland has been shown to involve the synergistic action of both ECM and 
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hormones (Schmidhauser et al., 1990, Medina et al., 1987), the culture was repeated and 
prolactin was added in addition to insulin and cortisol, but again no significant change in 
S100A19 gene expression was identified. The BLG gene was expressed in response to IFP but 
not IF, confirming cell response to hormone treatment. Hence, we can conclude that the 
wallaby S100A19 gene is not regulated by ECM alone or in combination with IFP. However, 
the subsequent culture of MECs from pregnant tammars on ECM from pregnant and phase 
2A mammary glands with the inclusion of oestrogen and thyroid hormone in addition to IFP 
would be worthwhile in order to identify cooperative effects between these hormones and 
ECM in the control of S100A19 gene expression.  
Furthermore, the ECM used in the present study was derived from one animal per 
lactation phase, and replication of the experiment with ECM from additional animals would 
confirm the results presented here. Further exploration of the effect of hormones and 
matrix on S100A19 gene expression was unfortunately hampered by the lack of animal 
tissue available at the time of writing of this thesis.  
4.5.1 C/EBPβ may act as a transcriptional activator of the S100A19 gene 
The C/EBPβ gene was found to have an expression profile in the mammary gland which 
correlated with the S100A19 gene expression profile. The C/EBPβ profile in the wallaby 
mammary gland during lactation is similar to that of the human and mouse, with 
comparatively high levels of expression observed the non-pregnant, pregnant and involuting 
mammary gland and low levels during lactation. While human data was generated from 
somatic cells derived from milk, these cells originate from the mammary gland and express 
the major milk protein genes only during lactation, thus are representative of expression 
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levels in the mammary gland. In addition, the expression profile of the C/EBPβ gene is 
comparable to that previously reported in both the mouse (Gigliotti and DeWille, 1998) and 
rat (Raught et al., 1995). The expression profile of the C/EBPβ gene in the human and mouse 
also correlates with a number of S100 genes in these species, encouraging exploration of 
the potential C/EBPβ regulatory activity in the promoters of these genes and other 
members of the S100 family. Moreover, binding of C/EBPβ to the promoter regions of 
human S100A6, S100A10, S100A11 and S100A4 genes has been confirmed through the 
ENCODE project, and the CCAAT binding motif is also present within the wallaby S100A19 
gene promoter.  
The C/EBP family consists of six proteins, named C/EBPα, C/EBPβ, C/EBPγ, C/EBPδ, 
C/EBPε and C/EBPζ. Dimerisation can occur between any two members of the family or 
between different groups of leucine zipper proteins (Cao et al., 1991), and different 
combinations of dimers are thought to have different binding affinities and/or trans-
activating potentials (Lamb and McKnight, 1991). Dimerisation is a prerequisite to DNA 
binding, and dimers readily dissociate back to monomers when DNA is not bound (Patel et 
al., 1994). C/EBPβ and C/EBPδ are the only two members of the family which have 
conclusive actions in the mammary gland, and are temporally expressed during mammary 
gland development. C/EBPβ is essential for growth and epithelial cell differentiation in the 
mammary gland (Robinson et al., 1998), while C/EBPδ controls growth arrest and apoptosis 
(O’Rourke et al., 1999). A report has suggested that C/EBPα is also differentially expressed in 
the mouse mammary gland (Sabatakos et al., 1998), but this conflicts with other 
publications which found that C/EBPα is expressed at highest levels in the virgin gland, but is 
generally low and remains unchanged throughout mammary gland development (Robinson 
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et al., 1998, Seagroves et al., 1998). Thus, the expression profile of C/EBPα is unclear to 
date, and further studies must be carried out to further the understanding of its role in the 
mammary gland.  
C/EBPβ plays a vital, cell autonomous role in cell proliferation in the mammary gland 
and in the differentiation of mammary epithelial cells into secretory cells during pregnancy. 
(Robinson et al., 1998). A study showed that C/EBPβ-/- mice experienced delayed ductal 
outgrowth, distended ducts, decreased branching and an inability to express milk protein 
genes (Robinson et al., 1998). Markers of differentiation of the mammary epithelium, WAP 
and β-casein, were undetectable, and expression of the WDNM1 gene was extremely low. 
Although expression levels of both β-casein and WAP were undetectable in the mutant 
mice, the β-casein promoter contains four C/EBPβ binding sites while the WAP promoter 
contains none. Hence, the β-casein gene was suggested to be a direct target of C/EBPβ, and 
WAP an indirect target possibly via blockage of epithelial cell differentiation  (Robinson et 
al., 1998).  
 The impaired mammary gland development in C/EBPβ knockout mice may be 
partially attributed to impaired ovarian function (Seagroves et al., 1998, Robinson et al., 
1998). C/EBPβ-/- female mice are sterile, as the transcription factor is required for normal 
ovarian follicle development (Sterneck et al., 1997). Transplantation of functional wildtype 
ovaries into knockout females did allow pregnancy to occur, however ductal abnormalities 
remained and alveoli were sparse with a complete absence of milk production. Stoma was 
also ruled out as a causative of abnormal mammary glands in knockout females via 
transplant of normal mammary epithelia into mutant fat pads (Robinson et al., 1998). Thus, 
the role of C/EBPβ in the mammary epithelial cells is well established in eutherians, in 
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particular for growth, ductal development and differentiation of mammary epithelial cells 
during pregnancy. It is possible that the transcription factor binds to the marsupial S100A19 
promoter via the CCAAT box, participating in the upregulation of S100A19 gene 
transcription in the mammary gland during pregnancy. This hypothesis agrees with our prior 
findings regarding the proliferative effects of S100A19 protein. 
Interferons, which promote the development of immune responses, are known to 
induce C/EBPβ expression (Li et al., 2007). This is consistent with the upregulation of the 
C/EBPβ gene during involution, and suggests that C/EBPβ may also regulate various other 
genes involved in immune defence and protection of the mammary gland in addition to 
S100A19. Furthermore, C/EBPβ regulates the S100A9 gene (Henkel et al., 2002, Kuruto-Niwa 
et al., 1998) and possibly S100A8 (Németh et al., 2009) gene in humans, and may therefore 
play a role in the regulation of a variety of other S100 genes in mammals, particularly those 
with similar expression profiles to the transcription factor (Clarkson and Watson, 2003, 
Nazarov et al., 2013).   
While further experimental validation is necessary to confirm a role for C/EBPβ in 
S100A19 gene regulation, the findings presented in this chapter support the hypothesis and 
demonstrate the likelihood that this transcription factor is involved in control of S100A19 
gene expression. To investigate the potential role of C/EBPβ in regulating S100A19 gene 
expression, a construct containing the wallaby C/EBPβ gene could be transfected into phase 
2A MECs cultured on ECM from phase 2A mammary glands in the presence of either 
lactogenic hormone complex or no hormone. Changes in S100A19 gene expression in 
response to the upregulation of the C/EBPβ gene could then be assayed by quantitative PCR. 
Overexpression of C/EBPβ in mammary epithelial cells has previously been used to examine 
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the effect of the transcription factor on the growth cascade (Zahnow et al., 2001). This study 
illustrated the need to use cells expressing low endogenous levels of C/EBPβ; hence MECs 
from lactating tammars would be best for this experiment. Although the transfection of 
primary cells is generally considered highly challenging, successful transfection of WallMECs 
has been described previously by Wanyonyi et al. (2013b). The published method should be 
followed and transfection of an empty vector construct included as a control. Increased 
quantities of S100A19 transcripts in response to increased C/EBPβ levels (measured by 
quantitative PCR) would be consistent with a role for C/EBPβ in S100A19 gene regulation.  
The C/EBPβ gene could then be downregulated in phase 1 wallaby MECs expressing 
the S100A19 gene cultured on phase 1 ECM with and without the lactogenic hormone 
complex. This experiment would involve the addition of a short RNA oligos complementary 
to the coding region/s of the C/EBPβ mRNA. This method of siRNA induced silencing has 
been used successfully to demonstrate the effects of C/EBPδ on the production of 
proinflammatory cytokines and chemokines (Do-Umehara et al., 2013), and to examine the 
association between C/EBPα and acetaldehyde (Mir and Chauhan, 2011). The synthetic RNA 
would bind to the C/EBPβ transcript, preventing translation of the bound mRNA to result in 
‘knock down’ of the gene. If C/EBPβ stimulates S100A19 gene transcription, a reduction in 
the quantity of S100A19 mRNA would be evident and could be quantitated by real-time 
PCR.  
Since C/EBPβ regulates various genes involved in critical processes such as cell 
proliferation as discussed, manipulation of the gene by either overexpressing or silencing 
may be problematic. Experiments up- and down-regulating the C/EBPβ gene could be 
complimented by the use of a reporter assay whereby the native CCAAT box within the 
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wallaby S100A19 promoter and the flanking region is cloned into an expression vector 
upstream of a reporter gene such as luciferase and transfected into wallaby MECs. A 
construct with a mutated CCAAT motif should also be included in the experiment to test for 
a negative response. A similar method has been successfully used to identify the specific 
region of regulatory activity in the promoter of the wallaby MaeuCath1a gene, another gene 
which is temporally regulated in the mammary gland, by transfecting the MECs with a series 
of promoter constructs (Wanyonyi et al., 2013b). If the section of the wallaby promoter 
containing the CCAAT box is operative (presumably binding C/EBPβ), production of 
luciferase would follow and could be quantitated using a luminometer as per Wanyonyi et 
al. (2013b). The study by Wanyonyi et al. (2013b) also used an electrophoretic gel mobility 
shift assay to demonstrate a band shift, confirming the interaction between nuclear proteins 
from MECs and the identified region of the promoter. A  gel shift assay could similarly be 
performed with nuclear extract containing C/EBPβ protein prepared from phase 1 MECs and 
the CCAAT box-containing region of the S100A19 promoter amplified from wallaby DNA 
using flanking oligo probes. These products would be combined in a binding reaction and 
resolved on a polyacrylamide gel and then imaged. Future options for confirmation of 
C/EBPβ control of S100A19 expression are further discussed in chapter 5.  
4.5.2 Post-transcriptional regulation of S100A19 gene expression by miRNA  
Interactions between miRNA and mRNA are essential for the control of various important 
genes throughout the growth and development of the mammary gland (Ucar et al., 2010, 
Tanaka et al., 2009, Avril-Sassen et al., 2009). While the exact mechanism of action is 
unclear, miRNAs bind to their targets through imperfect base pairing to repress protein 
translation. The mechanisms of action of miRNA described to date include mRNA transcript 
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deadenylation and degradation (Bagga et al., 2005, Valencia-Sanchez et al., 2006, Cannell et 
al., 2008), interference with initiation and elongation processes of translation, and the 
possible post-translational degradation of the nascent polypeptide (Valencia-Sanchez et al., 
2006, Pillai et al., 2007, Nottrott et al., 2006). An additional theory is that miRNA binding 
physically isolates the target mRNA by preventing interaction with ribosomes (Pillai et al., 
2007, Valencia-Sanchez et al., 2006). In this study we selected miRNA candidates based on 
base pair interactions and therefore focused on miRNA-mRNA interactions prior to peptide 
synthesis. We hypothesised that miRNA expression patterns inversely correlated with the 
pattern of the S100A19 gene expression may indicate a regulatory relationship (Nazarov et 
al., 2013). As the S100A19 gene is highly expressed during pregnancy with a marked 
decrease during lactation and subsequent increase at involution, we postulated that an 
increase of a particular miRNA during lactation may indicate that the miRNA binds to the 
S100A19 transcript, causing its degradation and resulting in low S100A19 mRNA levels 
during lactation. The present study did not provide preliminary evidence for miRNA control 
of S100A19 gene expression in the wallaby mammary gland, but further analysis of the 
miRNAs identified in this chapter in warranted. In silico experimentation suggests that all 10 
of the miRNAs have the ability to interact with the 5’ non-coding exon of S100A19 mRNA, 
and it is possible more than one miRNA regulates expression of the gene. Future 
experimental validation of miRNA-S100A19 interactions should involve overexpression of 
the miRNAs of interest in phase 1 MECs cultured on ECM from phase 1 mammary glands by 
transfection with a cloned expression vector containing the double stranded DNA coding the 
miRNAs, and validation of successful miRNA expression by qPCR. This method is effective if 
the miRNA of interest destabilises its target mRNA, and is commonly used to examine the 
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miRNA regulatory interactions (Guo et al., 2010, Martinez-Sanchez and Murphy, 2013). The 
effect of the miRNAs on S100A19 protein synthesis could then be analysed by methods such 
as Western blot, immunostaining or ELISA. 
Moreover, data presented in this chapter indicates that some of the miRNAs examined were 
temporally expressed in the mammary gland during the lactation cycle, indicating a 
potential role in the regulation of gene expression within the mammary gland. MiRNAs 
showing distinct phase specific expression are of particular interest. Let-7b, for example, is 
expressed at high levels in the mammary gland when compared with other miRNAs, and 
exists at particularly high levels in phase 2A and involution (Figure 4.10a). However, 
expression levels are comparatively low during phase 2B, suggesting that Let-7b may be 
involved in regulating the production of phase specific proteins in the mammary gland and 
milk, such as WAP, which is primarily produced during phase 2B of wallaby lactation (Sharp 
et al., 2009). If Let-7b interacts with milk protein mRNAs such as the WAP transcript, the 
lack of Let-7b during phase 2B in the wallaby may allow high expression levels of those 
proteins in milk. Computer modelling of putative Let-7b-WAP interactions to indicate the 
likelihood of this relationship are required before further functional analysis proceeds. 
4.6 Conclusion 
In this study, the mechanisms influencing wallaby S100A19 gene expression were explored. 
The data gives some insight into the regulatory mechanisms that may impact on S100A19 
gene expression. While prolactin, insulin and cortisol, the hormonal complex that regulates 
most milk protein genes stimulated an increase BLG gene expression in mammary explants, 
no effect on S100A19 gene expression was detected. Further experiments with additional 
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hormone combinations including oestrogen and thyroid hormone are required to determine 
whether a larger complex of hormones plays a role in the regulation S100A19 gene 
expression. MECs cultured on ECM from different stages of lactation showed no significant 
change in S100A19 gene expression, but additional experiments with the discussed 
hormone combinations and additional animals are necessary to confirm the results. The 
transcription factor C/EBPβ, which regulates gene expression of other members of the S100 
family, and a number of miRNAs were identified as possible regulators of the S100A19 gene, 
and further overexpression, silencing and/or reporter assays have been suggested. For more 
information on the proposed mechanisms for regulation of the S100A19 gene, see Chapter 
5. 
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Chapter 5 
General Discussion 
5.1 Introduction 
This thesis presents compelling new information, identifying and characterising an ancient 
member of the S100 family. S100A19 is a protein with selective antibacterial activity against 
pathogenic strains; an intriguing finding which presents opportunities for targeted 
therapeutic use. Many commercial antibiotics kill symbiotic microflora inhabiting the body 
which are important for general health and wellbeing. Hence, antimicrobial agents that kill 
harmful species while leaving commensal strains unharmed are of significant value. This 
study exploits the unique reproductive strategy of a marsupial that involves birth of an 
immune-compromised infant, which offers an excellent opportunity to study development 
of the mammalian immune system and maternal immune compounds. S100A19 protein is 
recognised for the first time as innate immune molecule that protects the mammary gland 
from infection and is also secreted by pouch epithelia for protection of the altricial neonate. 
5.2 Antibacterial S100A19 protein is secreted as an innate immune defence molecule in the 
mammary gland and as a maternal protective strategy in the pouch.  
Data presented in chapter 3 demonstrates the antimicrobial activity of wallaby 
S100A19 protein and its temporal expression in the mammary gland and pouch, and 
describes the secretion of the protein into the pouch for protection of the immuno-
incompetent neonate. Ambatipudi et al. (2008) tested the antimicrobial activity of 
compounds isolated from the tammar pouch and found greatest activity in samples 
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collected from females during oestrus when a young neonate is present. Baudinette et al. 
(2005) also tested samples collected from the wallaby pouch, but in unlike Ambatipudi et al. 
(2008), found no antibacterial activity in samples from between 2 days pre-partum to 6 days 
post-partum. These contrasting results are possibly due to the different collection methods; 
Ambatipudi et al. (2008) used washes from the pouch while Baudinette et al. (2005) used 
swabs. Therefore it is possible that Ambatipudi et al. (2008) collected a greater number or 
quantity of bioactive compounds from a larger area (Edwards et al., 2012). While both 
studies have been beneficial in gathering information regarding secretions in the pouch, a 
proteomics approach is problematic because pouches samples may be contaminated.  
Sample collection via the swabbing and washing methods collect not only secretions 
originating from the pouch epidermis, but also compounds from milk, excrement from the 
neonate, neonate skin secretions and compounds from maternal saliva. Proteomic data 
would be more valid when combined and substantiated with data derived from the analysis 
of gene expression in maternal pouch tissue, using methods such as the RNA sequencing 
and quantitative PCR used in the present study.  
The weakness of the proteomics method is evident from the presence of milk 
proteins in pouch washing samples (Ambatipudi et al., 2007, Ambatipudi et al., 2008). β-
lactoglobulin was identified at molecular weights between 15-60 kDa in wallaby pouch 
washes (Ambatipudi et al., 2008). The authors suggested that β-lactoglobulin may 
polymerise and become glycosylated under pouch conditions since these molecular weights 
are higher than those seen in the milk or gut. In the cow, β-lactoglobulin is known to exist as 
a dimer under certain biological conditions, and polymerises to become an octamer under 
low temperature and pH, and therefore Ambatipudi et al. (2008) suggested a similar 
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occurrence in the wallaby through changing pouch conditions. The β-lactoglobulin present 
in the pouch is most likely released from the mammary gland, either pre-oestrus or via 
neonatal excrement. β-lactoglobulin has previously been shown to pass  intact through the 
gut of pigs (Lovegrove et al., 1993) and rabbits (Caillard and Tome, 1994). Protein cleavage 
in the pouch may then result in peptides with antimicrobial activity, for instance the 
enzymatic proteolysis of β-lactoglobulin described in Hernández-Ledesma et al. (2008). 
While bioactive peptides derived from β-lactoglobulin may have a role in the pouch, the 
likelihood that β-lactoglobulin is secreted by the pouch epithelia was not substantiated by 
the RNA sequencing analysis presented in chapter 3. The existence of antimicrobial 
molecules synthesised by the pouch epithelia had not been confirmed prior to this study.  
In contrast to the present study, Ambatipudi et al. (2008) found that while the pouch 
washes were effective in inhibiting the growth of E. Coli, they had no effect on the growth of 
S. aureus. Results presented in chapter 3 show that S100A19 is effective against both of 
these bacterial species as well as P. aeruginosa and S. enterica. The differing results possibly 
relate to the limited quantity of protein in the pouch washes compared with the larger 
amount of recombinant S100A19 protein used in the present study. Bacterial species have 
varying sensitivity to the effects of antimicrobial proteins (James et al., 1996, Kisugi et al., 
1992, Suzuki et al., 1990). In the case of S100A19 protein, a lesser quantity may be required 
to kill E. coli when compared with S. aureus. While E. coli is a Gram negative rod, S. aureus is 
a Gram positive coccal bacterium; it is likely that the differences in sensitivity relate to the 
contrasting characteristics of the cell walls. The thicker peptidoglycan layer of gram-positive 
bacteria (which provides superior resistance to physical disruption), presence of teichoic 
acids, or the lack of the lipopolysaccharide layer are properties which may have a role in 
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conferring greater resistance in S. aureus (Moore et al., 2004, Laarman et al., 2010), limiting 
the mechanism of action of S100A19 protein, and explaining the requirement for a larger 
dosage of the protein to kill or inhibit the  growth of S. aureus effectively. 
Furthermore, the method of collection used in the earlier study, involving lavage of 
the pouch with 1mL water (pH 5.5) followed by lyophilisation and resuspension in 
phosphate buffered saline, may have denatured the protein and reduced its activity. 
Lyophilisation, if suitable additives are not included in the formulation, can lead to protein 
damage.  The freeze-drying process can lead to a non-native secondary structure, which 
then results in immediate aggregation during the rehydration process and reduces the 
stability of the protein during storage (Carpenter et al., 2004). Ambatipudi et al. (2008) 
stored lyophilised pouch wash samples for up to 2 years.  
5.3 S100A19 protein exerts antimicrobial activity and selectivity via an unknown 
mechanism 
As for most antibacterial proteins, the target of S100A19 is most probably the 
bacterial membrane (Baranyi et al. 2003, Lee and Eckert, 2007, Michalek et al, 2007). 
However, the means in which S100A19 exerts its activity remains unknown. While the 
significance of the HXXXH and HHH zinc binding motifs and their role in zinc chelation and 
bacterial death (Loomans et al., 1998, Sohnle and Hahn, 2000) has been discussed in 
chapters 1 and 3, the mechanism responsible for S100A19 protein’s antibacterial activity is 
undetermined.  
The closely related S100A7 protein, a major antibacterial protein of the human skin, 
(Gläser et al. 2009), has been extensively studied in humans (Al-Haddad et al., 1999, 
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Alowami et al., 2003, Andresen et al., 2011, Brodersen et al., 1998, Emberley et al., 2003a & 
2003b, Hagens et al., 1999, Kulski et al., 2003, Lee and Eckert, 2007, Milder et al., 2010). 
S100A7 is known to have pore forming abilities that result is bacterial death, similar to 
amoebapore A, an ancient protein produced by Entamoeba histolytica (Michalek et al, 
2007). S100A7’s pore forming capacity, however, is pH dependent, as is the bacterial 
specificity of the protein. At pH 6, S100A7 kills gram positive B. megaterium by 
permeabilisation of its cytosolic membrane. At pH 7, however, the protein induces death in 
gram negative E. coli with no apparent disruption of the membrane (Michalek et al., 2007). 
The protein has also been suggested to protect against bacterial infection in wounds by 
cross-linking with other proteins to form a solid phase physical barrier, while S100A7 
monomers act as a liquid phase barrier (Lee and Eckert, 2007). Thus, the mechanism of 
action of S100A7 protein at pH 7 and above has not been elucidated. However, it is clear 
that the direct association of S100A7 with bacteria plays an important part is eliciting 
antibacterial activity (Lee and Eckert, 2007). Other proteins are believed to exert their 
antibacterial activity following translocation across the bacterial membrane, where they 
may alter cytosolic membrane formation, hinder cell wall synthesis or inhibit enzyme 
activity (Brogden, 2005).  
To investigate S100A19 protein’s mechanism of action, it could first be heat 
denatured to test if the native tertiary structure is essential for activity. Next, bacterial 
expression constructs with mutated zinc and calcium binding domains could be tested, 
comparing bacteriostatic activity to that of the native sequence, as per Lee and Eckert 
(2007). Expression constructs could also be used to test the effectiveness of smaller 
peptides derived from the S100A19 sequence, and a fluorescent tag used to track the 
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protein or its active fragment and determine whether it binds to the cell surface of is 
internalised. Once the mechanism is better understood, it would be useful to track the 
active tagged protein or peptide in a culture containing commensal bacteria. Visualising 
S100A19 in culture may determine whether the protein’s selectivity is due the ability of 
commensal bacterial to externalise the protein or resist its effects by some other means.  
5.4 Regulation of the S100A19 gene is likely to involve complex interactions between 
extracellular stimuli, transcription factors and small RNA.  
Gene expression is controlled by complex interactions between regulatory factors 
such as hormones, growth factors and ECM (Nagamatsu and Oka, 1983, Topper and 
Freeman, 1980, Bissell et al., 1982) which in turn effects the transcriptome at a molecular 
level through specific signalling molecules such as transcription factors and small RNAs 
(Groner, 2002, Rosen et al., 1998, Avril-Sassen et al., 2009). The research presented in 
chapter 4 explores the initial steps in identifying factors involved in the regulation of the 
S100A19 gene. Future directions for this research are discussed in part in chapter 4; 
however some further discussion is warranted.  
The expression profile of C/EBPβ mRNA provides limited information for assessing 
the role of this transcription factor in regulating gene expression. It is important to consider 
the multiple isoforms produced by the C/EBPβ gene, which have opposing functions. In 
humans and rodents, three isoforms are expressed, including the full length protein, liver-
enriched activating protein (LAP) 1 and 2 (38kDa and 35kDa respectively in mouse, slightly 
larger in human), and liver-enriched inhibitory protein (LIP). The most highly expressed and 
readily detected isoforms are LAP2 and LIP. Both LAP and LIP have equivalent binding and 
204 
 
dimerisation domains, although LIP lacks the majority of the trans-activation domain and 
thus cannot activate gene transcription (Descombes and Schibler, 1991). While the LAP 
isoform activates transcription, LIP competes for the DNA binding sites with higher DNA 
affinity, and blocks transcription of the target gene. LIP is therefore considered to have a 
dominant negative function (Descombes and Schibler, 1991). C/EBPβ isoforms are 
expressed in different ratios in different tissues, and the ratio is thought to change in 
response to various stimuli (Cao et al., 1991, Hsu and Chen-Kiang, 1993). Due to the 
dominance of LIP, a small change can have a significant effect on the transcription of C/EBP-
responsive genes. While C/EBPβ may bind the S100A19 promoter, the specific isoform 
which occupies the binding site will determine whether transcription is initiated or blocked. 
Therefore, the isoform ratios as well as the complex dimerisation relationships of C/EBPβ 
are key to interpreting regulatory interactions or the transcription factor. 
As discussed in chapter 4, dimerisation can occur between any two members of the 
C/EBP family or between different groups of leucine zipper proteins. The extensive 
dimerisation possibilities of this family add to the complexity involved in interpreting the 
activity of these transcription factors, as does the presence of endogenous C/EBPs both in 
vitro and in situ. Overexpression and knockout experiments are complicated by the wide 
expression of C/EBPs by many cell types, where they regulate many genes often essential 
for normal cell function (MacDougald et al., 1995, Dearth et al., 2001, Wu et al., 1995, 
Sterneck et al., 1997, Seagroves et al., 1998). Manipulation of the C/EBPβ gene in wallaby 
MECs may therefore impact on cells in various undesirable and unascertained ways which 
are not the result of a direct binding relationship between the transcription factor and the 
S100A19 gene promoter. However, these changes might alter S100A19 gene expression as a 
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secondary effect, and care must be taken in interpretation of results. Overexpression or 
gene silencing experiments should be used in combination with studies examining the 
physical interaction of C/EBPβ and the S100A19 promoter, such as the luciferase reporter 
assay and gel shift (discussed in chapter 4), which would ideally be followed by mass 
spectrometry to confirm the identity of the interacting nuclear protein. Alternatively, 
overexpression of the S100A19 gene in the mammary glands of transgenic mice may not 
only be useful in order to further elucidate the biological role of S100A19 protein in 
mammary gland development, but also to examine the mechanisms that regulate gene 
expression. Tissue-specific expression of S100A19 in the mammary gland could be achieved 
by placing the gene under control of the mouse mammary tumour virus (MMTV) promoter 
as per Shin et al. (2011). RT-PCR and immunohistochemistry may then be used to examine 
the changes in expression of the C/EBPβ isoforms.  
It is also likely that cooperative binding of a number of transcription factors together 
regulate the S100A19 gene. This type of regulation is common, particularly for genes which 
are spatially and developmentally regulated (Jiang and Levine, 1993, Kel et al., 1995). The 
transcription factors bind to composite response elements (CoREs) in the promoter region 
to activate or inhibit transcription through integration of signal transduction pathways. The 
cooperative binding within the CoRE commonly achieves a greater level of transcription 
than that of the individual transcription factors alone (Kel et al., 1995).  This type of 
transcription factor regulation is known to regulate the β-casein gene in the mammary gland 
(Wyszomierski and Rosen, 2001). Transcription factor binding within the β-casein CoRE is 
controlled by the lactogenic hormones prolactin, insulin and cortisol in mammary epithelial 
cells, and gene activation involves simultaneous binding of signal transducer and activator of 
206 
 
transcription (STAT) 5, glucocorticoid receptor (GR) and C/EBPβ (Wyszomierski and Rosen, 
2001). Interestingly, cooperative transactivation does not occur in the absence of full-length 
transcriptionally active GR. Furthermore, cooperative binding of these three transcription 
factors is specific to the LAP C/EBPβ isoform (Wyszomierski and Rosen, 2001). This example 
further elucidates the complexity of transcription factor control, and thus it should be 
considered that a number of transcription factors interact to activate or inhibit S100A19 
gene activity. Such cooperative binding may involve TBP, MYCBP2 or POLR2A which were 
identified in chapter 4 as transcription factors binding to the promoter region of S100 genes 
in the human mammary gland with expression profiles correlating with that of S100A19 in 
the wallaby. The activity of these transcription factors may be explored in future by 
methods such as gene expression analysis, gene knockdown and/or reporter assays, and 
chromatin immunoprecipitation experiments could be used to isolate bound transcription 
factors from the nucleus of wallaby MECs and  confirm cooperative binding relationships. 
A possible stimulus for upregulation S100A19 gene expression is the presence of 
bacteria or bacterial products, a concept explored by challenging mammary tissue with 
microbes and quantitating S100A19 expression levels. Wallaby teat cisterns could be directly 
injected with small amounts of bacteria and tissue collected over a subsequent time period 
of hours or days. This experimental approach has been is use for over 40 years and has 
proven effective in examining the onset of mastitis in several species including cows 
(Regenhard et al., 2010, Prasad and Newbould, 1968) mice (Anderson, 1978, Chandler, 
1970) and sheep (Mavrogianni et al., 2005). When the timing of S100A19 gene upregulation 
in the pouch is considered, it seems possible that the qualitative changes in bacterial 
population, which vary according to age of the pouch young (Old and Deane, 1998), cause 
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the changes in gene expression in the pouch epithelium demonstrated in chapter 3. Old and 
Deane (1998) reported 15 species of bacteria which were unique to the empty pouch, and 6 
species of bacteria present in pouches containing pouch young older than 3 weeks which 
were absent from pouches containing younger neonates. The species present during late 
phase 2A/phase 2B but not shortly after parturition included 3 gram negative rods; 
Enterobacter aerogenes, Aeromonas hydrophilia and Pasteurella spp., and 3 gram positive 
cocci; Streptococcus spp., Micrococcus spp., and Enterococcus hirae. These results are 
consistent with a role for bacterial species changes as a regulatory stimulus of the S100A19 
gene; the expression profile of the S100A19 gene in the wallaby pouch reported in this 
thesis shows differential regulation between the early phase 2A pouch epithelia (samples 
from between day 1 and 40 post-partum) and phase 2B pouch epithelia (samples from 
between 136 and 151 post-partum). The importance of the relationship between bacterial 
populations and host gene expression has been examined in the gut of humans and mice 
(Sommer and Bäckhed, 2013, Everard et al., 2013, Clemente et al., 2012, Sekirov et al., 
2010, Sina et al., 2013), and alterations in microbiota of the gut have been shown to induce 
transcriptional changes influencing intestinal permeability, systemic inflammation levels and 
host metabolism (Everard et al., 2013, Derrien et al., 2011). 
Nonetheless, while the S100A19 gene is expressed by involuting mammary tissue 
which may encounter increased bacterial numbers due to milk stastis and cell debris 
(Sordillo et al., 1987), it is also expressed during pregnancy, a period when the tissue may 
have limited exposure to bacteria. Thus, neither the presence of pathogens nor qualitative 
changes in bacterial population is likely to be the sole trigger for upregulation of S100A19 
gene expression. There may be multiple influences on S100A19 gene expression, including 
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bacterial stimuli, ECM and/or hormones, and experimentation with pouch tissue in addition 
to cells and tissue from the mammary gland may be useful in determining the factors driving 
S100A19 gene expression. It may be of benefit to include a pouch explant model in addition 
to the previously described explant culture experiments to examine the effect of lactogenic 
hormones on S100A19 gene expression in the pouch skin. Excised sections of skin are 
commonly cultured as explants in a similar manner to mammary explants (Mutasim et al., 
1993, Vangipuram et al., 2013). To test whether ECM has a role in regulating S100A19 gene 
expression in the pouch, ECM from the pouches of pregnant, phase 2A and phase 2B 
tammars could also be extracted and primary cells prepared from the pouch epithelium of 
these animals cultured on ECM from various phases as described in chapter 4. In addition, 
bacterial preparations containing species usually exclusive to empty pouches could be 
applied directly to the pouch skin of phase 2A tammars, a method used by Glaser et al. 
(2005) to test the effect of bacteria on S100A7 gene expression. A biopsy of pouch skin 
could be excised the following day, RNA extracted and examined by PCR for expressional 
changes S100A19 mRNA.  
5.5 Economic significance  
Antibiotic resistance of pathogenic bacteria is a significant and growing problem 
throughout the world, and mortality rates associated with multidrug-resistant Gram-
negative organisms alone range from 30 to 70% (Bratu et al., 2005, Bryan et al., 1983, 
Gudiol et al., 2011). An unsustainable cycle is created by the excessive and frequently 
inappropriate use of broad-spectrum antibiotics, which contributes to the emergence of 
new resistant strains and broadens the scope of resistance of already problematic strains 
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(Rice, 2009, Tamma et al., 2012). Relatively limited numbers of antimicrobial agents have 
entered the drug development pipeline in recent years, and currently available drugs that 
remain effective are dwindling (Bush, 2010). While the incorrect use of antibiotics must be 
addressed, the discovery and development of new antibiotic agents is imperative. Marsupial 
S100A19 protein emerges as a potential therapeutic and may hold value as an antimicrobial 
agent for the treatment of infections caused by antibiotic resistant pathogens.  
In addition, the use of broad spectrum antibiotics often has negative consequences, 
resulting in illness such as diarrhoea and thrush which are caused by an imbalance in 
beneficial flora occupying the gut or vagina respectively (Samonis et al., 1994, Kennedy and 
Volz, 1985, Wolfson, 2005). Antimicrobial agents which exhibit selectivity for particular 
species circumvent this issue, killing only target species while leaving others unharmed. 
S100A19 protein does not kill the commensal bacterial species E. facealis, and may also be 
infective against other symbiotic species, potentially offering an alternative treatment with 
fewer unwanted side effects. Future in-depth experimentation with S100A19 protein will 
decide whether it is suitable for the pharmaceutical pipeline.   
5.6 Summary 
x This thesis has identified and characterised a novel wallaby S100 protein expressed 
by both the mammary gland and the pouch epithelium.  
x This protein, named S100A19, has selective antimicrobial activity against harmful 
bacterial strains and is expressed at elevated levels during periods of increased 
susceptibility to infection for protection of the infant and the maternal mammary 
gland. The S100A19 protein also appears to influence growth rates of mammary 
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epithelial cells during pregnancy; a time during which the mammary gland 
experiences extensive proliferation as ducts extend throughout the stroma and 
alveolar buds form.  
x As the S100A19 gene is temporally regulated in the mammary gland, the 
mechanisms controlling gene expression were investigated. Following recent data 
presenting compelling evidence for ECM-driven changes in the expression of 
mammary genes together with the established knowledge regarding hormonal 
control of many mammary and milk protein genes, the question of whether IFP or 
ECM influence S100A19 gene expression was addressed. There was no evidence for 
ECM or the complex of lactogenic hormones controlling S100A19 gene expression. 
However, the transcription factor C/EBPβ emerged as a possible participant in 
regulation of the gene.  
x The 5’ non-coding exon is a feature of unknown function common to most proteins 
belonging to the S100 calcium binding family. Since miRNA-mRNA interactions are 
vital for normal mammary gland development and function, this study examined 
whether miRNAs potentially interact with the non-coding region of the S100A19 
transcript; interactions which may explain the preservation of this untranslated 
region within this protein family and across species. Various miRNAs with the 
theoretical ability to interact with the S100A19 transcript were differentially 
regulated in the mammary gland, but further exploration is required to substantiate 
miRNA-S100A19 transcript interactions. 
x Marsupial S100A19 protein presents as a potential therapeutic, as an alternative to 
traditional chemical antibiotics and a possible option for the treatment of infection 
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caused by antibiotic resistant bacteria. The selective nature of the protein may also 
offer further benefits, reducing the side effects associated with traditional methods.  
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Appendix 1: Proteins used in S100 family phylogram (Figure 2.1), correct as of October 2012. 
Protein Species Genbank Assession/Ensembl id/Ensembl location 
S100A1 Macaca mulatta AFI35880.1 
 Canis lupus familiaris XP_003434950.1 
 Equus callubus XP_001494920.1 
 Homo sapiens CAI19677.1 
 Pan troglodytes XP_001140144.2 
 Bos taurus DAA31796.1 
 Danio rerio BAK26517.1 
 Rattus norvegicus AAB53657.1 
 Mus musculus NP_035439.1 
 Monodelphis domestica XP_001365057.1 
 Oryctolagus cuniculus ENSOCUP00000002387 
 Orthithorhynchus anatinus - 
 Macropus eugenii - 
 Gallus gallus - 
 Sus scrofa - 
S100A2 Macaca mulatta AFE70129.1 
 Canis lupus familiaris XP_855158.1 
 Equus callubus XP_001494717.1 
 Homo sapiens CAA69033.1 
 Pan troglodytes XP_001139397.1 
 Bos taurus DAA31784.1 
 Danio rerio - 
 Rattus norvegicus - 
 Mus musculus NP_001182689.1 
 Monodelphis domestica - 
 Oryctolagus cuniculus - 
 Orthithorhynchus anatinus XP_001513332.1 
 Macropus eugenii - 
 Sus scrofa - 
 Gallus gallus - 
S100A3 Macaca mulatta ENSMMUP00000038986 
 Canis lupus familiaris XP_547582.1 
 Equus callubus - 
 Homo sapiens CAG46982.1 
 Pan troglodytes - 
 Bos taurus DAA31829.1 
 Danio rerio - 
 Rattus norvegicus NP_446133.1 
 Mus musculus NP_035440.1 
 Monodelphis domestica XP_001372310.1 
 Oryctolagus cuniculus ENSOCUP00000007470 
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 Orthithorhynchus anatinus ENSOANP00000022311 
 Macropus eugenii - 
 Sus scrofa - 
 Gallus gallus - 
S100A4 Macaca mulatta XP_002801839.1 
 Canis lupus familiaris NP_001003161.1 
 Equus callubus XP_001494655.1 
 Homo sapiens CAG29341.1 
 Pan troglodytes XP_001138744.1 
 Bos taurus DAA31755.1 
 Danio rerio - 
 Rattus norvegicus NP_036750.1 
 Mus musculus NP_035441.1 
 Monodelphis domestica XP_001364907.1 
 Oryctolagus cuniculus ENSOCUP00000007467 
 Orthithorhynchus anatinus ENSOANP00000022310 
 Macropus eugenii ENSMEUP00000005804 
 Sus scrofa AET05830.1 
 Gallus gallus - 
S100A5 Macaca mulatta XP_001110702.2 
 Canis lupus familiaris XP_003639201.1 
 Equus callubus - 
 Homo sapiens CAI14753.1 
 Pan troglodytes XP_001138899.2 
 Bos taurus DAA31864.1 
 Danio rerio - 
 Rattus norvegicus NP_001099908.1 
 Mus musculus NP_035442.1 
 Monodelphis domestica - 
 Oryctolagus cuniculus ENSOCUP00000007465 
 Orthithorhynchus anatinus - 
 Macropus eugenii - 
 Sus scrofa - 
 Gallus gallus - 
S100A6 Macaca mulatta NP_001248728.1 
 Canis lupus familiaris XP_003434952.1 
 Equus callubus NP_001075310.1 
 Homo sapiens CAI14752.1 
 Pan troglodytes XP_001138809.2 
 Bos taurus DAA31882.1 
 Danio rerio - 
 Rattus norvegicus NP_445937.1 
 Mus musculus AAH03832.1 
 Monodelphis domestica XP_001372287.2 
 Oryctolagus cuniculus ENSOCUP00000017711 
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 Orthithorhynchus anatinus ENSOANP00000022308 
 Macropus eugenii - 
 Sus scrofa NP_001038022.1 
 Gallus gallus NP_989479.1 
S100A7 Macaca mulatta XP_001110603.1 
 Canis lupus familiaris - 
 Equus callubus NP_001075349.1 
 Homo sapiens CAG46961.1 
 Pan troglodytes XP_001138487.1 
 Bos taurus DAA31756.1 
 Danio rerio - 
 Rattus norvegicus - 
 Mus musculus - 
 Monodelphis domestica - 
 Oryctolagus cuniculus ENSOCUT00000007510 
 Orthithorhynchus anatinus - 
 Macropus eugenii - 
 Sus scrofa XP_003125797.3 
 Gallus gallus - 
S100A7-like 2 Homo sapiens NP_001038944.2 
 Pan troglodytes XP_524883.3 
S100A7a Homo sapiens NP_789793.1 
 Pan troglodytes XP_524882.3 
S100A8 Macaca mulatta NP_001253836.1 
 Canis lupus familiaris ACN71234.1 
 Equus callubus - 
 Homo sapiens CAG28602.1 
 Pan troglodytes XP_003308533.1 
 Bos taurus DAA31821.1 
 Danio rerio - 
 Rattus norvegicus NP_446274.2 
 Mus musculus NP_038678.1 
 Monodelphis domestica ENSMODP00000021721 
 Oryctolagus cuniculus - 
 Orthithorhynchus anatinus ENSOANP00000021636 
 Macropus eugenii - 
 Sus scrofa NP_001153743.1 
 Gallus gallus - 
S100A9 Macaca mulatta XP_001110367.1 
 Canis lupus familiaris XP_003434954.1 
 Equus callubus XP_001493535.2 
 Homo sapiens CAG47020.1 
 Pan troglodytes XP_003308531.1 
 Bos taurus DAA31802.1 
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 Danio rerio - 
 Rattus norvegicus NP_446039.1 
 Mus musculus CAC14292.1 
 Monodelphis domestica ENSMODP00000021730 
 Oryctolagus cuniculus - 
 Orthithorhynchus anatinus - 
 Macropus eugenii - 
 Sus scrofa ACG60601.1 
 Gallus gallus - 
S100A10 Macaca mulatta AFI35187.1 
 Canis lupus familiaris XP_003432305.1 
 Equus callubus NP_001157339.1 
 Homo sapiens CAG46959.1 
 Pan troglodytes XP_513807.3 
 Bos taurus DAA31646.1 
 Danio rerio - 
 Rattus norvegicus NP_112376.1 
 Mus musculus NP_033138.1 
 Monodelphis domestica ENSMODP00000037593 
 Oryctolagus cuniculus - 
 Orthithorhynchus anatinus - 
 Macropus eugenii - 
 Sus scrofa XP_003125806.1 
 Gallus gallus NP_990837.1 
S100A11 Macaca mulatta AFE66224.1 
 Canis lupus familiaris XP_533061.1 
 Equus callubus XP_001493486.1 
 Homo sapiens NP_005611.1 
 Pan troglodytes XP_003308442.1 
 Bos taurus AAI42379.1 
 Danio rerio - 
 Rattus norvegicus NP_001004095.1 
 Mus musculus NP_058020.1 
 Monodelphis domestica XP_001366952.1 
 Oryctolagus cuniculus - 
 Orthithorhynchus anatinus ENSOANP00000015386 
 Macropus eugenii - 
 Sus scrofa NP_001004045.1 
 Gallus gallus NP_990497.1 
S100A12 Macaca mulatta - 
 Canis lupus familiaris XP_003434953.1 
 Equus callubus XP_001494448.1 
 Homo sapiens NP_005612.1 
 Pan troglodytes XP_525220.2 
 Bos taurus DAA31757.1 
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 Danio rerio - 
 Rattus norvegicus - 
 Mus musculus - 
 Monodelphis domestica - 
 Oryctolagus cuniculus - 
 Orthithorhynchus anatinus - 
 Macropus eugenii - 
 Sus scrofa NP_001153744.1 
 Gallus gallus - 
S100A13 Macaca mulatta AFI35091.1 
 Canis lupus familiaris XP_003434951.1 
 Equus callubus XP_001494839.1 
 Homo sapiens CAG46946.1 
 Pan troglodytes XP_003308542.1 
 Bos taurus DAA31762.1 
 Danio rerio - 
 Rattus norvegicus NP_001178536.1 
 Mus musculus NP_033139.2 
 Monodelphis domestica XP_001364977.1 
 Oryctolagus cuniculus ENSOCUP00000002383 
 Orthithorhynchus anatinus ENSOANP00000004253 
 Macropus eugenii ENSMEUP00000009342 
 Sus scrofa XP_428126.3 
 Gallus gallus XP_428126.3 
S100A14 Macaca mulatta - 
 Canis lupus familiaris XP_855157.1 
 Equus callubus XP_001915963.1 
 Homo sapiens NP_065723.1 
 Pan troglodytes XP_001139808.1 
 Bos taurus DAA31824.1 
 Danio rerio - 
 Rattus norvegicus XP_001063574.2 
 Mus musculus NP_001156997.1 
 Monodelphis domestica XP_001372383.1 
 Oryctolagus cuniculus ENSOCUP00000002376 
 Orthithorhynchus anatinus - 
 Macropus eugenii ENSMEUP00000009337 
 Sus scrofa NP_001177097.1 
 Gallus gallus - 
S100A15 Macaca mulatta ENSMMUP00000006419 
 Canis lupus familiaris ENSCAFP00000025870 
 Equus callubus ENSECAP00000006794 
 Homo sapiens - 
 Pan troglodytes - 
 Bos taurus XP_001254067.1 
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 Danio rerio - 
 Rattus norvegicus NP_001102941.1 
 Mus musculus NP_955454.1 
 Monodelphis domestica XP_001372172.1 
 Oryctolagus cuniculus ENSOCUT00000028533 
 Orthithorhynchus anatinus XP_001518033.1 
 Macropus eugenii Ensembl scaffold:Meug_1.0:Scaffold42740 
 Sus scrofa ENSSSCP00000007026 
 Gallus gallus - 
S100A16 Macaca mulatta AFI35788.1 
 Canis lupus familiaris XP_547580.1 
 Equus callubus XP_001494817.1 
 Homo sapiens CAE51865.1 
 Pan troglodytes XP_003308544.1 
 Bos taurus DAA31771.1 
 Danio rerio - 
 Rattus norvegicus AAI58599.1 
 Mus musculus NP_080692.1 
 Monodelphis domestica XP_001372337.1 
 Oryctolagus cuniculus - 
 Orthithorhynchus anatinus - 
 Macropus eugenii - 
 Sus scrofa NP_001177137.1 
 Gallus gallus - 
S100A17 (TCHH) Macaca mulatta - 
 Canis lupus familiaris - 
 Equus callubus - 
 Homo sapiens ENSP00000357796 
 Pan troglodytes - 
 Bos taurus ENSBTAP00000021074 
 Danio rerio - 
 Rattus norvegicus - 
 Mus musculus ENSMUSP00000029516 
 Monodelphis domestica ENSMODP00000023663 
 Oryctolagus cuniculus - 
 Orthithorhynchus anatinus - 
 Macropus eugenii ENSMEUP00000013834 
 Sus scrofa - 
 Gallus gallus - 
S100A18 (HRNR) Macaca mulatta - 
 Canis lupus familiaris - 
 Equus callubus - 
 Homo sapiens NP_001009931.1 
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 Pan troglodytes - 
 Bos taurus - 
 Danio rerio - 
 Rattus norvegicus - 
 Mus musculus NP_598459.2 
 Monodelphis domestica - 
 Oryctolagus cuniculus - 
 Orthithorhynchus anatinus - 
 Macropus eugenii - 
 Sus scrofa - 
 Gallus gallus - 
S100A19 Macropus eugenii Scaffold63159: 10,413-14,571 
 Monodelphis domestica XP_001372238.1 
 Orthithorhynchus anatinus XP_001520422.1 
S100B Macaca mulatta AFJ71224.1 
 Canis lupus familiaris XP_548737.3 
 Equus callubus XP_001487942.3 
 Homo sapiens CAG46920.1 
 Pan troglodytes XP_003319181.1 
 Bos taurus ABA39829.1 
 Danio rerio - 
 Rattus norvegicus AAH87026.1 
 Mus musculus NP_033141.1 
 Monodelphis domestica - 
 Oryctolagus cuniculus - 
 Orthithorhynchus anatinus ENSOANP00000021370 
 Macropus eugenii - 
 Sus scrofa XP_003362027.1 
 Gallus gallus XP_001233035.1 
S100P Macaca mulatta ENSMMUP00000028820 
 Canis lupus familiaris XP_852856.2 
 Equus callubus - 
 Homo sapiens NP_005971.1 
 Pan troglodytes XP_001156309.1 
 Bos taurus - 
 Danio rerio - 
 Rattus norvegicus - 
 Mus musculus - 
 Monodelphis domestica ENSMODP00000003527 
 Oryctolagus cuniculus - 
 Orthithorhynchus anatinus - 
 Macropus eugenii - 
 Sus scrofa - 
 Gallus gallus - 
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S100G Macaca mulatta XP_001102900.1 
 Canis lupus familiaris XP_849066.1 
 Equus callubus NP_001075359.1 
 Homo sapiens EAW98916.1 
 Pan troglodytes XP_001139782.1 
 Bos taurus DAA12577.1 
 Danio rerio - 
 Rattus norvegicus NP_036653.1 
 Mus musculus NP_033919.1 
 Monodelphis domestica ENSMODP00000021433 
 Oryctolagus cuniculus - 
 Orthithorhynchus anatinus - 
 Macropus eugenii - 
 Sus scrofa - 
 Gallus gallus NP_999305.1 
S100Z Macaca mulatta - 
 Canis lupus familiaris XP_853219.2 
 Equus callubus XP_001504000.2 
 Homo sapiens NP_570128.2 
 Pan troglodytes XP_526887.2 
 Bos taurus DAA25903.1 
 Danio rerio NP_001019562.1 
 Rattus norvegicus NP_001178630.1 
 Mus musculus NP_001074628.1 
 Monodelphis domestica XP_001367941.1 
 Oryctolagus cuniculus - 
 Orthithorhynchus anatinus XP_001513822.1 
 Macropus eugenii ENSMEUP00000005046 
 Sus scrofa XP_003123762.1 
 Gallus gallus XP_429152.2 
GBA Macaca mulatta - 
 Canis lupus familiaris - 
 Equus callubus ENSECAP00000020319 
 Homo sapiens ENSP00000445560 
 Pan troglodytes ENSPTRP00000051730 
 Bos taurus ENSBTAP00000019765 
 Danio rerio - 
 Rattus norvegicus - 
 Mus musculus ENSMUSP00000130660 
 Monodelphis domestica ENSMODP00000033884 
 Oryctolagus cuniculus - 
 Orthithorhynchus anatinus - 
 Macropus eugenii - 
 Sus scrofa ENSSSCP00000006950 
 Gallus gallus - 
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Appendix 2: Genes used in S100A7/A15/A19 tree (Figure 2.2), correct as of October 2012. 
Gene Species Genbank Assession/Ensembl id/Ensembl location 
S100A1 (root) Homo sapiens ENST00000292169 
S100A7 Macaca mulatta ENSMMUT00000006827 
 Homo sapiens NM_002963.3 
 Pan troglodytes XM_524884.2 
 Bos taurus NM_174596.2 
 Equus callubus ENSECAT00000008848 
 Canis lupus familiaris - 
 Rattus norvegicus - 
 Mus musculus - 
 Monodelphis domestica - 
 Oryctolagus cuniculus ENSOCUT00000007510 
 Orthithorhynchus anatinus - 
 Macropus eugenii - 
 Sus scrofa XM_003125749.3 
S100A7a Homo sapiens ENST00000329256 
 Pan troglodytes XM_524882.3 
S100A7L1 Macaca mulatta ENSMMUT00000006828 
S100A7L2 Macaca mulatta ENSMMUT00000006829 
 Pan troglodytes XM_524883.3 
 Homo sapiens NM_001045479.1 
S100A7-like Bos taurus ENSBTAT00000046857 
S100A15 Macaca mulatta ENSMMUT00000006826 
 Homo sapiens - 
 Pan troglodytes - 
 Bos taurus XM_002686003.1 
 Equus callubus ENSECAT00000008996 
 Canis lupus familiaris ENSCAFT00000027820 
 Rattus norvegicus NM_001109471.1 
 Mus musculus NM_199422.1 
 Monodelphis domestica XM_001372135.1 
 Oryctolagus cuniculus ENSOCUT00000028533 
 Orthithorhynchus anatinus NW_001744319.1 
 Macropus eugenii Ensembl scaffold:Meug_1.0:Scaffold42740  
 Sus scrofa ENSSSCT00000007220 
Psuedo-S100A15 Homo sapiens ENST00000421658 
S100A19 Orthithorhynchus anatinus NW_001750754.1 
 Macropus eugenii Ensembl Scaffold63159: 10,413-14,571  
 Monodelphis domestica NC_008802.1 
 
